LADDER CAPITAL CORP, 10-Q filed on 10/27/2025
Quarterly Report
v3.25.3
Cover Page - shares
9 Months Ended
Sep. 30, 2025
Oct. 17, 2025
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2025  
Document Transition Report false  
Entity File Number 001-36299  
Entity Registrant Name Ladder Capital Corp  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 80-0925494  
Entity Address, Address Line One 320 Park Avenue,  
Entity Address, City or Town New York,  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10022  
City Area Code 212  
Local Phone Number 715-3170  
Title of 12(b) Security Class A common stock, $0.001 par value  
Trading Symbol LADR  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Smaller Reporting Company false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Central Index Key 0001577670  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus (i.e. Q1,Q2,Q3,FY) Q3  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Class A Common Stock    
Entity Common Stock, Shares Outstanding   127,321,390
Class B Common Stock    
Entity Common Stock, Shares Outstanding   0
v3.25.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
[1]
Assets    
Cash and cash equivalents $ 49,434 $ 1,323,481
Restricted cash 13,476 12,608
Mortgage loan receivables held for investment, net, at amortized cost:    
Mortgage loans receivable 1,920,588 1,591,322
Allowance for credit losses (52,135) (52,323)
Mortgage loan receivables held for sale 27,970 26,898
Securities 1,940,547 1,080,839
Real estate and related lease intangibles, net 705,511 670,803
Investments in and advances to unconsolidated ventures 18,489 19,923
Derivative instruments 284 437
Accrued interest receivable 14,485 12,936
Other assets 47,895 158,149
Total assets 4,686,544 4,845,073
Liabilities    
Debt obligations, net 2,997,232 3,135,617
Dividends payable 31,357 31,838
Accrued expenses 55,446 74,824
Other liabilities 109,095 69,855
Total liabilities 3,193,130 3,312,134
Commitments and contingencies (refer to Note 16) 0 0
Equity    
Additional paid-in capital 1,784,005 1,777,118
Treasury stock, 3,469,201 and 2,776,538 shares, at cost (38,128) (30,475)
Retained earnings (dividends in excess of earnings) (246,686) (206,874)
Accumulated other comprehensive income (loss) (3,339) (4,866)
Total shareholders’ equity 1,495,979 1,535,030
Noncontrolling interests in consolidated ventures (2,565) (2,091)
Total equity 1,493,414 1,532,939
Total liabilities and equity 4,686,544 4,845,073
Class A Common Stock    
Equity    
Class A common stock, par value $0.001 per share, 600,000,000 shares authorized; 130,790,591 and 129,883,019 shares issued and 127,321,390 and 127,106,481 shares outstanding as of September 30, 2025 and December 31, 2024, respectively. $ 127 $ 127
[1] Includes amounts relating to consolidated variable interest entities. Refer to Note 2 and Note 6.
v3.25.3
Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2025
Dec. 31, 2024
Treasury stock (in shares) 3,469,201 2,776,538
Class A Common Stock    
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, authorized (in shares) 600,000,000 600,000,000
Common stock, issued (in shares) 130,790,591 129,883,019
Common stock, outstanding (in shares) 127,321,390 127,106,481
v3.25.3
Consolidated Statements of Income - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Net interest income        
Interest income $ 71,768 $ 96,092 $ 198,829 $ 280,520
Interest expense 43,978 57,676 129,180 170,647
Net interest income (expense) 27,790 38,416 69,649 109,873
Provision for (release of) loan loss reserves, net (31) 3,063 (154) 13,886
Net interest income (expense) after provision for (release of) loan loss reserves 27,821 35,353 69,803 95,987
Other income (loss)        
Real estate operating income 26,666 25,294 74,214 75,314
Net result from mortgage loan receivables held for sale (377) 1,092 4,700 638
Gain (loss) on real estate, net 0 315 3,807 12,858
Fee and other income 3,864 6,609 11,952 13,947
Net result from derivative transactions 21 (766) 1,870 3,871
Earnings (loss) from investment in unconsolidated ventures (414) (14) (1,434) (11)
Gain on extinguishment of debt (106) 20 151 197
Total other income (loss) 29,654 32,550 95,260 106,814
Costs and expenses        
Compensation and employee benefits 11,552 14,407 41,874 48,917
Operating expenses 5,276 4,508 14,559 14,331
Real estate operating expenses 11,424 10,751 30,456 30,930
Investment related expenses 855 1,628 2,887 5,909
Depreciation and amortization 8,238 8,146 23,617 24,861
Total costs and expenses 37,345 39,440 113,393 124,948
Income (loss) before taxes 20,130 28,463 51,670 77,853
Income tax expense (benefit) 960 901 3,836 1,737
Net income (loss) 19,170 27,562 47,834 76,116
Net (income) loss attributable to noncontrolling interests in consolidated ventures $ 19 $ 351 $ 459 $ 753
Earnings per share:        
Basic (in dollars per share) $ 0.15 $ 0.22 $ 0.38 $ 0.61
Diluted (in dollars per share) $ 0.15 $ 0.22 $ 0.38 $ 0.61
Weighted average shares outstanding:        
Basic (in shares) 125,339,188 125,705,754   125,586,075
Diluted (in shares) 126,115,547 125,905,528   125,757,114
Class A Common Stock        
Costs and expenses        
Net income (loss) attributable to Class A common shareholders $ 19,189 $ 27,913 $ 48,293 $ 76,869
Earnings per share:        
Basic (in dollars per share) $ 0.15 $ 0.22 $ 0.38 $ 0.61
Diluted (in dollars per share) $ 0.15 $ 0.22 $ 0.38 $ 0.61
Weighted average shares outstanding:        
Basic (in shares) 125,339,188 125,705,754 125,587,121 125,586,075
Diluted (in shares) 126,115,547 125,905,528 126,198,822 125,757,114
v3.25.3
Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Net income (loss) $ 19,170 $ 27,562 $ 47,834 $ 76,116
Gain (loss) on available for sale securities, net of tax:        
Unrealized gain (loss) on securities, available for sale 4,131 2,041 3,570 5,165
Reclassification adjustment for (gain) loss included in net income (loss) (1,831) 0 (2,043) (23)
Total other comprehensive income (loss) 2,300 2,041 1,527 5,142
Comprehensive income (loss) 21,470 29,603 49,361 81,258
Comprehensive (income) loss attributable to noncontrolling interest in consolidated ventures 19 351 459 753
Class A Common Stock        
Gain (loss) on available for sale securities, net of tax:        
Comprehensive income (loss) attributable to Class A common shareholders $ 21,489 $ 29,954 $ 49,820 $ 82,011
v3.25.3
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Class A Common Stock
Class A Common Stock
Additional Paid- in-Capital
Treasury Stock
Retained Earnings (Dividends in Excess of Earnings)
Accumulated Other Comprehensive Income (Loss)
Consolidated Ventures
Beginning Balance (in shares) at Dec. 31, 2023     126,912,000          
Beginning Balance at Dec. 31, 2023 $ 1,532,198   $ 127 $ 1,756,750 $ (12,001) $ (197,875) $ (13,853) $ (950)
Increase Decrease in Stockholders' Equity                
Distributions (224)             (224)
Amortization of equity based compensation 16,592     16,592        
Grants of restricted stock (in shares)     1,856,000          
Grants of restricted stock 2   $ 2          
Purchase of treasury stock (in shares)     (180,000)          
Purchase of treasury stock (2,049)       (2,049)      
Shares acquired to satisfy minimum required federal and state tax withholding on vesting restricted stock (in shares)     (812,000)          
Shares acquired to satisfy minimum required federal and state tax withholding on vesting restricted stock (8,894)   $ (1)   (8,893)      
Forfeitures (in shares)     (11,000)          
Forfeitures 0     110 (110)      
Dividends declared (88,191)         (88,191)    
Net income (loss) 76,116         76,869   (753)
Other comprehensive income (loss) 5,142           5,142  
Ending Balance (in shares) at Sep. 30, 2024     127,765,000          
Ending Balance at Sep. 30, 2024 1,530,692   $ 128 1,773,452 (23,053) (209,197) (8,711) (1,927)
Beginning Balance (in shares) at Jun. 30, 2024     127,866,000          
Beginning Balance at Jun. 30, 2024 1,528,495   $ 128 1,770,275 (21,852) (207,728) (10,752) (1,576)
Increase Decrease in Stockholders' Equity                
Amortization of equity based compensation 3,177     3,177        
Grants of restricted stock 0              
Purchase of treasury stock (in shares)     (100,000)          
Purchase of treasury stock (1,191)       (1,191)      
Shares acquired to satisfy minimum required federal and state tax withholding on vesting restricted stock (in shares)     (1,000)          
Shares acquired to satisfy minimum required federal and state tax withholding on vesting restricted stock (10)       (10)      
Dividends declared (29,382)         (29,382)    
Net income (loss) 27,562         27,913   (351)
Other comprehensive income (loss) 2,041           2,041  
Ending Balance (in shares) at Sep. 30, 2024     127,765,000          
Ending Balance at Sep. 30, 2024 1,530,692   $ 128 1,773,452 (23,053) (209,197) (8,711) (1,927)
Beginning Balance (in shares) at Dec. 31, 2024   127,106,481 127,106,000          
Beginning Balance at Dec. 31, 2024 1,532,939 [1]   $ 127 1,777,118 (30,475) (206,874) (4,866) (2,091)
Increase Decrease in Stockholders' Equity                
Distributions (15)             (15)
Amortization of equity based compensation 17,260     17,260        
Grants of restricted stock (in shares)     1,852,000          
Grants of restricted stock 2   $ 2 (10,373) 10,373      
Purchase of treasury stock (in shares)     (877,000)          
Purchase of treasury stock (9,311)   $ (1)   (9,310)      
Shares acquired to satisfy minimum required federal and state tax withholding on vesting restricted stock (in shares)     (760,000)          
Shares acquired to satisfy minimum required federal and state tax withholding on vesting restricted stock (8,717)   $ (1)   (8,716)      
Dividends declared (88,105)         (88,105)    
Net income (loss) 47,834         48,293   (459)
Other comprehensive income (loss) 1,527           1,527  
Ending Balance (in shares) at Sep. 30, 2025   127,321,390 127,321,000          
Ending Balance at Sep. 30, 2025 1,493,414   $ 127 1,784,005 (38,128) (246,686) (3,339) (2,565)
Beginning Balance (in shares) at Jun. 30, 2025     127,461,000          
Beginning Balance at Jun. 30, 2025 1,500,070   $ 127 1,781,307 (36,584) (236,595) (5,639) (2,546)
Increase Decrease in Stockholders' Equity                
Amortization of equity based compensation 3,049     3,049        
Grants of restricted stock (in shares)     32,000          
Grants of restricted stock 0   $ 0 (351) 351      
Purchase of treasury stock (in shares)     (171,000)          
Purchase of treasury stock (1,885)       (1,885)      
Shares acquired to satisfy minimum required federal and state tax withholding on vesting restricted stock (in shares)     (1,000)          
Shares acquired to satisfy minimum required federal and state tax withholding on vesting restricted stock (10)   $ 0   (10)      
Dividends declared (29,280)         (29,280)    
Net income (loss) 19,170         19,189   (19)
Other comprehensive income (loss) 2,300           2,300  
Ending Balance (in shares) at Sep. 30, 2025   127,321,390 127,321,000          
Ending Balance at Sep. 30, 2025 $ 1,493,414   $ 127 $ 1,784,005 $ (38,128) $ (246,686) $ (3,339) $ (2,565)
[1] Includes amounts relating to consolidated variable interest entities. Refer to Note 2 and Note 6.
v3.25.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income (loss) $ 47,834 $ 76,116
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
(Gain) loss on extinguishment of debt (151) (197)
Depreciation and amortization 23,617 24,861
Unrealized (gain) loss on derivative instruments 174 1,552
Unrealized (gain) loss on securities (613) 0
Provision for (release of) loan loss reserves, net (154) 13,886
Amortization of equity based compensation 17,260 16,592
Amortization of deferred financing costs included in interest expense 7,263 8,203
Amortization of (premium)/discount on mortgage loan financing included in interest expense (493) (558)
Amortization of above- and below-market lease intangibles (1,067) (1,287)
(Accretion)/amortization of discount, premium and other fees on mortgage loans receivable (7,742) (10,935)
(Accretion)/amortization of discount and premium on securities (1,213) (724)
Net result from mortgage loan receivables held for sale (4,700) (638)
Realized (gain) loss on securities (3,061) (75)
(Gain) loss on real estate, net (3,807) (12,858)
Realized (gain) loss on sale of derivative instruments 0 (290)
(Earnings) loss from investments in unconsolidated ventures in excess of distributions received 1,434 11
Origination of mortgage loan receivables held for sale (63,360) 0
Repayment of mortgage loan receivables held for sale 140 0
Proceeds from sales of mortgage loan receivables held for sale 66,847 0
Change in deferred tax liability 1,655 565
Changes in operating assets and liabilities:    
Accrued interest receivable (1,549) 7,530
Other assets (1,594) 2,928
Accrued expenses and other liabilities (35,064) 69,360
Net cash provided by (used in) operating activities 41,656 194,042
Cash flows from investing activities:    
Origination and funding of mortgage loan receivables held for investment (888,703) (71,810)
Repayment of mortgage loan receivables held for investment 604,058 1,122,690
Purchases of securities (1,480,218) (583,018)
Repayment of securities 364,848 208,414
Basis recovery of interest-only securities 1,501 2,589
Proceeds from sales of securities 316,730 10,581
Capital improvements of real estate (1,986) (4,846)
Proceeds from sale of real estate 13,079 57,645
Capital contributions and advances to investment in unconsolidated joint ventures 0 (13,125)
Proceeds from FHLB stock 0 5,175
Purchase of derivative instruments (76) (1,164)
Sale of derivative instruments 0 539
Net cash provided by (used in) investing activities (1,070,767) 733,670
Cash flows from financing activities:    
Deferred financing costs paid (11,099) (9,567)
Proceeds from borrowings under debt obligations 2,355,726 654,705
Repayment and repurchase of borrowings under debt obligations (2,490,852) (849,600)
Cash dividends paid to Class A common shareholders (88,586) (88,813)
Capital distributed to noncontrolling interests in consolidated ventures (15) (223)
Payment of liability assumed in exchange for shares for the minimum withholding taxes on vesting restricted stock (8,717) (8,894)
Repurchase of treasury stock (10,475) (2,049)
Net cash provided by (used in) financing activities (254,018) (304,441)
Net increase (decrease) in cash, cash equivalents and restricted cash (1,283,129) 623,271
Cash, cash equivalents and restricted cash at beginning of period 1,346,039 1,075,942
Cash, cash equivalents and restricted cash at end of period 62,910 1,699,213
Non-cash investing and financing activities:    
Securities purchased, not settled 56,858 0
Repurchase of treasury stock, not settled 350 0
Repayments in transit of securities (other assets) 522 0
Repayment in transit of mortgage loans receivable held for investment (other assets) (125) (27,519)
Non-cash disposition of loans via foreclosure (65,078) (55,946)
Real estate and real estate held for sale acquired in settlement of mortgage loans receivable held for investment, net 65,078 48,796
Transfer of real estate, net into real estate held for sale 0 18,078
Dividends declared, not paid $ 31,357 $ 31,673
v3.25.3
Consolidated Statements of Cash Flows - Additional Information - USD ($)
$ in Thousands
Sep. 30, 2025
Sep. 30, 2024
Statement of Cash Flows [Abstract]    
Cash and cash equivalents $ 49,434 $ 1,607,204
Restricted cash 13,476 12,301
Short-term unsettled U.S. Treasury securities classified in other assets on the consolidated balance sheet 0 79,708
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows $ 62,910 $ 1,699,213
v3.25.3
ORGANIZATION AND OPERATIONS
9 Months Ended
Sep. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND OPERATIONS
1. ORGANIZATION AND OPERATIONS
 
Ladder Capital Corp (“Ladder,” “Ladder Capital,” and the “Company”) is an investment grade-rated, internally-managed U.S. real estate investment trust (“REIT”) that is a leader in commercial real estate finance. The Company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The Company’s investment activities include: (i) the Company’s primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment grade securities secured by first mortgage loans on commercial real estate. Ladder Capital Corp, as the general partner of Ladder Capital Finance Holdings LLLP (“LCFH”), operates the Ladder Capital business through LCFH and its subsidiaries. As of September 30, 2025, Ladder Capital Corp has a 100% economic interest in LCFH and controls the management of LCFH as a result of its ability to appoint its board members. Accordingly, Ladder Capital Corp consolidates the financial results of LCFH and its subsidiaries. In addition, Ladder Capital Corp, through certain subsidiaries, which are treated as taxable REIT subsidiaries (each a “TRS”), is indirectly subject to U.S. federal, state and local income taxes. Other than such indirect U.S. federal, state and local income taxes, there are no material differences between Ladder Capital Corp’s consolidated financial statements and LCFH’s consolidated financial statements.

Ladder Capital Corp was formed as a Delaware corporation on May 21, 2013. The Company conducted its initial public offering (“IPO”) which closed on February 11, 2014. The Company used the net proceeds from the IPO to purchase newly-issued limited partnership units (“LP Units”) from LCFH. In connection with the IPO, Ladder Capital Corp also became a holding corporation and the general partner of, and obtained a controlling interest in, LCFH. Ladder Capital Corp’s only business is to act as the general partner of LCFH, and, as such, Ladder Capital Corp indirectly operates and controls all of the business and affairs of LCFH and its subsidiaries. The IPO transactions described herein are referred to as the “IPO Transactions.”
v3.25.3
SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES
2. SIGNIFICANT ACCOUNTING POLICIES
Basis of Accounting and Principles of Consolidation
The accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). In the opinion of management, the unaudited financial information for the interim periods presented in this report reflects all normal and recurring adjustments necessary for a fair statement of results of operations, financial position and cash flows. The interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2024, which are included in the Annual Report, as certain disclosures that would substantially duplicate those contained in the audited consolidated financial statements have not been included in this interim report. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year.
The consolidated financial statements include the Company’s accounts and those of its subsidiaries that are majority-owned and/or controlled by the Company and variable interest entities for which the Company has determined itself to be the primary beneficiary, if any. All significant intercompany transactions and balances have been eliminated.
 
Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810 — Consolidation (“ASC 810”), provides guidance on the identification of entities for which control is achieved through means other than voting rights (“variable interest entities” or “VIEs”) and the determination of which business enterprise, if any, should consolidate the VIEs. Generally, the consideration of whether an entity is a VIE applies when either: (1) the equity investors (if any) lack one or more of the essential characteristics of a controlling financial interest; (2) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support; or (3) the equity investors have voting rights that are not proportionate to their economic interests and the activities of the entity involve or are conducted on behalf of an investor with a disproportionately small voting interest. The Company consolidates VIEs in which it is considered to be the primary beneficiary. The primary beneficiary is the entity that has both of the following characteristics: (1) the power to direct the activities that, when taken together, most significantly impact the VIE’s performance; and (2) the obligation to absorb losses and right to receive the returns from the VIE that would be significant to the VIE. Refer to Note 6, Debt Obligations, Net, for further information.
The Company has investments in two unconsolidated ventures, which were determined to be VIEs. The Company determined that it was not the primary beneficiary of these VIEs because the Company does not have power over these entities and therefore does not have controlling financial interests in these VIEs. These investments are recorded on the consolidated balance sheets within investments in and advances to unconsolidated ventures. The Company’s maximum exposure to loss is limited to its investments in these VIEs. The Company has not provided financial support to these unconsolidated VIEs that it was not previously contractually required to provide.
Allowance for Loan Losses

The Company uses a current expected credit loss model (“CECL”) for estimating the provision for loan losses on its loan portfolio. The CECL model requires the consideration of possible credit losses over the life of an instrument and includes a portfolio-based component and an asset-specific component. The Company engages a third-party service provider to provide market data and a credit loss model. The credit loss model is a forward-looking, econometric, commercial real estate (“CRE”) loss forecasting tool. It is comprised of a probability of default (“PD”) model and a loss given default (“LGD”) model that, layered together with the Company’s loan-level data, fair value of collateral, net operating income of collateral, selected forward-looking macroeconomic variables, and pool-level mean loss rates, produces life of loan expected losses (“EL”) at the loan and portfolio level. Where management has determined that the credit loss model does not fully capture certain external factors, including portfolio trends or loan-specific factors, a qualitative adjustment to the reserve is recorded. In addition, interest receivable on loans is not included in the Company’s CECL calculations as the Company performs timely write offs of aged interest receivable. The Company has made a policy election to write off aged receivables through interest income as opposed to through the CECL provision on its statements of income.

Loans for which the borrower or sponsor is experiencing financial difficulty, and where repayment of the loan is expected substantially through the operation or sale of the underlying collateral, are considered collateral dependent loans. For collateral dependent loans, the Company may elect a practical expedient that allows the Company to measure expected losses based on the difference between the collateral’s fair value and the amortized cost basis of the loan. When the repayment or satisfaction of the loan is dependent on a sale, rather than operations of the collateral, the fair value is adjusted for the estimated costs to sell the collateral. If foreclosure is probable, the Company is required to measure for expected losses using this methodology.

The Company generally will use the direct capitalization rate valuation methodology or the sales comparison approach to estimate the fair value of the collateral for loans and in certain cases will obtain external appraisals. Determining fair value of the collateral may take into account a number of assumptions including, but not limited to, cash flow projections, market capitalization rates, discount rates and data regarding recent comparable sales of similar properties. Such assumptions are generally based on current market conditions and are subject to economic and market uncertainties.

The Company’s loans are typically collateralized by real estate directly or indirectly. As a result, the Company regularly evaluates the extent and impact of any credit deterioration associated with the performance and/or value of the underlying collateral property as well as the financial and operating capability of the borrower/sponsor on a loan-by-loan basis. Specifically, a property’s operating results and any cash reserves are analyzed and used to assess: (i) whether cash flow from operations is sufficient to cover the debt service requirements currently and into the future; (ii) the ability of the borrower to refinance the loan at maturity; and/or (iii) the property’s liquidation value. The Company also evaluates the financial wherewithal of any loan guarantors as well as the borrower’s competency in managing and operating the properties. In addition, the Company considers the overall economic environment, real estate sector, and geographic submarket in which the collateral property is located. Such impairment analyses are completed and reviewed by asset management and underwriting personnel, who utilize various data sources, including: (i) periodic financial data such as property occupancy, tenant profile, rental rates, operating expenses, the borrowers’ business plan, and capitalization and discount rates; (ii) site inspections; and (iii) current credit spreads and other market data and ultimately presented to management for approval.

When a debtor is experiencing financial difficulties and a loan is modified, the effect of the modification will be included in the Company’s assessment of the CECL allowance for loan losses. If the Company provides principal forgiveness, the amortized cost basis of the loan is written off against the allowance for loan losses. Generally, when modifying loans, the Company will seek to protect its position by requiring incremental pay downs, additional collateral or guarantees and, in some cases, lookback features or equity interests to offset concessions granted should conditions impacting the loan improve.

The Company designates a loan as a non-accrual loan generally when: (i) the principal or coupon interest components of loan payments become 90-days past due; or (ii) in the opinion of the Company, recovery of principal and coupon interest is doubtful. Interest income on non-accrual loans in which the Company reasonably expects a recovery of the loan’s outstanding principal balance is recognized when received in cash. Otherwise, income recognition will be suspended and any cash received will be applied as a reduction to the amortized cost basis. A non-accrual loan is returned to accrual status at such time as the loan
becomes contractually current and future principal and coupon interest are reasonably assured to be received. A loan will be charged-off when management has determined principal and coupon interest is no longer realizable and deemed non-recoverable.
Transfers of Financial Assets

For a transfer of financial assets to be considered a sale, the transfer must meet the sale criteria of ASC 860, which, at the time of the transfer, require that the transferred assets qualify as recognized financial assets and the Company surrender control over the assets. Such surrender requires that the assets be isolated from the Company, even in bankruptcy or other receivership, the purchaser have the right to pledge or sell the assets transferred and the Company not have an option or obligation to reacquire the assets. If the sale criteria are not met, the transfer is considered to be a secured borrowing, the assets remain on the Company’s consolidated balance sheets and the sale proceeds are recognized as a liability. In November 2017, the SEC staff indicated that, despite transfer restrictions placed on qualified Third Party Purchasers by the risk retention rules of the Dodd-Frank Act, they would not take exception to a registrant treating transfers of financial instruments in a securitization as sales if the transfers otherwise met all the criteria for sale accounting. The Company believes treatment of such transfers as sales is consistent with the substance of such transactions and, accordingly, reflects such transfers as sales. The Company recognizes gains on sale of loans net of any costs related to that sale.
Debt Issued

From time to time, a subsidiary of the Company will originate a loan (each, an “inter-segment loan,” and collectively, “inter-segment loans”) to another subsidiary of the Company to finance the purchase of real estate. The mortgage loan receivable and the related obligation do not appear in the Company’s consolidated balance sheets as they are eliminated upon consolidation. Once the Company issues (sells) an inter-segment loan to a third-party securitization trust (for cash), the related mortgage note is recognized as a financing transaction and accounted for under ASC 470. The accounting for the securitization of an inter-segment loan—a financial instrument that has never been recognized in the consolidated financial statements as an asset—is considered a financing transaction under ASC 470 and ASC 835.

The periodic securitization of the Company’s mortgage loans involves both inter-segment loans and mortgage loans made to third parties with the latter recognized as financial assets in the Company’s consolidated financial statements as part of an integrated transaction. The Company receives aggregate proceeds equal to the transaction’s all-in securitization value and sales price. In accordance with the guidance under ASC 835, when initially measuring the obligation arising from an inter-segment loan’s securitization, the Company allocates the proceeds from each securitization transaction between the third-party loans and each inter-segment loan securitized on a relative fair value basis determined in accordance with the guidance in ASC 820. The difference between the amount allocated to each inter-segment loan and the loan’s face amount is recorded as a premium or discount, and is amortized, using the effective interest method, as a reduction or increase in reported interest expense, respectively.
Reclassification

Certain other prior period amounts have been reclassified to conform to the current period's presentation.
Recently Adopted Accounting Pronouncements

In November 2023, the FASB issued ASU 2023-07—Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied retrospectively to all prior periods presented in the financial statements. Upon transition, the segment expense categories and amounts disclosed in the prior periods should be based on the significant segment expense categories identified and disclosed in the period of adoption. The Company adopted ASU 2023-07 during the fourth quarter of 2024 and the adoption of ASU 2023-07 did not have a material impact on the Company’s consolidated financial statements.
Recent Accounting Pronouncements Pending Adoption

In December 2023, the FASB issued ASU 2023-09—Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 improves the transparency of income tax disclosures related to rate reconciliation and income taxes. ASU 2023-07 is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The amendments should be applied prospectively, however retrospective application is permitted. The adoption of ASU 2023-09 is not expected to have a material impact on the Company’s consolidated financial statements.

In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses (“DISE”). DISE requires disaggregated disclosure of income statement expenses for public business entities. ASU 2024-03 does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. As revised by ASU No. 2025-01, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures, the provisions of ASU 2024-03 are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. With the exception of expanding disclosures to include more granular income statement expense categories, we do not expect the adoption of ASU 2024-03 to have a material effect on our consolidated financial statements.

Any new accounting standards not disclosed above that have been issued or proposed by FASB and that do not require adoption until a future date are being evaluated or are not expected to have a material impact on the consolidated financial statements upon adoption.
v3.25.3
MORTGAGE LOAN RECEIVABLES
9 Months Ended
Sep. 30, 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]  
MORTGAGE LOAN RECEIVABLES
3. MORTGAGE LOAN RECEIVABLES

September 30, 2025 ($ in thousands)
Outstanding
Face Amount
Carrying
Value
Weighted
Average
Yield (1)(2)
Remaining
Maturity
(years)(2)(3)
Mortgage loan receivables held for investment, net, at amortized cost:
First mortgage loans$1,923,888 $1,913,275 8.14 %1.5
Mezzanine loans7,322 7,313 11.24 %0.8
Total mortgage loans receivable1,931,210 1,920,588 8.16 %1.5
Allowance for credit losses N/A (52,135)
Total mortgage loan receivables held for investment, net, at amortized cost1,931,210 1,868,453 
Mortgage loan receivables held for sale:
First mortgage loans31,350 27,970 (4)4.57 %6.4
Total$1,962,560 $1,896,423 (5)8.10 %1.6
(1)Includes the impact of interest rate floors. Term SOFR rates in effect as of September 30, 2025 are used to calculate weighted average yield for floating rate loans.
(2)Excludes three non-accrual loans with an amortized cost basis of $122.9 million. Refer to “Non-Accrual Status” below for further details.
(3)The remaining maturity is calculated based on the initial maturity. The weighted average extended maturity for all loans is 2.7 years.
(4)As a result of changes in prevailing rates, the Company recorded a lower of cost or market adjustment as of September 30, 2025. The adjustment was calculated using a 5.03% discount rate.
(5)Net of $10.8 million of deferred origination fees and other items as of September 30, 2025.

As of September 30, 2025, $1.6 billion, or 84.4%, of the outstanding face amount of the mortgage loan receivables held for investment, net, at amortized cost, were at variable interest rates linked to Term SOFR. Of this $1.6 billion, 100% of these variable interest rate mortgage loan receivables were subject to interest rate floors. As of September 30, 2025, $31.4 million, or 100%, of the outstanding face amount of the mortgage loan receivables held for sale were at fixed interest rates.

December 31, 2024 ($ in thousands)
Outstanding
Face Amount
Carrying
Value
Weighted
Average
Yield (1)(2)
Remaining
Maturity
(years)(2)(3)
Mortgage loan receivables held for investment, net, at amortized cost:
First mortgage loans$1,584,674 $1,579,740 9.34 %0.9
Mezzanine loans11,603 11,582 11.51 %1.1
Total mortgage loans receivable1,596,277 1,591,322 9.36 %0.9
Allowance for credit losses— (52,323)
Total mortgage loan receivables held for investment, net, at amortized cost1,596,277 1,538,999 
Mortgage loan receivables held for sale:
First mortgage loans31,350 26,898 (4)4.57 %7.2
Total$1,627,627 $1,565,897 (5)9.27 %1.0
(1)Includes the impact of interest rate floors. Term SOFR rates in effect as of December 31, 2024 are used to calculate weighted average yield for floating rate loans.
(2)Excludes two non-accrual loans with an amortized cost basis of $76.9 million. Refer to “Non-Accrual Status” below for further details.
(3)The remaining maturity is calculated based on the initial maturity. The weighted average extended maturity for all loans is 1.6 years.
(4)As a result of rising prevailing rates, the Company recorded a reversal of lower of cost or market adjustment as of December 31, 2024. The adjustment was calculated using a 5.20% discount rate.
(5)Net of $5.0 million of deferred origination fees and other items as of December 31, 2024.
As of December 31, 2024, $1.3 billion, or 83.3%, of the outstanding face amount of the mortgage loan receivables held for investment, net, at amortized cost, were at variable interest rates linked to Term SOFR. Of this $1.3 billion, 100.0% of these variable interest rate mortgage loan receivables were subject to interest rate floors. As of December 31, 2024, $31.4 million, or 100%, of the outstanding face amount of the mortgage loan receivables held for sale were at fixed interest rates.

For the nine months ended September 30, 2025 and 2024, loan portfolio activity was as follows ($ in thousands):
Mortgage loan receivables held for investment, net, at amortized cost:
 Mortgage loans receivableAllowance for credit lossesMortgage loan 
receivables held
for sale
Balance, December 31, 2024$1,591,322 $(52,323)$26,898 
Origination of mortgage loan receivables (1)888,703 — 63,360 
Repayment of mortgage loan receivables(502,101)— (141)
Proceeds from sales of mortgage loan receivables— — (66,847)
Non-cash disposition of loans via foreclosure(65,078)— — 
Net result from mortgage loan receivables held for sale (2)— — 4,700 
Accretion/amortization of discount, premium and other fees7,742 — — 
Release (addition) of provision for current expected credit loss, net (3)— 188 — 
Balance, September 30, 2025$1,920,588 $(52,135)$27,970 
(1)Includes funding of commitments on existing mortgage loans.
(2)Includes unrealized lower of cost or market adjustment reversal of $1.1 million and realized gain on loans held for sale of $3.6 million.
(3)Refer to “Allowance for Credit Losses” table below for further detail.
Mortgage loan receivables held for investment, net, at amortized cost:
 Mortgage loans receivableAllowance for credit lossesMortgage loan 
receivables held
for sale
Balance, December 31, 2023$3,155,089 $(43,165)$26,868 
Origination of mortgage loan receivables (1)71,810 — — 
Repayment of mortgage loan receivables (2)(1,142,343)— — 
Proceeds from sales of mortgage loan receivables (3)— — — 
Non-cash disposition of loans via foreclosure (4)(55,946)5,023 — 
Net result from mortgage loan receivables held for sale (5)— — 638 
Accretion/amortization of discount, premium and other fees10,935 — — 
Release (addition) of provision for current expected credit loss, net (6)— (14,134)— 
Balance, September 30, 2024$2,039,545 $(52,276)$27,506 
(1)Includes funding of commitments on existing mortgage loans.
(2)Includes $19.7 million of repayments in transit.
(3)Excludes $82.5 million of proceeds received from the sale of conduit mortgage loans collateralized by net leased properties in the Company’s real estate segment to a third-party securitization trust. The mortgage loan receivables, which were originated during the current period, and the related obligation do not appear in the Company’s consolidated balance sheets as they are eliminated upon consolidation. Upon the sale of the mortgage loan receivable to a third-party securitization trust (for cash), the related mortgage note is recognized as a financing transaction.
(4)Refer to Note 5, Real Estate and Related Lease Intangibles, Net, for further detail on foreclosures of real estate.
(5)Includes unrealized lower of cost or market adjustment and realized gain/loss on loans held for sale.
(6)Refer to “Allowance for Credit Losses” table below for further detail.
Allowance for Credit Losses and Non-Accrual Status ($ in thousands)
Three Months Ended September 30,Nine Months Ended September 30,
Allowance for Credit Losses2025202420252024
Allowance for credit losses at beginning of period$52,166 $54,107 $52,323 $43,165 
Provision for (release of) current expected credit loss, net(1)(31)3,192 (188)14,134 
Charge-offs (2)— (5,023)— (5,023)
Allowance for credit losses at end of period$52,135 $52,276 $52,135 $52,276 
(1)As of September 30, 2025 and 2024, there were no asset-specific reserves.
(2)The charge-off related to one loan that was resolved via foreclosure during the three months ended September 30, 2024. The loan was collateralized by an office property in Oakland, California.

Non-Accrual Status (1)
September 30,
2025(2)
December 31, 2024(3)
Amortized cost basis of loans on non-accrual status$122,920 $76,875 
(1)As of September 30, 2025, $122.9 million of loans on non-accrual status were greater than 90 days past due. As of December 31, 2024, $76.9 million of loans on non-accrual status were greater than 90 days past due. For the nine months ended September 30, 2025, the Company recognized $4.0 million of interest income on these loans while on non-accrual status.
(2)Comprised of one multi-family loan with an amortized cost basis of $60.9 million, one hotel loan with an amortized cost basis of $11.9 million and one multi-family loan with an amortized cost basis of $50.1 million, for which the Company determined no asset-specific reserves were necessary.
(3)Comprised of one multi-family loan with an amortized cost basis of $60.9 million and one mixed-use loan with an
amortized cost basis of $16.0 million, for which the Company determined no asset-specific reserve was necessary.

Current Expected Credit Loss

As of September 30, 2025, the Company had a $52.7 million allowance for current expected credit losses, of which $52.1 million pertained to mortgage loan receivables and $0.5 million related to unfunded commitments included in other liabilities in the consolidated balance sheet.

As of December 31, 2024, the Company had a $52.8 million allowance for current expected credit losses, of which $52.3 million pertained to mortgage loan receivables and $0.5 million related to unfunded commitments included in other liabilities in the consolidated balance sheet.
The release of loan loss reserves for the three and nine months ended September 30, 2025 was $31 thousand and $0.2 million, respectfully. The release recorded during the three and nine months ended September 30, 2025 reflects continued uncertainty in macroeconomic market conditions affecting commercial real estate.

The provision for loan loss reserves for the three and nine months ended September 30, 2024 was $3.1 million and $13.9 million, respectively. The provision recorded during the three and nine months ended September 30, 2024 was primarily due to continued uncertainty in macroeconomic market conditions affecting commercial real estate, partially offset by a decrease in the size of the Company’s balance sheet first mortgage loan portfolio as a result of repayments. During the three and nine months ended September 30, 2024, the Company charged-off $5.0 million of the existing allowance for credit losses related to a loan that was resolved via foreclosure.
Management’s method for monitoring credit is the performance of a loan. The primary credit quality indicator management utilizes to assess its current expected credit loss reserve is by viewing the Company’s mortgage loan portfolio by collateral type. The primary credit quality indicator is reviewed by management on a quarterly basis. The following tables summarize the amortized cost of the mortgage loan portfolio by collateral type as of September 30, 2025 and December 31, 2024, respectively ($ in thousands):

Amortized Cost Basis by Origination Year as of September 30, 2025
Collateral Type20252024202320222021 and EarlierTotal (2)(3)
Multifamily$662,980 $127,107 $14,641 $23,206 $110,977 $938,911 
Office 21,945 — — 55,950 572,551 650,446 
Industrial123,379 27,212 — — — 150,591 
Mixed Use18,198 — — — 33,121 51,319 
Other48,730 — — 11,945 — 60,675 
Retail14,824 10,457 — — 24,111 49,392 
Hospitality— — — — 19,254 19,254 
Subtotal mortgage loans receivable890,056 164,776 14,641 91,101 760,014 1,920,588 
Individually Impaired loans— — — — — — 
Total mortgage loans receivable (1)$890,056 $164,776 $14,641 $91,101 $760,014 $1,920,588 
Amortized Cost Basis by Origination Year as of December 31, 2024
Collateral Type20242023202220212020 and EarlierTotal (4)
Office$— $— $59,944 $518,663 $185,242 $763,849 
Multifamily126,588 14,636 105,324 272,291 — 518,839 
Mixed Use— — — 127,380 — 127,380 
Retail23,833 — — 48,628 — 72,461 
Hospitality— — — 13,064 55,260 68,324 
Industrial26,368 — — — — 26,368 
Other— — 14,101 — — 14,101 
Subtotal mortgage loans receivable176,789 14,636 179,369 980,026 240,502 1,591,322 
Individually Impaired loans— — — — — — 
Total mortgage loans receivable (5)(6)$176,789 $14,636 $179,369 $980,026 $240,502 $1,591,322 
(1)Not included above is $9.8 million of accrued interest receivable on all loans at September 30, 2025.
(2)For purposes of calculating our CECL allowance, one loan collateralized by a hospitality property and two loans collateralized by multifamily properties utilized valuations of the underlying collateral to calculate the allowance at September 30, 2025.
(3)The Company had one $228.0 million mortgage loan receivable with a borrower collateralized by an office property in the southeast that represents 12% of the total mortgage loan receivable held for investment at September 30, 2025.
(4)For purposes of calculating our CECL allowance, two loans collateralized by mixed-use, one loan collateralized by office, and one loan collateralized by multifamily utilized valuations of the underlying collateral to calculate the allowance at December 31, 2024.
(5)For the year ended December 31, 2024, there was a $5.0 million charge-off of an asset-specific allowance in connection with a foreclosure of one office property in Oakland, California.
(6)Not included above is $9.4 million of accrued interest receivable on all loans at December 31, 2024.
v3.25.3
SECURITIES
9 Months Ended
Sep. 30, 2025
Investments, Debt and Equity Securities [Abstract]  
SECURITIES
4. SECURITIES
 
The Company invests in primarily AAA-rated real estate securities, typically front pay securities, with relatively short duration and significant credit subordination.

Commercial mortgage-backed securities, including CRE CLOs (“CMBS”), CMBS interest-only securities, U.S. Agency securities, corporate bonds and U.S. Treasury securities are classified as available-for-sale and reported at fair value with changes in fair value recorded in the current period in other comprehensive income. As of September 30, 2025, the Company
does not intend to sell these investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases.

Government National Mortgage Association (“GNMA”) interest-only, Federal Home Loan Mortgage Corp (“FHLMC”) and equity securities are recorded at fair value with changes in fair value recognized in earnings in the consolidated statements of income. The following is a summary of the Company’s securities at September 30, 2025 and December 31, 2024 ($ in thousands):

September 30, 2025
    Gross Unrealized  Weighted Average
Asset TypeOutstanding
Face Amount
 Amortized Cost BasisGainsLosses (1)Carrying
Value
# of
Securities
Rating (2)Coupon %Yield %Remaining
Duration
(years)
CMBS$1,931,727  $1,930,288 $4,258 $(7,691)$1,926,855 (3)112 AAA5.63 %5.71 %2.79
CMBS interest-only(4)347,761 (4)1,660 94 — 1,754 (5)AAA0.44 %8.95 %0.62
GNMA interest-only(6)29,509 (4)149 122 (55)216 13 AAA0.31 %9.57 %2.79
Agency securities — — AAA4.00 %2.39 %0.38
Total debt securities$2,309,001 $1,932,101 $4,474 $(7,746)$1,928,829 (7)131 4.78 %5.68 %2.77
Equity securitiesN/A12,132 (400)11,738 N/AN/AN/AN/A
Allowance for current expected credit lossesN/A— — (20)(20)
Total securities$2,309,001  $1,944,233 $4,480 $(8,166)$1,940,547 139 

December 31, 2024
    Gross Unrealized  Weighted Average
Asset TypeOutstanding
Face Amount
 Amortized
Cost Basis
GainsLosses (1)Carrying
Value
# of
Securities
Rating (2)Coupon %Yield %Remaining
Duration
(years)
CMBS$1,065,985  $1,063,835 $3,335 $(8,296)$1,058,874 (3)92 AAA5.97 %6.13 %2.41
CMBS interest-only(4)769,724 (4)3,149 104 (9)3,244 (5)AAA0.38 %7.81 %0.87
GNMA interest-only(6)32,710 (4)160 53 (58)155 13 AAA0.33 %9.38 %3.64
Agency securities11  11 — — 11 AAA4.00 %2.60 %0.58
Total debt securities$1,868,430 $1,067,155 $3,492 $(8,363)$1,062,284 (7)113 3.56 %6.03 %2.37
Equity securitiesN/A19,511 (939)18,575 N/AN/AN/AN/A
Allowance for current expected credit lossesN/A— — (20)(20)
Total securities$1,868,430  $1,086,666  $3,495  $(9,322) $1,080,839 121   
(1)Based on the Company’s analysis, including review of interest rate changes and current levels of subordination, among other factors, the unrealized loss positions are determined to be due to market factors other than credit.
(2)Represents the weighted average of the ratings of all securities in each asset type, expressed as an S&P equivalent rating. For each security rated by multiple rating agencies, the highest rating is used. The ratings provided were determined by third-party rating agencies. The rates may not be current and are subject to change (including the assignment of a “negative outlook” or “credit watch”) at any time.
(3)As of September 30, 2025 and December 31, 2024, includes $8.8 million and $8.9 million, respectively, of restricted securities which are designated as risk retention securities under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, as amended (“Dodd-Frank Act”) and are therefore subject to transfer restrictions over the term of the securitization trust and are classified as held-to-maturity and reported at amortized cost.
(4)The amounts presented represent the principal amount of the mortgage loans outstanding in the pool in which the interest-only securities participate.
(5)As of September 30, 2025 and December 31, 2024, includes $0.1 million and $0.2 million, respectively, of restricted securities which are designated as risk retention securities under the Dodd-Frank Act and are therefore subject to transfer restrictions over the term of the securitization trust and are classified as held-to-maturity and reported at amortized cost.
(6)GNMA interest-only securities are recorded at fair value with changes in fair value recorded in current period earnings. The Company’s GNMA interest-only securities are considered to be hybrid financial instruments that contain embedded derivatives. As a result, the Company has elected to account for them as hybrid instruments in their entirety at fair value with changes in fair value recognized in unrealized gain (loss) on securities in the consolidated statements of income.
(7)The Company’s investments in debt securities represent an ownership interest in unconsolidated VIEs. The Company’s maximum exposure to loss from these unconsolidated VIEs is the amortized cost basis of the securities which represents the purchase price of the investment adjusted by any unamortized premiums or discounts as of the reporting date.
 
The following tables summarize the carrying value of the Company’s debt securities by remaining maturity based upon expected cash flows at September 30, 2025 and December 31, 2024 ($ in thousands):
 
September 30, 2025
Asset TypeWithin 1 year1-5 years5-10 yearsAfter 10 yearsTotal
CMBS$355,351 $1,571,504 $— $— $1,926,855 
CMBS interest-only1,754 — — — 1,754 
GNMA interest-only28 188 — — 216 
Agency securities— — — 
Total securities (1)$357,137 $1,571,692 $ $ $1,928,829 
(1)Excluded from the table above are $11.7 million of equity securities and $(20.0) thousand of allowance for current expected credit losses.
 
December 31, 2024
Asset TypeWithin 1 year1-5 years5-10 yearsTotal
CMBS$170,874 $888,000 $— $1,058,874 
CMBS interest-only2,937 307 — 3,244 
GNMA interest-only53 13 89 155 
Agency securities11 — — 11 
Total securities (1)$173,875 $888,320 $89 $1,062,284 
(1)Excluded from the table above are $18.6 million of equity securities and $(20.0) thousand of allowance for current expected credit losses.
During the three and nine months ended September 30, 2025, the Company sold $9.5 million and $42.1 million of equity securities, respectively. During the three months ended September 30, 2024, the Company did not sell any equity securities. During the nine months ended September 30, 2024, the Company sold $1.8 million of equity securities.

The following table summarizes the Company’s realized and unrealized gain (loss) on securities, included within “Fee and Other Income” on the Company’s consolidated statements of income for the three and nine months ended September 30, 2025 and September 30, 2024 ($ in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Realized gain (loss) on securities$2,032 $— $3,061 $75 
Unrealized gain (loss) on securities(176)613 (22)
Total realized and unrealized gain (loss) on securities$1,856 $5 $3,674 $53 
v3.25.3
REAL ESTATE AND RELATED LEASE INTANGIBLES, NET
9 Months Ended
Sep. 30, 2025
Real Estate [Abstract]  
REAL ESTATE AND RELATED LEASE INTANGIBLES, NET 5. REAL ESTATE AND RELATED LEASE INTANGIBLES, NET
The Company’s real estate assets were comprised of the following ($ in thousands):
September 30, 2025December 31, 2024
Land$190,277 $173,798 
Building653,051 622,701 
In-place leases and other intangibles116,304 107,899 
Undepreciated real estate and related lease intangibles959,632 904,398 
Less: Accumulated depreciation and amortization(254,121)(233,595)
Real estate and related lease intangibles, net(1)$705,511 $670,803 
Below market lease intangibles, net (other liabilities)(2)$(23,180)$(25,340)
(1)There was unencumbered real estate of $308.5 million and $213.4 million as of September 30, 2025 and December 31, 2024, respectively.
(2)Below market lease intangibles is net of $17.7 million and $16.5 million of accumulated amortization as of September 30, 2025 and December 31, 2024, respectively.

As of September 30, 2025 and December 31, 2024, the Company had no real estate and lease intangibles held for sale.
The following table presents depreciation and amortization expense on real estate recorded by the Company ($ in thousands):
 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Depreciation expense(1)$6,250 $6,323 $18,766 $19,058 
Amortization expense1,988 1,823 4,851 5,803 
Total real estate depreciation and amortization expense$8,238 $8,146 $23,617 $24,861 
(1)Depreciation expense on the consolidated statements of income also includes $0.1 million of depreciation on corporate fixed assets for each of the three months ended September 30, 2025 and September 30, 2024 and $0.3 million of depreciation on corporate fixed assets for each of the nine months ended September 30, 2025 and September 30, 2024
The Company’s intangible assets are comprised of in-place leases, above market leases and other intangibles. The following tables present additional detail related to the intangible assets ($ in thousands):
 September 30, 2025December 31, 2024
Gross intangible assets(1)$116,304 $107,899 
Accumulated amortization62,051 57,281 
Net intangible assets$54,253 $50,618 
(1)Includes $4.5 million and $2.3 million of unamortized above market lease intangibles, which are included in real estate and related lease intangibles, net on the consolidated balance sheets as of September 30, 2025 and December 31, 2024, respectively.

The following table presents increases/reductions in operating lease income related to the amortization of above or below market leases recorded by the Company ($ in thousands):
 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Reduction in operating lease income for amortization of above market lease intangibles acquired$(189)$(93)$(439)$(285)
Increase in operating lease income for amortization of below market lease intangibles acquired509 518 1,506 1,572 
Total$320 $425 $1,067 $1,287 
The following table presents expected adjustment to operating lease income and expected amortization expense during the next five years and thereafter related to the above and below market leases and acquired in-place lease and other intangibles for property owned as of September 30, 2025 ($ in thousands):
Period Ending December 31,Increase/(Decrease) to Operating Lease IncomeAmortization Expense
2025 (last three months)$248 $1,768 
2026997 6,606 
2027961 6,430 
20281,023 5,359 
20291,194 3,589 
Thereafter14,295 27,538 
Total$18,718 $51,290 

Rent Receivables

There were $2.8 million and $2.6 million of rent receivables included in other assets on the consolidated balance sheets as of September 30, 2025 and December 31, 2024, respectively.
Operating Lease Income & Tenant Reimbursements

The following table is a schedule of non-cancellable, contractual, future minimum rent under leases (excluding property operating expenses paid directly by tenant under net leases) at September 30, 2025 ($ in thousands):
Period Ending December 31,Amount
2025 (last three months)$18,240 
202667,378 
202757,108 
202851,313 
202948,242 
Thereafter133,934 
Total$376,215 

Tenant reimbursements, which consist of real estate taxes and utilities paid by the Company, which were reimbursable by the Company’s tenants pursuant to the terms of the lease agreements, were $1.5 million and $4.0 million for the three and nine months ended September 30, 2025, respectively, and $1.8 million and $5.1 million for the three and nine months ended September 30, 2024, respectively. Tenant reimbursements are included in operating lease income on the Company’s consolidated statements of income.
Acquisitions

The Company acquired the following properties during the nine months ended September 30, 2025 ($ in thousands):
Acquisition DateTypePrimary Location(s)Purchase Price/Fair Value on the Date of ForeclosureOwnership Interest (1)
April 2025(2)OfficeCarmel, IN$42,400 100%
September 2025(3)OfficeRockville, MD22,678 100%
Total real estate acquisitions$65,078 
(1)Properties were consolidated as of acquisition date.
(2)In April 2025, the Company acquired an office portfolio consisting of two buildings in Carmel, IN via foreclosure. The portfolio served as collateral for a mortgage loan receivable held for investment. The $42.4 million fair value was determined by using the direct capitalization approach. A capitalization rate of 11.6% was used to determine fair value. There was no gain or loss resulting from the foreclosure of the loan. The key inputs used to determine fair value were determined to be Level 3 inputs.
(3)In September 2025, the Company acquired an office property in Rockville, MD through foreclosure of a mortgage loan receivable held for investment. The fair value of $22.7 million was determined by using the direct capitalization approach with a capitalization rate of 10.8%, a Level 3 input. There was no gain or loss resulting from the foreclosure of the loan.
The Company acquired the following properties during the nine months ended September 30, 2024 ($ in thousands):
Acquisition DateTypePrimary Location(s)Purchase Price/Fair Value on the Date of ForeclosureOwnership Interest (1)
February 2024(2)MultifamilyLos Angeles, CA$14,110 100%
April 2024(3)MultifamilyLongview, TX6,080 100%
April 2024(4)MultifamilyAmarillo, TX9,651 100%
June 2024(5)MultifamilyLos Angeles, CA11,455 100%
September 2024(6)OfficeOakland, CA7,500 100.0%
Total real estate acquisitions$48,796 
(1)Properties were consolidated as of acquisition date.
(2)In February 2024, the Company acquired a multifamily portfolio consisting of three properties in Los Angeles, CA via foreclosure. The portfolio served as collateral for a mortgage loan receivable held for investment. The Company obtained a third-party appraisal of the properties. The $14.1 million fair value was determined by using the sales comparison and direct capitalization approaches. The appraiser utilized a capitalization rate of 5.5%. There was no gain or loss resulting from the foreclosure of the loan. The key inputs used to determine fair value were determined to be Level 3 inputs. The portfolio was sold in June 2024.
(3)In April 2024, the Company acquired a multifamily portfolio consisting of two properties in Longview, TX via foreclosure. The portfolio served as collateral for a mortgage loan receivable held for investment. There was a $0.4 million gain recognized in connection with the foreclosure of the loan. During June 2024, the Company sold the portfolio for $6.1 million. The fair value at foreclosure was based on the sales price.
(4)In April 2024, the Company acquired a multifamily property in Amarillo, TX via foreclosure. The property served as collateral for a mortgage loan receivable held for investment. The Company determined the fair value of $9.7 million by using the sales comparison approach utilizing a terminal capitalization rate of 8.3%. There was no gain or loss resulting from the foreclosure of the loan. The key inputs used to determine fair value were determined to be Level 3 inputs.
(5)In June 2024, the Company acquired a multifamily portfolio consisting of three properties in Los Angeles, CA via foreclosure. The portfolio served as collateral for a mortgage loan receivable held for investment. The $11.5 million fair value was determined by using the sales comparison approach. There was no gain or loss resulting from the foreclosure of the loan.
(6)In September 2024, the Company acquired an office property in Oakland, CA via foreclosure. The property served as collateral for a mortgage loan receivable held for investment. The $7.5 million fair value was determined by using the sales comparison approach and direct capitalization approach. There was a $5 million charge-off of allowance for credit loss resulting from the acquisition of the property. The Company used a terminal capitalization rate of 7.5%. The key inputs used to determine fair value were determined to be Level 3 inputs. Refer to Note 3, Mortgage Loan Receivables for further details.
Sales

The Company sold the following property during the nine months ended September 30, 2025 ($ in thousands):
Sales DateTypePrimary Location(s)Sales ProceedsNet Book ValueRealized Gain/(Loss)Properties
March 2025RetailJenks, OK$13,079 $9,272 $3,807 1
Totals$13,079 $9,272 $3,807 
The Company sold the following properties during the nine months ended September 30, 2024 ($ in thousands):
Sales DateTypePrimary Location(s)Sales ProceedsNet Book ValueRealized Gain/(Loss)Properties
May 2024OfficePeoria, IL$1,227 $2,320 $(1,093)1
June 2024MultifamilyLos Angeles, CA14,834 13,911 923 3
June 2024RetailWaldorf, MD23,734 11,424 12,310 1
June 2024MultifamilyLongview, TX(1)6,080 6,080 403 2
July 2024MultifamilyLos Angeles, CA11,770 11,455 315 1
Totals$57,645 $45,190 $12,858 
(1)The Company recognized a $0.4 million gain on foreclosure which is recognized in gain (loss) on real estate, net on the consolidated statements of income.
v3.25.3
DEBT OBLIGATIONS, NET
9 Months Ended
Sep. 30, 2025
Debt Disclosure [Abstract]  
DEBT OBLIGATIONS, NET
6. DEBT OBLIGATIONS, NET

The details of the Company’s debt obligations at September 30, 2025 and December 31, 2024 are as follows ($ in thousands):
 
September 30, 2025

Debt ObligationsCommitted AmountOutstanding Principal AmountCarrying ValueAverage Cost of Funds(1)Current MaturityFinal Stated Maturity(2)Carrying Value of Collateral
Loan Repurchase Facility$300,000 $— $— —%9/27/20289/27/2030$— 
Loan Repurchase Facility300,000 — — —%10/21/202710/21/2029— 
Loan Repurchase Facility200,000 — — —%10/3/202510/3/202714,641 
Loan Repurchase Facility56,000 — — —%4/30/20264/30/2029— 
Loan Repurchase Facilities(3)$856,000 $— $— $14,641 
Securities Repurchases— 361,638 361,638 4.69%10/3/202510/30/2025402,329 
Total Repurchase Facilities$856,000 $361,638 $361,638 $416,970 
Mortgage Debt N/A 399,092 401,656 6.18%2025-2034(4)2027-2048397,053 
Unsecured Revolving Credit Facility(5)850,000 20,000 20,000 5.37%12/20/202812/20/2029 N/A
Senior Unsecured Notes N/A 2,233,409 2,213,938 5.29%2027-20312027-2031 N/A
Total Debt Obligations, net$1,706,000 $3,014,139 $2,997,232 $814,023 
(1)Interest rates on floating rate debt reflect the applicable index in effect as of September 30, 2025. Excludes deferred financing costs.
(2)Final Stated Maturity assumes extensions at our option are exercised with consent of financing providers, where applicable.
(3)Carrying value excludes $2.8 million of unamortized deferred financing costs included in Other Assets.
(4)Anticipated Repayment Dates.
(5)Carrying Value excludes $7.5 million of unamortized deferred financing costs included in Other Assets.
December 31, 2024

Debt ObligationsCommitted AmountOutstanding Principal AmountCarrying ValueAverage Cost of Funds(1)Current MaturityFinal Stated Maturity(2)Carrying Value of Collateral
Loan Repurchase Facility$500,000 $62,738 $62,738 6.55%9/27/20259/27/2027$97,254 
Loan Repurchase Facility300,000 — — —%10/21/202710/21/2029— 
Loan Repurchase Facility200,000 — — —%10/3/202510/3/202714,636 
Loan Repurchase Facility100,000 — — —%1/22/20251/22/2026— 
Loan Repurchase Facility56,000 — — —%4/30/20264/30/2029— 
Loan Repurchase Facilities(3)$1,156,000 $62,738 $62,738 $111,890 
Mortgage Debt N/A 443,733 446,397 6.09%2025-2034(4)2027-2048451,880 
CLO Debt N/A 601,464 601,429 6.36%2025-2026(5)2036-2038831,270 
Unsecured Revolving Credit Facility(6)725,000 — — —%12/20/202812/20/2029N/A
Senior Unsecured NotesN/A2,041,557 2,025,053 5.22%2025-20312025-2031  N/A
Total Debt Obligations, net$1,881,000 $3,149,492 $3,135,617 $1,395,040 
(1)Interest rates on floating rate debt reflect the applicable index in effect as of December 31, 2024. Excludes deferred financing costs.
(2)Final Stated Maturity assumes extensions at our option are exercised with consent of financing providers, where applicable.
(3)Carrying value excludes $2.1 million of unamortized deferred financing costs included in Other Assets.
(4)Anticipated Repayment Dates.
(5)Represents the estimated maturity dates based on the underlying loan maturities.
(6)The obligations under the Unsecured Revolving Credit Facility are secured by equity pledges of certain subsidiaries of the Company. Carrying Value excludes $7.1 million of unamortized deferred financing costs included in Other Assets.
Senior Unsecured Notes
As of September 30, 2025, the Company had $2.2 billion of senior unsecured notes outstanding. These unsecured financings were comprised of $599.5 million in aggregate principal amount of 4.25% senior notes due 2027 (the “2027 Notes”), $633.9 million in aggregate principal amount of 4.75% senior notes due 2029 (the “2029 Notes”), $500.0 million in aggregate principal amount of 5.50% senior notes due 2030 (the “2030 Notes”) that were issued during the three months ended September 30, 2025, and $500.0 million in aggregate principal amount of 7.00% senior notes due 2031 (the “2031 Notes,” collectively with the 2027 Notes, the 2029 Notes, and the 2030 Notes, the “Notes”). The Company currently guarantees the obligations under the Notes and the indenture.

The Notes require interest payments semi-annually in cash in arrears, are unsecured, and in some cases, are subject to an unencumbered assets to unsecured debt covenant. The Company may redeem the Notes prior to their stated maturity, in whole or in part, at any time or from time to time, with required notice and at a redemption price as specified in each respective indenture governing the Notes, plus accrued and unpaid interest, if any, to the redemption date. The board of directors has authorized the Company to repurchase any or all of the Notes from time to time without further approval. During the nine months ended September 30, 2025, the Company fully redeemed the 5.25% senior notes due 2025 and repurchased $12.4 million of the 2027 Notes, recognizing a loss on extinguishment of debt of $99 thousand and a gain on bond repurchase of $250 thousand, respectively.
Unsecured Revolving Credit Facilities
The Company’s Unsecured Revolving Credit Facility is available on a revolving basis to finance the Company’s working capital needs and for general corporate purposes. On January 2, 2025, the Company increased the aggregate maximum borrowing amount of the Unsecured Revolving Credit Facility to $850.0 million, following the upsize to $725 million on December 20, 2024. The Unsecured Revolving Credit Facility also allows the Company to enter into additional incremental revolving commitments up to an aggregate facility size of $1.3 billion subject to certain customary conditions. Borrowings under the Unsecured Revolving Credit Facility bear interest at a rate equal to term SOFR plus a margin of 125 basis points as of September 30, 2025. The margin for borrowings is subject to adjustment based on the Company's credit rating and may range between 77.5 and 170 basis points. As of September 30, 2025, the Company had $20.0 million outstanding borrowings on the Unsecured Revolving Credit Facility.
Effective May 27, 2025, the date on which the Company received investment grade ratings from Moody’s and Fitch, the Unsecured Revolving Credit Facility was automatically amended, the pledge of the shares of (or other ownership or equity interest in) certain subsidiaries was terminated, and each guarantor (other than Ladder Capital Corp and any subsidiary that is a trigger guarantor) was released and discharged from all obligations as a guarantor and/or pledgor.

In September 2025, the Company entered into an unsecured Money Market Borrowing Arrangement to provide short-term financing up to $100 million. The arrangement has a five-year term. No borrowing on this facility is permitted over a quarter end date, and as such, no balance was utilized under this arrangement as of September 30, 2025.

Collateralized Loan Obligations (“CLO”) Debt

On July 13, 2021, the Company financed a pool of $607.5 million of loans at an 82% advance rate on a matched term, non-mark-to-market and non-recourse basis in a managed CLO transaction (“LCCM 2021-FL2”), which generated $498.2 million of gross proceeds to Ladder. The Company retained an 18% subordinate and controlling interest in LCCM 2021-FL2. The Company retained control over major decisions made with respect to the administration of the loans in LCCM 2021-FL2, including broad discretion in managing these loans, and had the ability to appoint the special servicer. LCCM 2021-FL2 was a VIE and the Company was the primary beneficiary and, therefore, consolidated the VIE. On February 18, 2025, the Company redeemed all outstanding obligations of LCCM 2021-FL2 and no longer consolidated this VIE as of March 31, 2025.

On December 2, 2021, the Company financed a pool of $729.4 million of loans at a 77.6% advance rate on a matched term, non-mark-to-market and non-recourse basis in a managed CLO transaction (“LCCM 2021-FL3”), which generated $566.2 million of gross proceeds to Ladder. The Company retained a 15.6% subordinate and controlling interest in the LCCM 2021-FL3 and held two additional tranches totaling 6.8% as investments. The Company retained control over major decisions made with respect to the administration of the loans in LCCM 2021-FL3, including broad discretion in managing these loans, and had the ability to appoint the special servicer. LCCM 2021-FL3 was a VIE and the Company was the primary beneficiary and, therefore, consolidated the VIE. On June 16, 2025, the Company redeemed all outstanding obligations of LCCM 2021-FL3 and no longer consolidated this VIE as of June 30, 2025.

At December 31, 2024, the Company had $601.4 million of matched term, non-mark-to-market and non-recourse CLO debt included in debt obligations on its consolidated balance sheet, as a result, the Company consolidated two CLOs that were considered VIE's on its consolidated balance sheet as of December 31, 2024 ($ in thousands):

December 31, 2024
Mortgage loan receivables held for investment, net, at amortized cost$831,270 
Accrued interest receivable5,530 
Other assets42,621 
Total assets$879,421 
Debt obligations, net$601,429 
Accrued expenses1,806 
Total liabilities603,235 
Net equity in VIEs (eliminated in consolidation)276,186 
Total equity276,186 
Total liabilities and equity$879,421 
Loan and Securities Repurchase Financing
As of September 30, 2025, the Company has entered into four committed master repurchase agreements to finance its lending activities, totaling $856.0 million of credit capacity with no balance outstanding.

Assets pledged as collateral under these facilities are generally limited to first lien whole mortgage loans, mezzanine loans and certain interests in such first mortgage and mezzanine loans. The lenders have sole discretion to include collateral in these facilities and to determine the market value of the collateral. In certain cases the lenders may require additional collateral, a full or partial repayment of the facilities (margin call) or a reduction in undrawn availability under the facilities.
The Company has also entered into master repurchase agreements with several counterparties to finance real estate securities. The securities that serve as collateral for these borrowings are typically highly liquid AAA-rated CMBS with relatively short duration and significant subordination. As of September 30, 2025, the Company had $361.6 million of securities repurchase debt outstanding.

As of September 30, 2025, one loan repurchase facility was scheduled to mature within 30 days of September 30, 2025 and had no balance outstanding. No counterparties held collateral that exceeded the amounts borrowed under the related loan and securities repurchase agreements by more than $149.3 million, or 10% of the Company’s total equity.
Mortgage Loan Financing

The Company typically finances its real estate investments with long-term, non-recourse mortgage financing. These mortgage loans have carrying amounts of $401.7 million and $446.4 million, net of unamortized premiums of $3.2 million and $3.7 million as of September 30, 2025 and December 31, 2024, respectively, representing proceeds received upon financing greater than the contractual amounts due under these agreements. The premiums are being amortized over the remaining life of the respective debt instruments using the effective interest method. The Company recorded $0.2 million and $0.5 million of premium amortization for the three and nine months ended September 30, 2025, respectively, and $0.2 million and $0.6 million of premium amortization for the three and nine months ended September 30, 2024, respectively. During the three and nine months ended September 30, 2025, the Company executed no new term debt agreements. During the three and nine months ended September 30, 2024, the Company executed six and 16 new term debt agreements, respectively, to finance properties in its real estate portfolio with a carrying amount of $13.0 million and $81.9 million, respectively.
Financial Covenants

Our borrowings under certain financing agreements are subject to financial covenants, including maximum leverage ratio limits, minimum net worth requirements, minimum liquidity requirements, minimum fixed charge coverage ratio requirements, and minimum unencumbered assets to unsecured debt requirements. The Company’s subsidiary, Tuebor Captive Insurance Company LLC (“Tuebor”), was previously a captive insurance company subject to state regulations, which required regulatory approval for dividend distributions, limiting the Company's ability to utilize cash held by Tuebor. Effective January 31, 2025, Tuebor was no longer licensed as a captive insurer and was no longer subject to state regulation.
The Company was in compliance with all covenants as of September 30, 2025.

Combined Maturity of Debt Obligations

The following schedule reflects the Company’s contractual payments under borrowings by maturity ($ in thousands): 
Period ending December 31,Borrowings by
Maturity(1)
2025 (last three months)$376,033 
202626,424 
2027805,391 
202824,317 
2029689,484 
Thereafter1,092,490 
Subtotal3,014,139 
Debt issuance costs included in senior unsecured notes(19,472)
Debt issuance costs included in mortgage loan financings(662)
Net premiums included in mortgage loan financings (2)3,227 
Total$2,997,232 
(1)The allocation of repayments under the Company’s committed loan repurchase facilities is based on the earlier of: (i) the final stated maturity date of each agreement; or (ii) the maximum maturity date of the collateral loans, assuming all extension options are exercised by the borrower. Repayments of the Company's mortgage debt is based on the anticipated repayment dates as defined in the mortgage loan agreements.
(2)Represents sales proceeds received in excess of loan amounts sold into securitizations that are amortized as a reduction to interest expense using the effective interest method over the life of the underlying loan.
v3.25.3
DERIVATIVE INSTRUMENTS
9 Months Ended
Sep. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS
7. DERIVATIVE INSTRUMENTS
 
The Company primarily uses derivative instruments to economically manage the fair value variability of fixed rate assets caused by interest rate fluctuations and overall portfolio market risk. The following is a breakdown of the derivatives outstanding as of September 30, 2025 and December 31, 2024 ($ in thousands):
 
September 30, 2025
  Fair ValueRemaining
Maturity
(years)
Contract TypeNotionalAsset(1)Liability(1)
Caps    
1 Month Term SOFR$90,000 $$— 1.04
Futures   
10-year Treasury-Note Futures22,500 276 — 0.26
Total futures22,500 276 — 
Options   
S&P 500 Put OptionsN/A(2)— 0.09
Total derivatives$112,500 $284 $  
(1)Shown as derivative instruments in the accompanying consolidated balance sheet.
(2)The Company held 75 options contracts as of September 30, 2025.


December 31, 2024
  Fair ValueRemaining
Maturity
(years)
Contract TypeNotionalAsset(1)Liability(1)
Caps    
1 Month Term SOFR$90,000 $432 $ 0.62
Options    
OptionsN/A(2)— 0.05
Total credit derivatives 5   
Total derivatives$90,000 $437 $  
(1)Shown as derivative instruments in the accompanying consolidated balance sheet.
(2)The Company held 275 options contracts as of December 31, 2024.
 
The following table summarizes the net realized gains (losses) and unrealized gains (losses) on derivatives, by primary underlying risk exposure, as included in net result from derivatives transactions in the consolidated statements of income for the three and nine months ended September 30, 2025 and 2024 ($ in thousands):

 Three Months Ended September 30, 2025Nine Months Ended September 30, 2025
Contract TypeUnrealized
Gain/(Loss)
Realized
Gain/(Loss)
Net Result
from
Derivative
Transactions
Unrealized
Gain/(Loss)
Realized
Gain/(Loss)
Net Result
from
Derivative
Transactions
Caps$(142)$126 $(16)$(450)$504 $54 
Futures154 (66)88 276 1,596 1,872 
Options— (51)(51)— (56)(56)
Total$12 $9 $21 $(174)$2,044 $1,870 
 
 Three Months Ended September 30, 2024Nine Months Ended September 30, 2024
Contract TypeUnrealized
Gain/(Loss)
Realized
Gain/(Loss)
Net Result
from
Derivative
Transactions
Unrealized
Gain/(Loss)
Realized
Gain/(Loss)
Net Result
from
Derivative
Transactions
Caps$(589)$421 $(168)$(1,220)$1,258 $38 
Futures(311)(282)(593)(376)4,215 3,839 
Options— (5)(5)— (6)(6)
Total$(900)$134 $(766)$(1,596)$5,467 $3,871 
Futures

Collateral posted with the Company’s futures counterparties is segregated in the Company’s books and records. Interest rate futures are centrally cleared by the Chicago Mercantile Exchange (“CME”) through a futures commission merchant. Interest rate futures that are governed by an International Swaps and Derivatives Association (“ISDA”) agreement provide for bilateral collateral pledging based on the counterparties’ market value. The counterparties have the right to re-pledge the collateral posted but have the obligation to return the pledged collateral, or substantially the same collateral, if agreed to by us, as the market value of the interest rate futures change.

The Company is required to post initial margin and daily variation margin for its interest rate futures that are centrally cleared by CME. CME determines the fair value of the Company’s centrally cleared futures, including daily variation margin. Variation margin pledged on the Company’s centrally cleared interest rate futures is settled against the realized results of these futures. The Company’s counterparties held $0.6 million of cash margin as collateral for derivatives as of September 30, 2025, which is included in restricted cash in the consolidated balance sheets and no cash margin as collateral for derivatives as of December 31, 2024.
v3.25.3
OFFSETTING ASSETS AND LIABILITIES
9 Months Ended
Sep. 30, 2025
Offsetting [Abstract]  
OFFSETTING ASSETS AND LIABILITIES
8. OFFSETTING ASSETS AND LIABILITIES
 
The following tables present both gross information and net information about derivatives and other instruments eligible for offset in the statement of financial position as of September 30, 2025 and December 31, 2024. The Company’s accounting policy is to record derivative asset and liability positions on a gross basis; therefore, the following tables present the gross derivative asset and liability positions recorded on the balance sheets, while also disclosing the eligible amounts of financial instruments and cash collateral to the extent those amounts could offset the gross amount of derivative asset and liability positions. The actual amounts of collateral posted by or received from counterparties may be in excess of the amounts disclosed in the following tables as the following only disclose amounts eligible to be offset to the extent of the recorded gross derivative positions.

The following table represents offsetting of financial assets and derivative assets as of September 30, 2025 ($ in thousands): 
DescriptionGross amounts of
recognized assets
Gross amounts
offset in the
balance sheet
Net amounts of
assets presented
in the balance
sheet
Gross amounts not offset in the
balance sheet
Net amount
Financial
instruments
Cash collateral
received/(posted)(1)
Derivatives$284 $— $284 $— $(574)$(290)
Total$284 $ $284 $ $(574)$(290)
(1)Included in restricted cash on consolidated balance sheet.
The following table represents offsetting of financial liabilities and derivative liabilities as of September 30, 2025 ($ in thousands): 
DescriptionGross amounts of
recognized
liabilities
Gross amounts
offset in the
balance sheet
Net amounts of
liabilities
presented in the
balance sheet
Gross amounts not offset in the
balance sheet
Net amount
Financial
instruments
collateral
Cash collateral
posted/(received)(1)
Repurchase agreements$361,638 $— $361,638 $361,638 $— $361,638 
Total$361,638 $ $361,638 $361,638 $ $361,638 
(1)Included in restricted cash on consolidated balance sheet.
The following table represents offsetting of financial assets and derivative assets as of December 31, 2024 ($ in thousands):
DescriptionGross amounts of
recognized assets
Gross amounts
offset in the
balance sheet
Net amounts of
assets presented
in the balance
sheet
Gross amounts not offset in the
balance sheet
Net amount
Financial
instruments
Cash collateral
received/(posted)(1)
Derivatives$437 $— $437 $— $— $437 
Total$437 $ $437 $ $ $437 
(1)Included in restricted cash on consolidated balance sheet.
The following table represents offsetting of financial liabilities and derivative liabilities as of December 31, 2024 ($ in thousands):
DescriptionGross amounts of
recognized
liabilities
Gross amounts
offset in the
balance sheet
Net amounts of
liabilities
presented in the
balance sheet
Gross amounts not offset in the
balance sheet
Net amount
Financial
instruments
collateral
Cash collateral
posted/(received)(1)
Repurchase agreements$62,738 $— $62,738 $62,738 $— $62,738 
Total$62,738 $ $62,738 $62,738 $ $62,738 
(1)Included in restricted cash on consolidated balance sheet.
Master netting agreements that the Company has entered into with its derivative and repurchase agreement counterparties allow for netting of the same transaction, in the same currency, on the same date. Assets, liabilities, and collateral subject to master netting agreements as of September 30, 2025 and December 31, 2024 are disclosed in the tables above. The Company does not present its derivative and repurchase agreements net on the consolidated financial statements as it has elected gross presentation.
v3.25.3
EQUITY
9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
EQUITY
9. EQUITY
Stock Repurchases

On April 23, 2025, the board of directors authorized the repurchase of $100.0 million of the Company’s Class A common stock from time to time without further approval. This authorization increased the remaining outstanding authorization per the April 24, 2024 authorization from $66.8 million to $100.0 million. Stock repurchases by the Company are generally made for cash in open market transactions at prevailing market prices but may also be made in privately negotiated transactions or otherwise. The timing and amount of purchases are determined based upon prevailing market conditions, the Company’s liquidity requirements, contractual restrictions and other factors. As of September 30, 2025, the Company has a remaining amount available for repurchase of $91.5 million, which represents 6.6% in the aggregate of its outstanding Class A common stock, based on the closing price of $10.91 per share on such date.

The following tables summarize the Company’s repurchase activity of its Class A common stock during the nine months ended September 30, 2025 and 2024 ($ in thousands):
SharesAmount(1)
Authorizations remaining as of December 31, 2024$67,604 
Additional authorizations (2)33,201 
Repurchases paid:
January 1, 2025 - January 31, 2025— — 
February 1, 2025 - February 28, 2025— — 
March 1, 2025 - March 31, 202570,506 (805)
April 1, 2025 - April 30, 2025— — 
May 1, 2025 - May 31, 2025401,396 (4,151)
June 1, 2025 - June 30, 2025234,094 (2,456)
July 1, 2025 - July 31, 202536,371 (397)
August 1, 2025 - August 31, 202543,020 (471)
September 1, 2025 - September 30, 202591,321 (1,017)
Authorizations remaining as of September 30, 2025$91,508 
(1)Amount excludes commissions paid associated with share repurchases.
(2)On April 23, 2025, the Board authorized repurchases up to $100.0 million in aggregate.

SharesAmount(1)
Authorizations remaining as of December 31, 2023$44,256 
Additional authorizations (2)31,391 
Repurchases paid:
January 1, 2024 - January 31, 2024— — 
February 1, 2024 - February 29, 2024— — 
March 1, 2024 - March 31, 202460,000 (647)
April 1, 2024 - April 30, 2024— — 
May 1, 2024 - May 31, 20242,100 (23)
June 1, 2024 - June 30, 202417,590 (189)
July 1, 2024 - July 31, 2024— — 
August 1, 2024 - August 31, 2024— — 
September 1, 2024 - September 30, 2024100,001 (1,190)
Authorizations remaining as of September 30, 2024$73,598 
(1)Amount excludes commissions paid associated with share repurchases.
(2)On April 24, 2024, the Board authorized repurchases up to $75.0 million in aggregate.
Dividends

The following table presents dividends declared (on a per share basis) of Class A common stock for the nine months ended September 30, 2025 and 2024:
Declaration DateDividend per Share
March 14, 2025$0.23 
June 13, 20250.23 
September 15, 20250.23 
Total$0.69 
March 15, 2024$0.23 
June 14, 20240.23 
September 13, 20240.23 
Total$0.69 
Changes in Accumulated Other Comprehensive Income (Loss)

The following table presents changes in accumulated other comprehensive income related to the cumulative difference between the fair market value and the amortized cost basis of securities classified as available for sale for the nine months ended September 30, 2025 and 2024 ($ in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Accumulated Other Comprehensive Income (Loss) beginning of period$(5,639)$(10,752)$(4,866)$(13,853)
Unrealized gain (loss) on securities, available for sale4,131 2,041 3,570 5,165 
Reclassification adjustment for (gain) loss included in net income (loss)(1,831)— (2,043)(23)
Accumulated Other Comprehensive Income (Loss) end of period$(3,339)$(8,711)$(3,339)$(8,711)
v3.25.3
NONCONTROLLING INTERESTS
9 Months Ended
Sep. 30, 2025
Noncontrolling Interest [Abstract]  
NONCONTROLLING INTERESTS
10. NONCONTROLLING INTERESTS

Noncontrolling Interests in Consolidated Ventures

As of September 30, 2025, the Company consolidates two ventures and in each, there are different noncontrolling investors, which own between 10.0% - 25.0% of such ventures. These ventures hold investments in a 40-building student housing portfolio in Isla Vista, CA with a book value of $77.0 million, and a single-tenant office building in Oakland County, MI with a book value of $8.3 million. The Company makes distributions and allocates income from these ventures to the noncontrolling interests in accordance with the terms of the respective governing agreements.
v3.25.3
EARNINGS PER SHARE
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
EARNINGS PER SHARE
11. EARNINGS PER SHARE
 
The Company’s net income (loss) and weighted average shares outstanding for the three and nine months ended September 30, 2025 and 2024 consist of the following:
Three Months Ended September 30,Nine Months Ended September 30,
($ in thousands except share amounts)2025202420252024
Basic and Diluted Net income (loss) available for Class A common shareholders$19,189 $27,913 $48,293 $76,869 
Weighted average shares outstanding:    
Basic125,339,188 125,705,754 125,587,121 125,586,075 
Diluted126,115,547 125,905,528 126,198,822 125,757,114 
 
The calculation of basic and diluted net income (loss) per share amounts for the three and nine months ended September 30, 2025 and 2024 consist of the following:
Three Months Ended September 30,Nine Months Ended September 30,
(In thousands except share and per share amounts) (1)2025202420252024
Basic Net Income (Loss) Per Share of Class A Common Stock    
Numerator:
    
Net income (loss) attributable to Class A common shareholders$19,189 $27,913 $48,293 $76,869 
Denominator:
    
Weighted average number of shares of Class A common stock outstanding125,339,188 125,705,754 125,587,121 125,586,075 
Basic net income (loss) per share of Class A common stock$0.15 $0.22 $0.38 $0.61 
Diluted Net Income (Loss) Per Share of Class A Common Stock  
Numerator:  
Net income (loss) attributable to Class A common shareholders$19,189 $27,913 $48,293 $76,869 
Diluted net income (loss) attributable to Class A common shareholders19,189 27,913 48,293 76,869 
Denominator:  
Basic weighted average number of shares of Class A common stock outstanding125,339,188 125,705,754 125,587,121 125,586,075 
Add - dilutive effect of:    
Incremental shares of unvested Class A restricted stock(1)776,359 199,774 611,701 171,039 
Diluted weighted average number of shares of Class A common stock outstanding (2)(3)126,115,547 125,905,528 126,198,822 125,757,114 
Diluted net income (loss) per share of Class A common stock$0.15 $0.22 $0.38 $0.61 
The Company applies the treasury stock method.
(2)There were 15 and 11,251 anti-dilutive shares for the three and nine months ended September 30, 2025, respectively.
(3)There were 166,571 and 335,482 anti-dilutive shares for the three and nine months ended September 30, 2024, respectively.
v3.25.3
STOCK-BASED AND OTHER COMPENSATION PLANS
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED AND OTHER COMPENSATION PLANS
12. STOCK-BASED AND OTHER COMPENSATION PLANS
 
Summary of Stock and Shares Unvested/Outstanding

The following table summarizes the impact on the consolidated statements of income of the various stock-based compensation plans and other compensation plans ($ in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Stock-based compensation expense$3,049 $3,177 $17,260 $16,592 
Total Stock-Based Compensation Expense$3,049 $3,177 $17,260 $16,592 


A summary of the grants is presented below:
 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Number
of Shares/Options
Weighted
Average
Fair Value
Per Share
Number
of Shares
Weighted
Average
Fair Value
Per Share
Number
of Shares
Weighted
Average
Fair Value
Per Share
Number
of Shares
Weighted
Average
Fair Value
Per Share
Grants - Class A Common Stock31,989 $11.16 — $— 1,852,016 $11.67 1,855,541 $10.70 

The table below presents the number of unvested shares of Class A common stock and outstanding stock options at September 30, 2025 and changes during 2025 of the Class A common stock and stock options of Ladder Capital Corp:
Restricted StockWeighted Average Grant Date Fair ValueStock Options
Nonvested/Outstanding at December 31, 20242,020,752 $12.28 623,788 
Granted1,852,016 11.67 — 
Vested(1,778,588)11.49 — 
Expired— — (439,760)
Nonvested/Outstanding at September 30, 20252,094,180 $12.42 184,028 
Exercisable at September 30, 2025 (1)184,028 
(1)The weighted average exercise price of outstanding options is $11.86 at September 30, 2025.

At September 30, 2025, there was $13.3 million of total unrecognized compensation cost related to certain share-based compensation awards that is expected to be recognized over a period of up to 35.1 months, with a weighted average remaining vesting period of 23.8 months.

2014 Omnibus Incentive Plan

In connection with the IPO Transactions, the 2014 Ladder Capital Corp Omnibus Incentive Equity Plan (the “2014 Omnibus Incentive Plan”) was adopted by the board of directors on February 11, 2014, and provided certain members of management, employees and directors of the Company or its affiliates with additional incentives including grants of stock options, stock appreciation rights, restricted stock, other stock-based awards and other cash-based awards.

2023 Omnibus Incentive Plan

At the Company’s Annual Meeting held on June 6, 2023, the stockholders of the Company approved the Ladder Capital Corp 2023 Omnibus Incentive Plan (the “2023 Omnibus Incentive Plan”), effective as of the date of the Annual Meeting (the “Effective Date”). The 2023 Omnibus Incentive Plan superseded and replaced the 2014 Omnibus Incentive Plan in its entirety as of the Effective Date.

The aggregate number of shares of the Company’s Class A common stock that will be available for issuance to employees, non-employee directors and consultants of the Company and its affiliates under the 2023 Omnibus Incentive Plan will not exceed
3,000,000 shares of Class A common stock, plus an additional amount, not to exceed 10,253,867 shares of Class A common stock, remaining available for new awards under the 2014 Omnibus Incentive Plan as of the Effective Date, subject to the terms and conditions set forth in the 2023 Omnibus Incentive Plan.

Annual Incentive Awards Granted in 2025 with respect to 2024 Performance

For 2024 performance, certain employees received stock-based incentive equity in February 2025. Restricted stock subject to time-based vesting criteria will vest in three installments on February 18 of each of 2026, 2027 and 2028, subject to continued employment on the applicable vesting dates. The Company has elected to recognize the compensation expense related to the time-based vesting of the annual restricted stock awards for the entire award on a straight-line basis over the requisite service period for the entire award. Restricted stock subject to performance criteria is eligible to vest in three equal installments upon the Board’s confirmation that the Company achieves a pre-tax return on average equity, based on distributable earnings divided by the Company’s average shareholders’ equity, equal to or greater than 8% for such year (the “Performance Target”) for the years ended December 31, 2025, 2026 and 2027, respectively. If the Company misses the Performance Target during either the first or second calendar year but meets the Performance Target for a subsequent year during the three-year performance period and the Company’s return on equity for such subsequent year and any years for which it missed its Performance Target equals or exceeds the compounded pre-tax return on average equity of 8% based on distributable earnings divided by the Company’s average shareholders’ equity, the performance-vesting restricted stock which failed to vest because the Company previously missed its Performance Target will vest subject to continued employment on the applicable vesting date (the “Catch-Up Provision”). Approximately 2/3 of all the shares subject to attainment of the Performance Target are also subject to the Catch-Up Provision, as the Catch-Up Provision is not available for the missed performance during the third performance year and has the effect of requiring the Company to achieve an average 8% return over the full three-year performance plan in order to be effective. Accruals of compensation cost for an award with a performance condition shall be based on the probable outcome of that performance condition. Therefore, compensation cost shall be accrued if it is probable that the performance condition will be achieved and shall not be accrued if it is not probable that the performance condition will be achieved. The probability of meeting the performance outcome is assessed quarterly.

On February 18, 2025, in connection with 2024 performance, annual stock awards were granted to management employees (each, a “Management Grantee”), with an aggregate grant date fair value of $11 million, which represents 962,821 shares of Class A common stock. The grant to Mr. Harris and approximately half of the grants to each of Ms. McCormack and Mr. Perelman were unrestricted. The other half of incentive equity granted to each of Ms. McCormack and Mr. Perelman is restricted stock subject to attainment of the Performance Target for the applicable years and is also subject to the Catch-Up Provision described above. For the grants to Mr. Miceli and Ms. Porcella (a total of 125,871 shares with an aggregate fair value of $1.5 million), approximately half of the awards are subject to time-based vesting criteria and the remaining half are subject to attainment of the Performance Target, including the Catch-Up Provision, for the applicable years.

On February 18, 2025, in connection with 2024 performance, annual stock awards were granted to certain non-management employees (“Non-Management Grantees”) with an aggregate grant date fair value of $9.6 million, which represents 825,016 shares of Class A common stock. Of these awards, 21,658 shares were unrestricted, 390,859 shares are subject to time-based vesting criteria and the remaining 412,499 shares are subject to the attainment of the Performance Target, including the Catch-Up Provision, for the applicable years.

Other 2025 Restricted Stock Awards

On February 18, 2025, certain members of the board of directors received annual restricted stock awards with a grant date fair value of $0.4 million, representing 32,190 shares of restricted Class A common stock, which will vest in full on the first anniversary of the date of grant, subject to continued service on the board of directors. Compensation expense related to the time-based vesting criteria of the award shall be recognized on a straight-line basis over the one-year vesting period.

Annual Incentive Awards Granted in 2024 with respect to 2023 Performance

For 2023 performance, certain employees received stock-based incentive equity in February 2024. Restricted stock subject to time-based vesting criteria will vest in three installments on February 18 of each of 2025, 2026 and 2027, subject to continued employment on the applicable vesting dates. The Company has elected to recognize the compensation expense related to the time-based vesting of the annual restricted stock awards for the entire award on a straight-line basis over the requisite service period for the entire award. Restricted stock subject to performance criteria is eligible to vest in three equal installments upon the compensation committee’s confirmation that the Company achieves the Performance Target for the years ended December 31, 2024, 2025 and 2026, respectively, subject to the Catch-Up Provision as described above.
On February 18, 2024, in connection with 2023 performance, annual stock awards were granted to Management Grantees with an aggregate grant date fair value of $10 million, which represents 937,560 shares of Class A common stock. The grant to Mr. Harris and approximately half of the grants to each of Ms. McCormack and Mr. Perelman were unrestricted. The other half of incentive equity granted to each of Ms. McCormack and Mr. Perelman is restricted stock subject to attainment of the Performance Target for the applicable years and is also subject to the Catch-Up Provision described above. For the grants to Mr. Miceli and Ms. Porcella (a total of 127,275 shares with an aggregate fair value of $1.4 million), approximately half of the awards are subject to time-based vesting criteria and the remaining half are subject to attainment of the Performance Target, including the Catch-Up Provision, for the applicable years.

On February 18, 2024, in connection with 2023 performance, annual stock awards were granted to certain Non-Management Grantees with an aggregate grant date fair value of $9.4 million, which represents 882,436 shares of Class A common stock. Of these awards, 22,939 shares were unrestricted, 418,285 shares are subject to time-based vesting criteria and the remaining 441,212 shares are subject to the attainment of the Performance Target, including the Catch-Up Provision, for the applicable years.

Other 2024 Restricted Stock Awards

On February 18, 2024, certain members of the board of directors received annual restricted stock awards with a grant date fair value of $0.4 million, representing 35,545 shares of restricted Class A common stock, which will vest in full on the first anniversary of the date of grant, subject to continued service on the board of directors. Compensation expense related to the time-based vesting criteria of the award shall be recognized on a straight-line basis over the one-year vesting period.

Annual Incentive Awards Granted in 2023 with respect to 2022 Performance

For 2022 performance, certain employees received stock-based incentive equity in February 2023. Restricted stock subject to time-based vesting criteria will vest in three installments on February 18 of each of 2024, 2025 and 2026, subject to continued employment on the applicable vesting dates. The Company has elected to recognize the compensation expense related to the time-based vesting of the annual restricted stock awards for the entire award on a straight-line basis over the requisite service period for the entire award. Restricted stock subject to performance criteria is eligible to vest in three equal installments upon the compensation committee’s confirmation that the Company achieves the Performance Target for the years ended December 31, 2023, 2024 and 2025, respectively, subject to the Catch-Up Provision as described above.

On February 18, 2023, in connection with 2022 performance, annual stock awards were granted to Management Grantees with an aggregate grant date fair value of $8.5 million, which represents 733,607 shares of Class A common stock. The grant to Mr. Harris and approximately half of the grants to each of Ms. McCormack and Mr. Perelman were unrestricted. The other half of incentive equity granted to each of Ms. McCormack and Mr. Perelman is restricted stock subject to attainment of the Performance Target for the applicable years and is also subject to the Catch-Up Provision described above. For the grants to Mr. Miceli and Ms. Porcella (a total of 101,344 shares with an aggregate fair value of $1.2 million), approximately half of the awards are subject to time-based vesting criteria and the remaining half are subject to attainment of the Performance Target, including the Catch-Up Provision, for the applicable years.

On February 18, 2023, in connection with 2022 performance, annual stock awards were granted to certain Non-Management Grantees with an aggregate grant date fair value of $7.5 million, which represents 651,429 shares of Class A common stock. Of these awards, 19,558 shares were unrestricted, 306,162 shares are subject to time-based vesting criteria and the remaining 325,709 shares are subject to the attainment of the Performance Target, including the Catch-Up Provision, for the applicable years.

Other 2023 Restricted Stock Awards

On February 18, 2023, certain members of the board of directors received annual restricted stock awards with a grant date fair value of $0.4 million, representing 32,525 shares of restricted Class A common stock, which will vest in full on the first anniversary of the date of grant, subject to continued service on the board of directors. Compensation expense related to the time-based vesting criteria of the award shall be recognized on a straight-line basis over the one-year vesting period.
Change in Control

Upon a change in control (as defined in the respective award agreements), restricted stock awards to Mr. Miceli, Ms. McCormack, Mr. Perelman, Ms. Porcella (for her February 18, 2024 award), and one Non-Management Grantee will become fully vested if: (1) such Grantee continues to be employed through the closing of the change in control; or (2) after the signing of definitive documentation related to the change in control, but prior to its closing, such Grantee’s employment is terminated without cause or due to death or disability or the Grantee resigns for Good Reason, as defined in each Grantee’s employment agreement. The compensation committee retains the right, in its sole discretion, to provide for the accelerated vesting (in whole or in part) of the restricted stock awards granted.

In the event a Non-Management Grantee (except for the one grantee mentioned above and including Ms. Porcella, in regards to her awards granted prior to February 18, 2024), is terminated by the Company without cause within six months of certain changes in control, all unvested time shares shall vest on the termination date and all unvested performance shares shall remain outstanding and be eligible to vest (or be forfeited) in accordance with the performance conditions.

Performance Target

On September 18, 2025, the Company changed the Performance Target to 6% for all shares eligible to vest based on the Company’s performance for the years ended December 31, 2025, 2026 and 2027. Because the awards were already expected to vest under the original performance conditions, and the modification did not increase the award’s fair value, no incremental compensation cost was recognized. There are currently 36 Ladder employees who were affected by the modification.
v3.25.3
FAIR VALUE OF FINANCIAL INSTRUMENTS
9 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
FAIR VALUE OF FINANCIAL INSTRUMENTS 13. FAIR VALUE OF FINANCIAL INSTRUMENTS
 
Fair value is based upon internal models, using market quotations, broker quotations, counterparty quotations or pricing services quotations, which provide valuation estimates based upon reasonable market order indications and are subject to significant variability based on market conditions, such as interest rates, credit spreads and market liquidity. The fair value of the mortgage loan receivables held for sale is based upon a securitization model utilizing market data from recent securitization spreads and pricing.
 
Fair Value Summary Table
 
The carrying values and estimated fair values of the Company’s financial instruments, which are both reported at fair value on a recurring basis or amortized cost/par, at September 30, 2025 and December 31, 2024 are as follows ($ in thousands):
 
September 30, 2025
      Weighted Average
Assets:Principal Amount Amortized Cost Basis/Purchase PriceFair ValueFair Value MethodYield
%
Remaining
Maturity/Duration (years)
CMBS(1)$1,931,727  $1,930,288 $1,926,855 Internal model5.71 %2.79
CMBS interest-only(1)347,761 (2)1,660 1,754 Internal model8.95 %0.62
GNMA interest-only(3)29,509 (2)149 216 Internal model9.57 %2.79
Agency securities(1) Internal model2.39 %0.38
Equity securities(3) N/A 12,132 11,738 Observable market pricesN/A N/A
Mortgage loan receivables held for investment, net, at amortized cost(4)1,931,210  1,920,588 1,910,180 Discounted Cash Flow(5)8.16 %1.53
Mortgage loan receivables held for sale31,350  27,970 27,970 Internal model, third-party inputs(6)4.57 %6.44
Nonhedge derivatives(1)(7)112,500  284 284 Counterparty quotationsN/A0.26
Liabilities:       
Repurchase agreements - short-term361,638  361,638 361,638 Cost plus Accrued Interest(8)4.69 %0.05
Unsecured Revolving Credit Facility20,000 20,000 20,000 (9)5.37 %3.22
Mortgage loan financing399,092  401,656 397,990 Discounted Cash Flow6.18 %3.37
Senior unsecured notes2,233,409  2,213,938 2,254,223 Internal model5.29 %3.79
(1)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded as a component of other comprehensive income (loss) in equity.
(2)Represents notional outstanding balance of underlying collateral.
(3)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded in current period earnings.
(4)Balance does not include impact of allowance for current expected credit losses of $52.1 million at September 30, 2025.
(5)Fair value for floating rate mortgage loan receivables, held for investment is estimated to approximate the outstanding face amount given the short interest rate reset risk (30 days) and no significant change in credit spreads since origination. Fair value for fixed rate mortgage loan receivables, held for investment is measured using a discounted cash flow model.
(6)Fair value for mortgage loan receivables, held for sale is measured using a hypothetical securitization model utilizing market data from recent securitization spreads and pricing.
(7)The outstanding face amount of the nonhedge derivatives represents the notional amount of the underlying contracts.
(8)For repurchase agreements - short term, the value approximates the cost plus accrued interest.
(9)Fair value for the Unsecured Revolving Credit Facility is estimated to approximate the outstanding face.

December 31, 2024
      Weighted Average
Assets:Principal Amount Amortized Cost Basis/Purchase PriceFair ValueFair Value MethodYield
%
Remaining
Maturity/Duration (years)
CMBS(1)$1,065,985  $1,063,835 $1,058,873 Internal model6.13 %2.41
CMBS interest-only(1)769,724 (2)3,149 3,244 Internal model7.81 %0.87
GNMA interest-only(3)32,710 (2)160 155 Internal model9.38 %3.64
Agency securities(1)11  11 11 Internal model2.60 %0.58
Equity securities(3)N/A19,511 18,575 Observable market pricesN/A N/A
Mortgage loan receivables held for investment, net, at amortized cost(4)1,596,277  1,591,322 1,575,911 Discounted Cash Flow(5)9.36 %0.86
Mortgage loan receivables held for sale31,350  26,898 26,898 Internal model, third-party inputs(6)4.57 %7.18
Nonhedge derivatives(1)(9)90,000  437 437 Counterparty quotationsN/A0.62
Liabilities:       
Repurchase agreements - short-term62,738  62,738 62,738 Cost plus Accrued Interest(7)6.55 %0.74
Mortgage loan financing443,733  446,397 435,048 Discounted Cash Flow6.09 %3.36
CLO debt601,464 601,380 601,430 Discounted Cash Flow(8)2.01 %0.98
Senior unsecured notes2,041,557  2,025,053 2,001,207 Internal model5.22 %3.72
(1)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded as a component of other comprehensive income (loss) in equity.
(2)Represents notional outstanding balance of underlying collateral.
(3)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded in current period earnings.
(4)Balance does not include impact of allowance for current expected credit losses of $52.3 million at December 31, 2024.
(5)Fair value for floating rate mortgage loan receivables, held for investment is estimated to approximate the outstanding face amount given the short interest rate reset risk (30 days) and no significant change in credit spreads since origination. Fair value for fixed rate mortgage loan receivables, held for investment is measured using a discounted cash flow model.
(6)Fair value for mortgage loan receivables, held for sale is measured using a hypothetical securitization model utilizing market data from recent securitization spreads and pricing.
(7)For repurchase agreements - short term, the value approximates the cost plus accrued interest.
(8)For CLO debt, the carrying value approximates the fair value discounting the expected cash flows at current market rates. If the collateral is determined to be impaired, the related financing would be revalued accordingly. There are no impairments on any positions.
(9)The outstanding face amount of the nonhedge derivatives represents the notional amount of the underlying contracts.
The following table summarizes the Company’s financial assets and liabilities, which are both reported at fair value on a recurring basis (as indicated) or amortized cost/par, at September 30, 2025 and December 31, 2024 ($ in thousands):
 
September 30, 2025
 
Financial Instruments Reported at Fair Value on Consolidated Statements of Financial ConditionPrincipal
Amount
 Fair Value
 Level 1Level 2Level 3Total
Assets:      
CMBS(1)$1,922,777  $— $1,918,096 $— $1,918,096 
CMBS interest-only(1)339,765 (2)— 1,621 — 1,621 
GNMA interest-only(3)29,509 (2)— 216 — 216 
Agency securities(1) — — 
Equity securities N/A 11,738 — — 11,738 
Nonhedge derivatives(4)112,500 284 — — 284 
$12,022 $1,919,937 $ $1,931,959 
Financial Instruments Not Reported at Fair Value on Consolidated Statements of Financial ConditionPrincipal
Amount
 Fair Value
 Level 1Level 2Level 3Total
Assets:
Mortgage loan receivables held for investment, net, at amortized cost(5)$1,931,210  $— $— $1,910,180 $1,910,180 
Mortgage loan receivable held for sale(6)31,350  — — 27,970 27,970 
CMBS(7)8,951 — 8,759 — 8,759 
CMBS interest-only(7)7,996 — 133 — 133 
$ $8,892 $1,938,150 $1,947,042 
Liabilities:     
Repurchase agreements - short-term$361,638  $— $361,638 $— $361,638 
Unsecured Revolving Credit Facility20,000 — — 20,000 20,000 
Mortgage loan financing399,092  — — 397,990 397,990 
Senior unsecured notes2,233,409  — 2,254,223 — 2,254,223 
$ $2,615,861 $417,990 $3,033,851 
(1)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded as a component of other comprehensive income (loss) in equity.
(2)Represents notional outstanding balance of underlying collateral. 
(3)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded in current period earnings. 
(4)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded in current period earnings. The outstanding face amount of the nonhedge derivatives represents the notional amount of the underlying contracts.
(5)Balance does not include impact of allowance for current expected credit losses of $52.1 million at September 30, 2025.
(6)A lower of cost or market adjustment was recorded as of September 30, 2025.
(7)Restricted securities which are designated as risk retention securities under the Dodd-Frank Act and are therefore subject to transfer restrictions over the term of the securitization trust, are classified as held-to-maturity and reported at amortized cost.
December 31, 2024
 
Financial Instruments Reported at Fair Value on Consolidated Statements of Financial ConditionPrincipal
Amount
 Fair Value
 Level 1Level 2Level 3Total
Assets:      
CMBS(1)$1,056,844  $— $1,049,986 $— $1,049,986 
CMBS interest-only(1)761,537 (2)— 3,037 — 3,037 
GNMA interest-only(3)32,710 (2)— 155 — 155 
Agency securities(1)11  — 11 — 11 
Equity securities N/A 18,575 — — 18,575 
Nonhedge derivatives(4)90,000 — 437 — 437 
$18,575 $1,053,626 $ $1,072,201 
Financial Instruments Not Reported at Fair Value on Consolidated Statements of Financial ConditionPrincipal
Amount
 Fair Value
 Level 1Level 2Level 3Total
Assets:
Mortgage loan receivables held for investment, net, at amortized cost(5)$1,596,277  $— $— $1,575,911 $1,575,911 
Mortgage loan receivable held for sale(6)31,350  — — 26,898 26,898 
CMBS(7)9,142 — 8,887 — 8,887 
CMBS interest-only(7)8,187 — 207 — 207 
$ $9,094 $1,602,809 $1,611,903 
Liabilities:     
Repurchase agreements - short-term$62,738  $— $62,738 $— $62,738 
Mortgage loan financing443,733  — — 435,048 435,048 
CLO debt601,464 — 601,430 — 601,430 
Senior unsecured notes2,041,557  — 2,001,207 — 2,001,207 
$ $2,665,375 $435,048 $3,100,423 
(1)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded as a component of other comprehensive income (loss) in equity.
(2)Represents notional outstanding balance of underlying collateral. 
(3)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded in current period earnings. 
(4)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded in current period earnings. The outstanding face amount of the nonhedge derivatives represents the notional amount of the underlying contracts.
(5)Balance does not include impact of allowance for current expected credit losses of $52.3 million at December 31, 2024.
(6)A lower of cost or market adjustment was recorded as of December 31, 2024.
(7)Restricted securities which are designated as risk retention securities under the Dodd-Frank Act and are therefore subject to transfer restrictions over the term of the securitization trust, are classified as held-to-maturity and reported at amortized cost.
(8)As of December 31, 2024, the Company determined that $2.0 billion of senior unsecured notes were level 2 based on the Company’s increased observability of the inputs used to internally value the senior unsecured notes.

The Company did not have any Level 3 financial instruments as of September 30, 2025 and December 31, 2024.

Nonrecurring Fair Values

The Company measures fair value of certain assets on a nonrecurring basis when events or changes in circumstances indicate that the carrying value of the assets may be impaired. Adjustments to fair value generally result from the application of lower of amortized cost or fair value accounting for assets held for sale or write-down of assets value due to impairment. Refer to Note 3, Mortgage Loan Receivables and Note 5, Real Estate and Related Lease Intangibles, Net, for disclosure of Level 3 inputs for certain assets measured on a nonrecurring basis.
v3.25.3
INCOME TAXES
9 Months Ended
Sep. 30, 2025
Income Tax Disclosure [Abstract]  
INCOME TAXES
14. INCOME TAXES

The Company elected to be taxed as a REIT under the Internal Revenue Code (“the Code”), commencing with the taxable year ended December 31, 2015 (the REIT Election”). As such, the Company’s income is generally not subject to U.S. federal, state and local corporate income taxes other than as described below.
Certain of the Company’s subsidiaries have elected to be treated as TRSs. TRSs permit the Company to participate in certain activities from which REITs are generally precluded, as long as these activities meet specific criteria, are conducted within the parameters of certain limitations established by the Code, and are conducted in entities which elect to be treated as taxable subsidiaries under the Code. To the extent these criteria are met, the Company will continue to maintain its qualification as a REIT. The Company’s TRSs are not consolidated for U.S. federal income tax purposes, but are instead taxed as corporations. For financial reporting purposes, a provision for current and deferred taxes is established for the portion of earnings recognized by the Company with respect to its interest in TRSs. Current income tax expense (benefit) was $1.0 million and $2.1 million for the three and nine months ended September 30, 2025, respectively, and $0.4 million and $1.2 million for the three and nine months ended September 30, 2024, respectively.

As of September 30, 2025 and December 31, 2024, the Company’s net deferred tax assets (liabilities) were $(6.3) million and $(4.6) million, respectively, and are included in other assets (liabilities) in the Company’s consolidated balance sheets. Deferred income tax expense (benefit) included within the provision for income taxes was $(0.1) million and $0.5 million for the three months ended September 30, 2025 and September 30, 2024, respectively. Deferred income tax expense (benefit) included within the provision for income taxes was $1.7 million and $0.6 million for the nine months ended September 30, 2025 and September 30, 2024, respectively. The Company’s net deferred tax liability is comprised of deferred tax assets and deferred tax liabilities. The Company believes it is more likely than not that the deferred tax assets (aside from the exception noted below) will be realized in the future. Realization of the deferred tax assets is dependent upon the Company’s generation of sufficient taxable income in future years in appropriate tax jurisdictions to obtain benefit from the reversal of temporary differences. The amount of deferred tax assets considered realizable is subject to adjustment in future periods if estimates of future taxable income change.
 
As of September 30, 2025, the Company had a deferred tax asset of $0.1 million relating to capital losses which it may only use to offset capital gains. These tax attributes will begin to expire if unused by December 31, 2025. As the realization of these assets are not more likely than not to be realized before their expiration, the Company provided a full valuation allowance against this deferred tax asset. Additionally, as of September 30, 2025, the Company had $2.1 million of deferred tax assets related to the Code Section 163(j) interest expense limitation. As the Company is uncertain if this asset will be realized in the future, the Company provided a full valuation allowance against this deferred tax asset.

The Company’s tax returns are subject to audit by taxing authorities. Generally, as of September 30, 2025, the tax years 2021-2024 remain open to examination by the major taxing jurisdictions in which the Company is subject to taxes. Two of the Company’s subsidiary entities are currently under audit in New York City for tax years 2014-2020 and 2022-2023, respectively. The Company does not expect these audits to result in any material changes to the Company’s financial position or performance. The Company does not expect tax expense to have an impact on either short, or long-term liquidity or capital needs.

Under U.S. GAAP, a tax benefit related to an income tax position may be recognized when it is more likely than not that the position will be sustained upon examination by the tax authorities based on the technical merits of the position. As of September 30, 2025 and December 31, 2024, the Company did not have any unrecognized tax benefits. As of September 30, 2025, the Company has not recognized interest or penalties related to uncertain tax positions. In addition, the Company does not believe that it has any tax positions for which it is reasonably possible that it will be required to record a significant liability for unrecognized tax benefits within the next twelve months.

On July 4, 2025, H.R.1, referred to as the One Big Beautiful Bill Act (“OBBBA”), was signed into law. OBBBA permanently extends and modifies certain provisions of the Tax Cuts and Jobs Act of 2017, including the Internal Revenue Code Section 199A qualified business income deduction that allows certain investors to continue deducting 20% of their qualified REIT dividends. Additionally, OBBBA modifies the REIT asset test requirement with respect to TRSs, providing that not more than 25% (previously 20%) of the gross value of a REIT’s assets may be represented by securities of TRS subsidiaries (effective in 2026). The OBBBA legislation is not expected to have a material impact on our effective tax rate, deferred tax position, or results of operations in 2025.
v3.25.3
RELATED PARTY TRANSACTIONS
9 Months Ended
Sep. 30, 2025
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS
15. RELATED PARTY TRANSACTIONS

The Company has no material related party relationships to disclose.
v3.25.3
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Sep. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
16. COMMITMENTS AND CONTINGENCIES
Leases

As of September 30, 2025, the Company had a $14.9 million lease liability and a $14.0 million right-of-use asset on its consolidated balance sheet recorded within other liabilities and other assets, respectively. The right-of-use lease asset relates to the Company’s operating lease of office space. Right-of-use lease assets initially equal the lease liability. The Company recognized $0.9 million and $2.8 million for the three and nine months ended September 30, 2025, respectively, and $0.5 million and $1.6 million for the three and nine months ended September 30, 2024, respectively, in operating expenses in its consolidated statements of income relating to operating leases.
Future minimum lease payments under non-cancelable operating leases as of September 30, 2025 are as follows ($ in thousands):

Period ending December 31,Minimum Lease Payments
2025 (last three months)$873 
20262,597 
20272,232 
20282,306 
20292,409 
Thereafter8,629 
Total undiscounted cash flows19,046 
Present value discount (1)(4,151)
Lease liabilities (2)$14,895 
(1)Lease liabilities were discounted at the Company's weighted average incremental borrowing rate, estimated at the time of lease commencement, for similar collateral, which was 6.59%. The average remaining lease term is 7.6 years.
(2)The Company has a five-year extension option on its corporate headquarters office at 320 Park Avenue, New York, New York, which is not reflected in the total lease liability.

Unfunded Loan Commitments

As of September 30, 2025, the Company’s off-balance sheet arrangements consisted of $76.0 million of unfunded commitments on mortgage loan receivables held for investment to provide additional first mortgage loan financing over the next three years at rates to be determined at the time of funding. 52% of these unfunded commitments require the occurrence of certain “good news” events, such as the owner concluding a lease agreement with a major tenant in the building or reaching some pre-determined net operating income. As of December 31, 2024, the Company’s off-balance sheet arrangements consisted of $34.6 million of unfunded commitments on mortgage loan receivables held for investment to provide additional first mortgage loan financing.

Commitments are subject to the Company’s loan borrowers’ satisfaction of certain financial and nonfinancial covenants and may or may not be funded depending on a variety of circumstances including timing, credit metric hurdles, and other nonfinancial events occurring. The Company carefully monitors the progress of work at properties that serve as collateral underlying its commercial mortgage loans, including the progress of capital expenditures, construction, leasing and business plans in light of current market conditions. These commitments are not reflected on the consolidated balance sheets. 

Unsettled Trades

As of December 31, 2024, the Company had $10.0 million of U.S. Treasury securities traded and not yet settled on its consolidated balance sheet. The U.S. Treasury securities are recorded within other assets, and the related payable is recorded within other liabilities. These balances relate to the Company’s purchase of U.S. Treasury securities with maturities of less than three months, which will be recorded within cash and cash equivalents upon settlement. The payable within other liabilities at December 31, 2024 was paid during the nine months ended September 30, 2025.
v3.25.3
SEGMENT REPORTING
9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
SEGMENT REPORTING
17. SEGMENT REPORTING

The Company has determined that it has three reportable segments based on how the chief operating decision maker (“CODM”), the Chief Executive Officer, reviews and manages the business. The CODM uses net income (loss) to measure segment operating performance. All of the Company’s expenses are reviewed regularly and are included in segment operating performance. These reportable segments include loans, securities, and real estate. The loans segment includes all of the Company’s activities related to mortgage loan receivables held for investment (balance sheet loans) and mortgage loan receivables held for sale (conduit loans). The securities segment includes of all of the Company’s activities related to securities, which include investments in CMBS, U.S. Agency securities, corporate bonds, equity securities and U.S. Treasury securities not classified as cash and cash equivalents. The real estate segment includes all of the Company’s activities related to net leased properties, other diversified real estate and investments in unconsolidated ventures. Corporate/other includes cash and cash equivalents, senior unsecured notes, compensation and employee benefits, operating expenses, and unallocated items including any inter-segment eliminations necessary to reconcile to consolidated Company totals.
The Company evaluates performance based on the following financial measures for each segment ($ in thousands):

Three months ended September 30, 2025LoansSecuritiesReal Estate (1)Corporate/Other(2)Company 
Total
Net interest income
Interest income$42,549 $28,272 $39 $908 $71,768 
Interest expense(766)(4,267)(6,334)(32,611)(43,978)
Net interest income (expense)41,783 24,005 (6,295)(31,703)27,790 
(Provision for) release of loan loss reserves31 — — — 31 
Net interest income (expense) after provision for (release of) loan reserves41,814 24,005 (6,295)(31,703)27,821 
Other income (loss)
Real estate operating income— — 26,666 — 26,666 
Net result from mortgage loan receivables held for sale(377)— — — (377)
Fee and other income1,667 2,150 47 — 3,864 
Net result from derivative transactions— — (16)37 21 
Earnings (loss) from investment in unconsolidated ventures— — (414)— (414)
Gain (loss) on extinguishment of debt— — — (106)(106)
Total other income (loss)1,290 2,150 26,283 (69)29,654 
Costs and expenses
Compensation and employee benefits— — — (11,552)(11,552)
Operating expenses— — — (5,276)(5,276)
Real estate operating expenses— — (11,424)— (11,424)
Investment related expenses(643)(3)(132)(77)(855)
Depreciation and amortization— — (8,124)(114)(8,238)
Total costs and expenses(643)(3)(19,680)(17,019)(37,345)
Income (loss) before taxes42,461 26,152 308 (48,791)20,130 
Income tax (expense) benefit— — — (960)(960)
Segment net income (loss)$42,461 $26,152 $308 $(49,751)$19,170 
Total assets as of September 30, 2025$1,896,423 $1,940,547 $724,000 $125,574 $4,686,544 
Three months ended September 30, 2024LoansSecuritiesReal Estate (1)Corporate/Other(2)Company 
Total
Net interest income
Interest income$63,799 $11,727 $86 $20,480 $96,092 
Interest expense(21,718)(4)(7,945)(28,009)(57,676)
Net interest income (expense)42,081 11,723 (7,859)(7,529)38,416 
(Provision for) release of loan loss reserves(3,063)— — — (3,063)
Net interest income (expense) after provision for (release of) loan reserves39,018 11,723 (7,859)(7,529)35,353 
Other income (loss)
Real estate operating income— — 25,294 — 25,294 
Net result from mortgage loan receivables held for sale1,143 — — (51)1,092 
Gain (loss) on real estate, net— — 315 — 315 
Fee and other income6,499 17 25 68 6,609 
Net result from derivative transactions(249)— (168)(349)(766)
Earnings (loss) from investment in unconsolidated ventures— — (14)— (14)
Gain (loss) on extinguishment of debt— — — 20 20 
Total other income (loss)7,393 17 25,452 (312)32,550 
Costs and expenses
Compensation and employee benefits— — — (14,407)(14,407)
Operating expenses— — — (4,508)(4,508)
Real estate operating expenses— — (10,751)— (10,751)
Investment related expenses(691)(45)(97)(795)(1,628)
Depreciation and amortization— — (8,036)(110)(8,146)
Total costs and expenses(691)(45)(18,884)(19,820)(39,440)
Income (loss) before taxes45,720 11,695 (1,291)(27,661)28,463 
Income tax (expense) benefit— — — (901)(901)
Segment net income (loss)$45,720 $11,695 $(1,291)$(28,562)$27,562 
Total assets as of December 31, 2024$1,565,897 $1,080,839 $690,726 $1,507,611 $4,845,073 
Nine months ended September 30, 2025LoansSecuritiesReal Estate (1)Corporate/Other(2)Company 
Total
Net interest income
Interest income$112,780 $71,497 $238 $14,315 $198,829 
Interest expense(14,154)(5,299)(19,578)(90,149)(129,180)
Net interest income (expense)98,626 66,198 (19,340)(75,834)69,649 
(Provision for) release of loan loss reserves154 — — — 154 
Net interest income (expense) after provision for (release of) loan reserves98,780 66,198 (19,340)(75,834)69,803 
Other income (loss)
Real estate operating income— — 74,214 — 74,214 
Net result from mortgage loan receivables held for sale4,700 — — — 4,700 
Gain (loss) on real estate, net— — 3,807 — 3,807 
Fee and other income7,147 4,740 65 — 11,952 
Net result from derivative transactions1,301 — 55 514 1,870 
Earnings (loss) from investment in unconsolidated ventures— — (1,434)— (1,434)
Gain (loss) on extinguishment of debt— — — 151 151 
Total other income (loss)13,148 4,740 76,707 665 95,260 
Costs and expenses
Compensation and employee benefits— — — (41,874)(41,874)
Operating expenses— — — (14,559)(14,559)
Real estate operating expenses— — (30,456)— (30,456)
Investment related expenses(1,376)(170)(324)(1,017)(2,887)
Depreciation and amortization— — (23,286)(331)(23,617)
Total costs and expenses(1,376)(170)(54,066)(57,781)(113,393)
Income (loss) before taxes110,552 70,768 3,301 (132,950)51,670 
Income tax (expense) benefit— — — (3,836)(3,836)
Segment net income (loss)$110,552 $70,768 $3,301 $(136,786)$47,834 
Total assets as of September 30, 2025$1,896,423 $1,940,547 $724,000 $125,574 $4,686,544 
Nine months ended September 30, 2024LoansSecuritiesReal Estate (1)Corporate/Other(2)Company 
Total
Net interest income
Interest income$201,233 $27,670 $268 $51,349 $280,520 
Interest expense(77,159)(61)(24,567)(68,860)(170,647)
Net interest income (expense)124,074 27,609 (24,299)(17,511)109,873 
(Provision for) release of loan loss reserves(13,886)— — — (13,886)
Net interest income (expense) after provision for (release of) loan reserves110,188 27,609 (24,299)(17,511)95,987 
Other income (loss)
Real estate operating income— — 75,314 — 75,314 
Net result from mortgage loan receivables held for sale3,308 — — (2,670)638 
Gain (loss) on real estate, net— — 12,858 — 12,858 
Fee and other income12,195 100 1,352 300 13,947 
Net result from derivative transactions185 80 38 3,568 3,871 
Earnings (loss) from investment in unconsolidated ventures— — (11)— (11)
Gain (loss) on extinguishment of debt— — — 197 197 
Total other income (loss)15,688 180 89,551 1,395 106,814 
Costs and expenses
Compensation and employee benefits— — — (48,917)(48,917)
Operating expenses— — — (14,331)(14,331)
Real estate operating expenses— — (30,930)— (30,930)
Investment related expenses(3,910)(138)(449)(1,412)(5,909)
Depreciation and amortization— — (24,532)(329)(24,861)
Total costs and expenses(3,910)(138)(55,911)(64,989)(124,948)
Income (loss) before taxes121,966 27,651 9,341 (81,105)77,853 
Income tax (expense) benefit— — — (1,737)(1,737)
Segment net income (loss)$121,966 $27,651 $9,341 $(82,842)$76,116 
Total assets as of December 31, 2024$1,565,897 $1,080,839 $690,726 $1,507,611 $4,845,073 
Includes the Company’s investment in unconsolidated ventures that held real estate of $18.5 million and $19.9 million as of September 30, 2025 and December 31, 2024, respectively.
(2)Corporate/Other represents all corporate level and unallocated items including any inter-segment eliminations necessary to reconcile to consolidated Company totals. This segment also includes the Company’s senior unsecured notes of $2.2 billion and $2.0 billion at September 30, 2025 and December 31, 2024, respectively.
v3.25.3
SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2025
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
18. SUBSEQUENT EVENTS

The Company has evaluated subsequent events through the issuance date of the financial statements and determined that no additional disclosure is necessary.
v3.25.3
Insider Trading Arrangements
3 Months Ended
Sep. 30, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.3
SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Basis of Accounting and Principles of Consolidation
Basis of Accounting and Principles of Consolidation
The accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). In the opinion of management, the unaudited financial information for the interim periods presented in this report reflects all normal and recurring adjustments necessary for a fair statement of results of operations, financial position and cash flows. The interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2024, which are included in the Annual Report, as certain disclosures that would substantially duplicate those contained in the audited consolidated financial statements have not been included in this interim report. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year.
The consolidated financial statements include the Company’s accounts and those of its subsidiaries that are majority-owned and/or controlled by the Company and variable interest entities for which the Company has determined itself to be the primary beneficiary, if any. All significant intercompany transactions and balances have been eliminated.
 
Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810 — Consolidation (“ASC 810”), provides guidance on the identification of entities for which control is achieved through means other than voting rights (“variable interest entities” or “VIEs”) and the determination of which business enterprise, if any, should consolidate the VIEs. Generally, the consideration of whether an entity is a VIE applies when either: (1) the equity investors (if any) lack one or more of the essential characteristics of a controlling financial interest; (2) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support; or (3) the equity investors have voting rights that are not proportionate to their economic interests and the activities of the entity involve or are conducted on behalf of an investor with a disproportionately small voting interest. The Company consolidates VIEs in which it is considered to be the primary beneficiary. The primary beneficiary is the entity that has both of the following characteristics: (1) the power to direct the activities that, when taken together, most significantly impact the VIE’s performance; and (2) the obligation to absorb losses and right to receive the returns from the VIE that would be significant to the VIE.
The Company has investments in two unconsolidated ventures, which were determined to be VIEs. The Company determined that it was not the primary beneficiary of these VIEs because the Company does not have power over these entities and therefore does not have controlling financial interests in these VIEs. These investments are recorded on the consolidated balance sheets within investments in and advances to unconsolidated ventures. The Company’s maximum exposure to loss is limited to its investments in these VIEs. The Company has not provided financial support to these unconsolidated VIEs that it was not previously contractually required to provide.
Allowance for Loan Losses
Allowance for Loan Losses

The Company uses a current expected credit loss model (“CECL”) for estimating the provision for loan losses on its loan portfolio. The CECL model requires the consideration of possible credit losses over the life of an instrument and includes a portfolio-based component and an asset-specific component. The Company engages a third-party service provider to provide market data and a credit loss model. The credit loss model is a forward-looking, econometric, commercial real estate (“CRE”) loss forecasting tool. It is comprised of a probability of default (“PD”) model and a loss given default (“LGD”) model that, layered together with the Company’s loan-level data, fair value of collateral, net operating income of collateral, selected forward-looking macroeconomic variables, and pool-level mean loss rates, produces life of loan expected losses (“EL”) at the loan and portfolio level. Where management has determined that the credit loss model does not fully capture certain external factors, including portfolio trends or loan-specific factors, a qualitative adjustment to the reserve is recorded. In addition, interest receivable on loans is not included in the Company’s CECL calculations as the Company performs timely write offs of aged interest receivable. The Company has made a policy election to write off aged receivables through interest income as opposed to through the CECL provision on its statements of income.

Loans for which the borrower or sponsor is experiencing financial difficulty, and where repayment of the loan is expected substantially through the operation or sale of the underlying collateral, are considered collateral dependent loans. For collateral dependent loans, the Company may elect a practical expedient that allows the Company to measure expected losses based on the difference between the collateral’s fair value and the amortized cost basis of the loan. When the repayment or satisfaction of the loan is dependent on a sale, rather than operations of the collateral, the fair value is adjusted for the estimated costs to sell the collateral. If foreclosure is probable, the Company is required to measure for expected losses using this methodology.

The Company generally will use the direct capitalization rate valuation methodology or the sales comparison approach to estimate the fair value of the collateral for loans and in certain cases will obtain external appraisals. Determining fair value of the collateral may take into account a number of assumptions including, but not limited to, cash flow projections, market capitalization rates, discount rates and data regarding recent comparable sales of similar properties. Such assumptions are generally based on current market conditions and are subject to economic and market uncertainties.

The Company’s loans are typically collateralized by real estate directly or indirectly. As a result, the Company regularly evaluates the extent and impact of any credit deterioration associated with the performance and/or value of the underlying collateral property as well as the financial and operating capability of the borrower/sponsor on a loan-by-loan basis. Specifically, a property’s operating results and any cash reserves are analyzed and used to assess: (i) whether cash flow from operations is sufficient to cover the debt service requirements currently and into the future; (ii) the ability of the borrower to refinance the loan at maturity; and/or (iii) the property’s liquidation value. The Company also evaluates the financial wherewithal of any loan guarantors as well as the borrower’s competency in managing and operating the properties. In addition, the Company considers the overall economic environment, real estate sector, and geographic submarket in which the collateral property is located. Such impairment analyses are completed and reviewed by asset management and underwriting personnel, who utilize various data sources, including: (i) periodic financial data such as property occupancy, tenant profile, rental rates, operating expenses, the borrowers’ business plan, and capitalization and discount rates; (ii) site inspections; and (iii) current credit spreads and other market data and ultimately presented to management for approval.

When a debtor is experiencing financial difficulties and a loan is modified, the effect of the modification will be included in the Company’s assessment of the CECL allowance for loan losses. If the Company provides principal forgiveness, the amortized cost basis of the loan is written off against the allowance for loan losses. Generally, when modifying loans, the Company will seek to protect its position by requiring incremental pay downs, additional collateral or guarantees and, in some cases, lookback features or equity interests to offset concessions granted should conditions impacting the loan improve.

The Company designates a loan as a non-accrual loan generally when: (i) the principal or coupon interest components of loan payments become 90-days past due; or (ii) in the opinion of the Company, recovery of principal and coupon interest is doubtful. Interest income on non-accrual loans in which the Company reasonably expects a recovery of the loan’s outstanding principal balance is recognized when received in cash. Otherwise, income recognition will be suspended and any cash received will be applied as a reduction to the amortized cost basis. A non-accrual loan is returned to accrual status at such time as the loan
becomes contractually current and future principal and coupon interest are reasonably assured to be received. A loan will be charged-off when management has determined principal and coupon interest is no longer realizable and deemed non-recoverable.
Transfers of Financial Assets
Transfers of Financial Assets

For a transfer of financial assets to be considered a sale, the transfer must meet the sale criteria of ASC 860, which, at the time of the transfer, require that the transferred assets qualify as recognized financial assets and the Company surrender control over the assets. Such surrender requires that the assets be isolated from the Company, even in bankruptcy or other receivership, the purchaser have the right to pledge or sell the assets transferred and the Company not have an option or obligation to reacquire the assets. If the sale criteria are not met, the transfer is considered to be a secured borrowing, the assets remain on the Company’s consolidated balance sheets and the sale proceeds are recognized as a liability. In November 2017, the SEC staff indicated that, despite transfer restrictions placed on qualified Third Party Purchasers by the risk retention rules of the Dodd-Frank Act, they would not take exception to a registrant treating transfers of financial instruments in a securitization as sales if the transfers otherwise met all the criteria for sale accounting. The Company believes treatment of such transfers as sales is consistent with the substance of such transactions and, accordingly, reflects such transfers as sales. The Company recognizes gains on sale of loans net of any costs related to that sale.
Debt Issued
Debt Issued

From time to time, a subsidiary of the Company will originate a loan (each, an “inter-segment loan,” and collectively, “inter-segment loans”) to another subsidiary of the Company to finance the purchase of real estate. The mortgage loan receivable and the related obligation do not appear in the Company’s consolidated balance sheets as they are eliminated upon consolidation. Once the Company issues (sells) an inter-segment loan to a third-party securitization trust (for cash), the related mortgage note is recognized as a financing transaction and accounted for under ASC 470. The accounting for the securitization of an inter-segment loan—a financial instrument that has never been recognized in the consolidated financial statements as an asset—is considered a financing transaction under ASC 470 and ASC 835.
The periodic securitization of the Company’s mortgage loans involves both inter-segment loans and mortgage loans made to third parties with the latter recognized as financial assets in the Company’s consolidated financial statements as part of an integrated transaction. The Company receives aggregate proceeds equal to the transaction’s all-in securitization value and sales price. In accordance with the guidance under ASC 835, when initially measuring the obligation arising from an inter-segment loan’s securitization, the Company allocates the proceeds from each securitization transaction between the third-party loans and each inter-segment loan securitized on a relative fair value basis determined in accordance with the guidance in ASC 820. The difference between the amount allocated to each inter-segment loan and the loan’s face amount is recorded as a premium or discount, and is amortized, using the effective interest method, as a reduction or increase in reported interest expense, respectively.
Reclassification
Reclassification

Certain other prior period amounts have been reclassified to conform to the current period's presentation.
Recently Adopted Accounting Pronouncements and Recent Accounting Pronouncements Pending Adoption
Recently Adopted Accounting Pronouncements

In November 2023, the FASB issued ASU 2023-07—Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied retrospectively to all prior periods presented in the financial statements. Upon transition, the segment expense categories and amounts disclosed in the prior periods should be based on the significant segment expense categories identified and disclosed in the period of adoption. The Company adopted ASU 2023-07 during the fourth quarter of 2024 and the adoption of ASU 2023-07 did not have a material impact on the Company’s consolidated financial statements.
Recent Accounting Pronouncements Pending Adoption

In December 2023, the FASB issued ASU 2023-09—Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 improves the transparency of income tax disclosures related to rate reconciliation and income taxes. ASU 2023-07 is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The amendments should be applied prospectively, however retrospective application is permitted. The adoption of ASU 2023-09 is not expected to have a material impact on the Company’s consolidated financial statements.

In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses (“DISE”). DISE requires disaggregated disclosure of income statement expenses for public business entities. ASU 2024-03 does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. As revised by ASU No. 2025-01, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures, the provisions of ASU 2024-03 are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. With the exception of expanding disclosures to include more granular income statement expense categories, we do not expect the adoption of ASU 2024-03 to have a material effect on our consolidated financial statements.

Any new accounting standards not disclosed above that have been issued or proposed by FASB and that do not require adoption until a future date are being evaluated or are not expected to have a material impact on the consolidated financial statements upon adoption.
v3.25.3
MORTGAGE LOAN RECEIVABLES (Tables)
9 Months Ended
Sep. 30, 2025
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]  
Schedule of Mortgage Loan Receivables
September 30, 2025 ($ in thousands)
Outstanding
Face Amount
Carrying
Value
Weighted
Average
Yield (1)(2)
Remaining
Maturity
(years)(2)(3)
Mortgage loan receivables held for investment, net, at amortized cost:
First mortgage loans$1,923,888 $1,913,275 8.14 %1.5
Mezzanine loans7,322 7,313 11.24 %0.8
Total mortgage loans receivable1,931,210 1,920,588 8.16 %1.5
Allowance for credit losses N/A (52,135)
Total mortgage loan receivables held for investment, net, at amortized cost1,931,210 1,868,453 
Mortgage loan receivables held for sale:
First mortgage loans31,350 27,970 (4)4.57 %6.4
Total$1,962,560 $1,896,423 (5)8.10 %1.6
(1)Includes the impact of interest rate floors. Term SOFR rates in effect as of September 30, 2025 are used to calculate weighted average yield for floating rate loans.
(2)Excludes three non-accrual loans with an amortized cost basis of $122.9 million. Refer to “Non-Accrual Status” below for further details.
(3)The remaining maturity is calculated based on the initial maturity. The weighted average extended maturity for all loans is 2.7 years.
(4)As a result of changes in prevailing rates, the Company recorded a lower of cost or market adjustment as of September 30, 2025. The adjustment was calculated using a 5.03% discount rate.
(5)Net of $10.8 million of deferred origination fees and other items as of September 30, 2025.
December 31, 2024 ($ in thousands)
Outstanding
Face Amount
Carrying
Value
Weighted
Average
Yield (1)(2)
Remaining
Maturity
(years)(2)(3)
Mortgage loan receivables held for investment, net, at amortized cost:
First mortgage loans$1,584,674 $1,579,740 9.34 %0.9
Mezzanine loans11,603 11,582 11.51 %1.1
Total mortgage loans receivable1,596,277 1,591,322 9.36 %0.9
Allowance for credit losses— (52,323)
Total mortgage loan receivables held for investment, net, at amortized cost1,596,277 1,538,999 
Mortgage loan receivables held for sale:
First mortgage loans31,350 26,898 (4)4.57 %7.2
Total$1,627,627 $1,565,897 (5)9.27 %1.0
(1)Includes the impact of interest rate floors. Term SOFR rates in effect as of December 31, 2024 are used to calculate weighted average yield for floating rate loans.
(2)Excludes two non-accrual loans with an amortized cost basis of $76.9 million. Refer to “Non-Accrual Status” below for further details.
(3)The remaining maturity is calculated based on the initial maturity. The weighted average extended maturity for all loans is 1.6 years.
(4)As a result of rising prevailing rates, the Company recorded a reversal of lower of cost or market adjustment as of December 31, 2024. The adjustment was calculated using a 5.20% discount rate.
(5)Net of $5.0 million of deferred origination fees and other items as of December 31, 2024.
Schedule of Mortgage Loan Receivables by Loan Type
For the nine months ended September 30, 2025 and 2024, loan portfolio activity was as follows ($ in thousands):
Mortgage loan receivables held for investment, net, at amortized cost:
 Mortgage loans receivableAllowance for credit lossesMortgage loan 
receivables held
for sale
Balance, December 31, 2024$1,591,322 $(52,323)$26,898 
Origination of mortgage loan receivables (1)888,703 — 63,360 
Repayment of mortgage loan receivables(502,101)— (141)
Proceeds from sales of mortgage loan receivables— — (66,847)
Non-cash disposition of loans via foreclosure(65,078)— — 
Net result from mortgage loan receivables held for sale (2)— — 4,700 
Accretion/amortization of discount, premium and other fees7,742 — — 
Release (addition) of provision for current expected credit loss, net (3)— 188 — 
Balance, September 30, 2025$1,920,588 $(52,135)$27,970 
(1)Includes funding of commitments on existing mortgage loans.
(2)Includes unrealized lower of cost or market adjustment reversal of $1.1 million and realized gain on loans held for sale of $3.6 million.
(3)Refer to “Allowance for Credit Losses” table below for further detail.
Mortgage loan receivables held for investment, net, at amortized cost:
 Mortgage loans receivableAllowance for credit lossesMortgage loan 
receivables held
for sale
Balance, December 31, 2023$3,155,089 $(43,165)$26,868 
Origination of mortgage loan receivables (1)71,810 — — 
Repayment of mortgage loan receivables (2)(1,142,343)— — 
Proceeds from sales of mortgage loan receivables (3)— — — 
Non-cash disposition of loans via foreclosure (4)(55,946)5,023 — 
Net result from mortgage loan receivables held for sale (5)— — 638 
Accretion/amortization of discount, premium and other fees10,935 — — 
Release (addition) of provision for current expected credit loss, net (6)— (14,134)— 
Balance, September 30, 2024$2,039,545 $(52,276)$27,506 
(1)Includes funding of commitments on existing mortgage loans.
(2)Includes $19.7 million of repayments in transit.
(3)Excludes $82.5 million of proceeds received from the sale of conduit mortgage loans collateralized by net leased properties in the Company’s real estate segment to a third-party securitization trust. The mortgage loan receivables, which were originated during the current period, and the related obligation do not appear in the Company’s consolidated balance sheets as they are eliminated upon consolidation. Upon the sale of the mortgage loan receivable to a third-party securitization trust (for cash), the related mortgage note is recognized as a financing transaction.
(4)Refer to Note 5, Real Estate and Related Lease Intangibles, Net, for further detail on foreclosures of real estate.
(5)Includes unrealized lower of cost or market adjustment and realized gain/loss on loans held for sale.
(6)Refer to “Allowance for Credit Losses” table below for further detail.
Schedule of Provision for Loan Losses
Allowance for Credit Losses and Non-Accrual Status ($ in thousands)
Three Months Ended September 30,Nine Months Ended September 30,
Allowance for Credit Losses2025202420252024
Allowance for credit losses at beginning of period$52,166 $54,107 $52,323 $43,165 
Provision for (release of) current expected credit loss, net(1)(31)3,192 (188)14,134 
Charge-offs (2)— (5,023)— (5,023)
Allowance for credit losses at end of period$52,135 $52,276 $52,135 $52,276 
(1)As of September 30, 2025 and 2024, there were no asset-specific reserves.
(2)The charge-off related to one loan that was resolved via foreclosure during the three months ended September 30, 2024. The loan was collateralized by an office property in Oakland, California.

Non-Accrual Status (1)
September 30,
2025(2)
December 31, 2024(3)
Amortized cost basis of loans on non-accrual status$122,920 $76,875 
(1)As of September 30, 2025, $122.9 million of loans on non-accrual status were greater than 90 days past due. As of December 31, 2024, $76.9 million of loans on non-accrual status were greater than 90 days past due. For the nine months ended September 30, 2025, the Company recognized $4.0 million of interest income on these loans while on non-accrual status.
(2)Comprised of one multi-family loan with an amortized cost basis of $60.9 million, one hotel loan with an amortized cost basis of $11.9 million and one multi-family loan with an amortized cost basis of $50.1 million, for which the Company determined no asset-specific reserves were necessary.
(3)Comprised of one multi-family loan with an amortized cost basis of $60.9 million and one mixed-use loan with an
amortized cost basis of $16.0 million, for which the Company determined no asset-specific reserve was necessary.
Schedule of Individually Impaired Loans
Management’s method for monitoring credit is the performance of a loan. The primary credit quality indicator management utilizes to assess its current expected credit loss reserve is by viewing the Company’s mortgage loan portfolio by collateral type. The primary credit quality indicator is reviewed by management on a quarterly basis. The following tables summarize the amortized cost of the mortgage loan portfolio by collateral type as of September 30, 2025 and December 31, 2024, respectively ($ in thousands):

Amortized Cost Basis by Origination Year as of September 30, 2025
Collateral Type20252024202320222021 and EarlierTotal (2)(3)
Multifamily$662,980 $127,107 $14,641 $23,206 $110,977 $938,911 
Office 21,945 — — 55,950 572,551 650,446 
Industrial123,379 27,212 — — — 150,591 
Mixed Use18,198 — — — 33,121 51,319 
Other48,730 — — 11,945 — 60,675 
Retail14,824 10,457 — — 24,111 49,392 
Hospitality— — — — 19,254 19,254 
Subtotal mortgage loans receivable890,056 164,776 14,641 91,101 760,014 1,920,588 
Individually Impaired loans— — — — — — 
Total mortgage loans receivable (1)$890,056 $164,776 $14,641 $91,101 $760,014 $1,920,588 
Amortized Cost Basis by Origination Year as of December 31, 2024
Collateral Type20242023202220212020 and EarlierTotal (4)
Office$— $— $59,944 $518,663 $185,242 $763,849 
Multifamily126,588 14,636 105,324 272,291 — 518,839 
Mixed Use— — — 127,380 — 127,380 
Retail23,833 — — 48,628 — 72,461 
Hospitality— — — 13,064 55,260 68,324 
Industrial26,368 — — — — 26,368 
Other— — 14,101 — — 14,101 
Subtotal mortgage loans receivable176,789 14,636 179,369 980,026 240,502 1,591,322 
Individually Impaired loans— — — — — — 
Total mortgage loans receivable (5)(6)$176,789 $14,636 $179,369 $980,026 $240,502 $1,591,322 
(1)Not included above is $9.8 million of accrued interest receivable on all loans at September 30, 2025.
(2)For purposes of calculating our CECL allowance, one loan collateralized by a hospitality property and two loans collateralized by multifamily properties utilized valuations of the underlying collateral to calculate the allowance at September 30, 2025.
(3)The Company had one $228.0 million mortgage loan receivable with a borrower collateralized by an office property in the southeast that represents 12% of the total mortgage loan receivable held for investment at September 30, 2025.
(4)For purposes of calculating our CECL allowance, two loans collateralized by mixed-use, one loan collateralized by office, and one loan collateralized by multifamily utilized valuations of the underlying collateral to calculate the allowance at December 31, 2024.
(5)For the year ended December 31, 2024, there was a $5.0 million charge-off of an asset-specific allowance in connection with a foreclosure of one office property in Oakland, California.
(6)Not included above is $9.4 million of accrued interest receivable on all loans at December 31, 2024.
v3.25.3
SECURITIES (Tables)
9 Months Ended
Sep. 30, 2025
Investments, Debt and Equity Securities [Abstract]  
Schedule of Securities Which are Classified as Available-for-sale The following is a summary of the Company’s securities at September 30, 2025 and December 31, 2024 ($ in thousands):
September 30, 2025
    Gross Unrealized  Weighted Average
Asset TypeOutstanding
Face Amount
 Amortized Cost BasisGainsLosses (1)Carrying
Value
# of
Securities
Rating (2)Coupon %Yield %Remaining
Duration
(years)
CMBS$1,931,727  $1,930,288 $4,258 $(7,691)$1,926,855 (3)112 AAA5.63 %5.71 %2.79
CMBS interest-only(4)347,761 (4)1,660 94 — 1,754 (5)AAA0.44 %8.95 %0.62
GNMA interest-only(6)29,509 (4)149 122 (55)216 13 AAA0.31 %9.57 %2.79
Agency securities — — AAA4.00 %2.39 %0.38
Total debt securities$2,309,001 $1,932,101 $4,474 $(7,746)$1,928,829 (7)131 4.78 %5.68 %2.77
Equity securitiesN/A12,132 (400)11,738 N/AN/AN/AN/A
Allowance for current expected credit lossesN/A— — (20)(20)
Total securities$2,309,001  $1,944,233 $4,480 $(8,166)$1,940,547 139 

December 31, 2024
    Gross Unrealized  Weighted Average
Asset TypeOutstanding
Face Amount
 Amortized
Cost Basis
GainsLosses (1)Carrying
Value
# of
Securities
Rating (2)Coupon %Yield %Remaining
Duration
(years)
CMBS$1,065,985  $1,063,835 $3,335 $(8,296)$1,058,874 (3)92 AAA5.97 %6.13 %2.41
CMBS interest-only(4)769,724 (4)3,149 104 (9)3,244 (5)AAA0.38 %7.81 %0.87
GNMA interest-only(6)32,710 (4)160 53 (58)155 13 AAA0.33 %9.38 %3.64
Agency securities11  11 — — 11 AAA4.00 %2.60 %0.58
Total debt securities$1,868,430 $1,067,155 $3,492 $(8,363)$1,062,284 (7)113 3.56 %6.03 %2.37
Equity securitiesN/A19,511 (939)18,575 N/AN/AN/AN/A
Allowance for current expected credit lossesN/A— — (20)(20)
Total securities$1,868,430  $1,086,666  $3,495  $(9,322) $1,080,839 121   
(1)Based on the Company’s analysis, including review of interest rate changes and current levels of subordination, among other factors, the unrealized loss positions are determined to be due to market factors other than credit.
(2)Represents the weighted average of the ratings of all securities in each asset type, expressed as an S&P equivalent rating. For each security rated by multiple rating agencies, the highest rating is used. The ratings provided were determined by third-party rating agencies. The rates may not be current and are subject to change (including the assignment of a “negative outlook” or “credit watch”) at any time.
(3)As of September 30, 2025 and December 31, 2024, includes $8.8 million and $8.9 million, respectively, of restricted securities which are designated as risk retention securities under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, as amended (“Dodd-Frank Act”) and are therefore subject to transfer restrictions over the term of the securitization trust and are classified as held-to-maturity and reported at amortized cost.
(4)The amounts presented represent the principal amount of the mortgage loans outstanding in the pool in which the interest-only securities participate.
(5)As of September 30, 2025 and December 31, 2024, includes $0.1 million and $0.2 million, respectively, of restricted securities which are designated as risk retention securities under the Dodd-Frank Act and are therefore subject to transfer restrictions over the term of the securitization trust and are classified as held-to-maturity and reported at amortized cost.
(6)GNMA interest-only securities are recorded at fair value with changes in fair value recorded in current period earnings. The Company’s GNMA interest-only securities are considered to be hybrid financial instruments that contain embedded derivatives. As a result, the Company has elected to account for them as hybrid instruments in their entirety at fair value with changes in fair value recognized in unrealized gain (loss) on securities in the consolidated statements of income.
(7)The Company’s investments in debt securities represent an ownership interest in unconsolidated VIEs. The Company’s maximum exposure to loss from these unconsolidated VIEs is the amortized cost basis of the securities which represents the purchase price of the investment adjusted by any unamortized premiums or discounts as of the reporting date.
The following table summarizes the Company’s realized and unrealized gain (loss) on securities, included within “Fee and Other Income” on the Company’s consolidated statements of income for the three and nine months ended September 30, 2025 and September 30, 2024 ($ in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Realized gain (loss) on securities$2,032 $— $3,061 $75 
Unrealized gain (loss) on securities(176)613 (22)
Total realized and unrealized gain (loss) on securities$1,856 $5 $3,674 $53 
Schedule of Fair Value of the Company's Securities by Remaining Maturity Based Upon Expected Cash Flows
The following tables summarize the carrying value of the Company’s debt securities by remaining maturity based upon expected cash flows at September 30, 2025 and December 31, 2024 ($ in thousands):
 
September 30, 2025
Asset TypeWithin 1 year1-5 years5-10 yearsAfter 10 yearsTotal
CMBS$355,351 $1,571,504 $— $— $1,926,855 
CMBS interest-only1,754 — — — 1,754 
GNMA interest-only28 188 — — 216 
Agency securities— — — 
Total securities (1)$357,137 $1,571,692 $ $ $1,928,829 
(1)Excluded from the table above are $11.7 million of equity securities and $(20.0) thousand of allowance for current expected credit losses.
 
December 31, 2024
Asset TypeWithin 1 year1-5 years5-10 yearsTotal
CMBS$170,874 $888,000 $— $1,058,874 
CMBS interest-only2,937 307 — 3,244 
GNMA interest-only53 13 89 155 
Agency securities11 — — 11 
Total securities (1)$173,875 $888,320 $89 $1,062,284 
(1)Excluded from the table above are $18.6 million of equity securities and $(20.0) thousand of allowance for current expected credit losses.
v3.25.3
REAL ESTATE AND RELATED LEASE INTANGIBLES, NET (Tables)
9 Months Ended
Sep. 30, 2025
Real Estate [Abstract]  
Schedule of Real Estate Properties by Category
The Company’s real estate assets were comprised of the following ($ in thousands):
September 30, 2025December 31, 2024
Land$190,277 $173,798 
Building653,051 622,701 
In-place leases and other intangibles116,304 107,899 
Undepreciated real estate and related lease intangibles959,632 904,398 
Less: Accumulated depreciation and amortization(254,121)(233,595)
Real estate and related lease intangibles, net(1)$705,511 $670,803 
Below market lease intangibles, net (other liabilities)(2)$(23,180)$(25,340)
(1)There was unencumbered real estate of $308.5 million and $213.4 million as of September 30, 2025 and December 31, 2024, respectively.
(2)Below market lease intangibles is net of $17.7 million and $16.5 million of accumulated amortization as of September 30, 2025 and December 31, 2024, respectively.
Schedule of Depreciation and Amortization Expense Recorded
The following table presents depreciation and amortization expense on real estate recorded by the Company ($ in thousands):
 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Depreciation expense(1)$6,250 $6,323 $18,766 $19,058 
Amortization expense1,988 1,823 4,851 5,803 
Total real estate depreciation and amortization expense$8,238 $8,146 $23,617 $24,861 
(1)Depreciation expense on the consolidated statements of income also includes $0.1 million of depreciation on corporate fixed assets for each of the three months ended September 30, 2025 and September 30, 2024 and $0.3 million of depreciation on corporate fixed assets for each of the nine months ended September 30, 2025 and September 30, 2024
Schedule of Lease Intangible Assets
The Company’s intangible assets are comprised of in-place leases, above market leases and other intangibles. The following tables present additional detail related to the intangible assets ($ in thousands):
 September 30, 2025December 31, 2024
Gross intangible assets(1)$116,304 $107,899 
Accumulated amortization62,051 57,281 
Net intangible assets$54,253 $50,618 
(1)Includes $4.5 million and $2.3 million of unamortized above market lease intangibles, which are included in real estate and related lease intangibles, net on the consolidated balance sheets as of September 30, 2025 and December 31, 2024, respectively.

The following table presents increases/reductions in operating lease income related to the amortization of above or below market leases recorded by the Company ($ in thousands):
 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Reduction in operating lease income for amortization of above market lease intangibles acquired$(189)$(93)$(439)$(285)
Increase in operating lease income for amortization of below market lease intangibles acquired509 518 1,506 1,572 
Total$320 $425 $1,067 $1,287 
Schedule of Expected Amortization Expense Related to the Acquired In-place Lease Intangibles, for Property Owned
The following table presents expected adjustment to operating lease income and expected amortization expense during the next five years and thereafter related to the above and below market leases and acquired in-place lease and other intangibles for property owned as of September 30, 2025 ($ in thousands):
Period Ending December 31,Increase/(Decrease) to Operating Lease IncomeAmortization Expense
2025 (last three months)$248 $1,768 
2026997 6,606 
2027961 6,430 
20281,023 5,359 
20291,194 3,589 
Thereafter14,295 27,538 
Total$18,718 $51,290 
Schedule of Contractual Future Minimum Rent Under Leases
The following table is a schedule of non-cancellable, contractual, future minimum rent under leases (excluding property operating expenses paid directly by tenant under net leases) at September 30, 2025 ($ in thousands):
Period Ending December 31,Amount
2025 (last three months)$18,240 
202667,378 
202757,108 
202851,313 
202948,242 
Thereafter133,934 
Total$376,215 
Schedule of Real Estate Properties Acquired
The Company acquired the following properties during the nine months ended September 30, 2025 ($ in thousands):
Acquisition DateTypePrimary Location(s)Purchase Price/Fair Value on the Date of ForeclosureOwnership Interest (1)
April 2025(2)OfficeCarmel, IN$42,400 100%
September 2025(3)OfficeRockville, MD22,678 100%
Total real estate acquisitions$65,078 
(1)Properties were consolidated as of acquisition date.
(2)In April 2025, the Company acquired an office portfolio consisting of two buildings in Carmel, IN via foreclosure. The portfolio served as collateral for a mortgage loan receivable held for investment. The $42.4 million fair value was determined by using the direct capitalization approach. A capitalization rate of 11.6% was used to determine fair value. There was no gain or loss resulting from the foreclosure of the loan. The key inputs used to determine fair value were determined to be Level 3 inputs.
(3)In September 2025, the Company acquired an office property in Rockville, MD through foreclosure of a mortgage loan receivable held for investment. The fair value of $22.7 million was determined by using the direct capitalization approach with a capitalization rate of 10.8%, a Level 3 input. There was no gain or loss resulting from the foreclosure of the loan.
The Company acquired the following properties during the nine months ended September 30, 2024 ($ in thousands):
Acquisition DateTypePrimary Location(s)Purchase Price/Fair Value on the Date of ForeclosureOwnership Interest (1)
February 2024(2)MultifamilyLos Angeles, CA$14,110 100%
April 2024(3)MultifamilyLongview, TX6,080 100%
April 2024(4)MultifamilyAmarillo, TX9,651 100%
June 2024(5)MultifamilyLos Angeles, CA11,455 100%
September 2024(6)OfficeOakland, CA7,500 100.0%
Total real estate acquisitions$48,796 
(1)Properties were consolidated as of acquisition date.
(2)In February 2024, the Company acquired a multifamily portfolio consisting of three properties in Los Angeles, CA via foreclosure. The portfolio served as collateral for a mortgage loan receivable held for investment. The Company obtained a third-party appraisal of the properties. The $14.1 million fair value was determined by using the sales comparison and direct capitalization approaches. The appraiser utilized a capitalization rate of 5.5%. There was no gain or loss resulting from the foreclosure of the loan. The key inputs used to determine fair value were determined to be Level 3 inputs. The portfolio was sold in June 2024.
(3)In April 2024, the Company acquired a multifamily portfolio consisting of two properties in Longview, TX via foreclosure. The portfolio served as collateral for a mortgage loan receivable held for investment. There was a $0.4 million gain recognized in connection with the foreclosure of the loan. During June 2024, the Company sold the portfolio for $6.1 million. The fair value at foreclosure was based on the sales price.
(4)In April 2024, the Company acquired a multifamily property in Amarillo, TX via foreclosure. The property served as collateral for a mortgage loan receivable held for investment. The Company determined the fair value of $9.7 million by using the sales comparison approach utilizing a terminal capitalization rate of 8.3%. There was no gain or loss resulting from the foreclosure of the loan. The key inputs used to determine fair value were determined to be Level 3 inputs.
(5)In June 2024, the Company acquired a multifamily portfolio consisting of three properties in Los Angeles, CA via foreclosure. The portfolio served as collateral for a mortgage loan receivable held for investment. The $11.5 million fair value was determined by using the sales comparison approach. There was no gain or loss resulting from the foreclosure of the loan.
(6)In September 2024, the Company acquired an office property in Oakland, CA via foreclosure. The property served as collateral for a mortgage loan receivable held for investment. The $7.5 million fair value was determined by using the sales comparison approach and direct capitalization approach. There was a $5 million charge-off of allowance for credit loss resulting from the acquisition of the property. The Company used a terminal capitalization rate of 7.5%. The key inputs used to determine fair value were determined to be Level 3 inputs. Refer to Note 3, Mortgage Loan Receivables for further details.
Schedule of Properties Sold
The Company sold the following property during the nine months ended September 30, 2025 ($ in thousands):
Sales DateTypePrimary Location(s)Sales ProceedsNet Book ValueRealized Gain/(Loss)Properties
March 2025RetailJenks, OK$13,079 $9,272 $3,807 1
Totals$13,079 $9,272 $3,807 
The Company sold the following properties during the nine months ended September 30, 2024 ($ in thousands):
Sales DateTypePrimary Location(s)Sales ProceedsNet Book ValueRealized Gain/(Loss)Properties
May 2024OfficePeoria, IL$1,227 $2,320 $(1,093)1
June 2024MultifamilyLos Angeles, CA14,834 13,911 923 3
June 2024RetailWaldorf, MD23,734 11,424 12,310 1
June 2024MultifamilyLongview, TX(1)6,080 6,080 403 2
July 2024MultifamilyLos Angeles, CA11,770 11,455 315 1
Totals$57,645 $45,190 $12,858 
(1)The Company recognized a $0.4 million gain on foreclosure which is recognized in gain (loss) on real estate, net on the consolidated statements of income.
v3.25.3
DEBT OBLIGATIONS, NET (Tables)
9 Months Ended
Sep. 30, 2025
Debt Disclosure [Abstract]  
Schedule of Debt Obligations
The details of the Company’s debt obligations at September 30, 2025 and December 31, 2024 are as follows ($ in thousands):
 
September 30, 2025

Debt ObligationsCommitted AmountOutstanding Principal AmountCarrying ValueAverage Cost of Funds(1)Current MaturityFinal Stated Maturity(2)Carrying Value of Collateral
Loan Repurchase Facility$300,000 $— $— —%9/27/20289/27/2030$— 
Loan Repurchase Facility300,000 — — —%10/21/202710/21/2029— 
Loan Repurchase Facility200,000 — — —%10/3/202510/3/202714,641 
Loan Repurchase Facility56,000 — — —%4/30/20264/30/2029— 
Loan Repurchase Facilities(3)$856,000 $— $— $14,641 
Securities Repurchases— 361,638 361,638 4.69%10/3/202510/30/2025402,329 
Total Repurchase Facilities$856,000 $361,638 $361,638 $416,970 
Mortgage Debt N/A 399,092 401,656 6.18%2025-2034(4)2027-2048397,053 
Unsecured Revolving Credit Facility(5)850,000 20,000 20,000 5.37%12/20/202812/20/2029 N/A
Senior Unsecured Notes N/A 2,233,409 2,213,938 5.29%2027-20312027-2031 N/A
Total Debt Obligations, net$1,706,000 $3,014,139 $2,997,232 $814,023 
(1)Interest rates on floating rate debt reflect the applicable index in effect as of September 30, 2025. Excludes deferred financing costs.
(2)Final Stated Maturity assumes extensions at our option are exercised with consent of financing providers, where applicable.
(3)Carrying value excludes $2.8 million of unamortized deferred financing costs included in Other Assets.
(4)Anticipated Repayment Dates.
(5)Carrying Value excludes $7.5 million of unamortized deferred financing costs included in Other Assets.
December 31, 2024

Debt ObligationsCommitted AmountOutstanding Principal AmountCarrying ValueAverage Cost of Funds(1)Current MaturityFinal Stated Maturity(2)Carrying Value of Collateral
Loan Repurchase Facility$500,000 $62,738 $62,738 6.55%9/27/20259/27/2027$97,254 
Loan Repurchase Facility300,000 — — —%10/21/202710/21/2029— 
Loan Repurchase Facility200,000 — — —%10/3/202510/3/202714,636 
Loan Repurchase Facility100,000 — — —%1/22/20251/22/2026— 
Loan Repurchase Facility56,000 — — —%4/30/20264/30/2029— 
Loan Repurchase Facilities(3)$1,156,000 $62,738 $62,738 $111,890 
Mortgage Debt N/A 443,733 446,397 6.09%2025-2034(4)2027-2048451,880 
CLO Debt N/A 601,464 601,429 6.36%2025-2026(5)2036-2038831,270 
Unsecured Revolving Credit Facility(6)725,000 — — —%12/20/202812/20/2029N/A
Senior Unsecured NotesN/A2,041,557 2,025,053 5.22%2025-20312025-2031  N/A
Total Debt Obligations, net$1,881,000 $3,149,492 $3,135,617 $1,395,040 
(1)Interest rates on floating rate debt reflect the applicable index in effect as of December 31, 2024. Excludes deferred financing costs.
(2)Final Stated Maturity assumes extensions at our option are exercised with consent of financing providers, where applicable.
(3)Carrying value excludes $2.1 million of unamortized deferred financing costs included in Other Assets.
(4)Anticipated Repayment Dates.
(5)Represents the estimated maturity dates based on the underlying loan maturities.
(6)The obligations under the Unsecured Revolving Credit Facility are secured by equity pledges of certain subsidiaries of the Company. Carrying Value excludes $7.1 million of unamortized deferred financing costs included in Other Assets.
Schedule of Variable Interest Entities
December 31, 2024
Mortgage loan receivables held for investment, net, at amortized cost$831,270 
Accrued interest receivable5,530 
Other assets42,621 
Total assets$879,421 
Debt obligations, net$601,429 
Accrued expenses1,806 
Total liabilities603,235 
Net equity in VIEs (eliminated in consolidation)276,186 
Total equity276,186 
Total liabilities and equity$879,421 
Schedule of Contractual Payments Under All Borrowings by Maturity
The following schedule reflects the Company’s contractual payments under borrowings by maturity ($ in thousands): 
Period ending December 31,Borrowings by
Maturity(1)
2025 (last three months)$376,033 
202626,424 
2027805,391 
202824,317 
2029689,484 
Thereafter1,092,490 
Subtotal3,014,139 
Debt issuance costs included in senior unsecured notes(19,472)
Debt issuance costs included in mortgage loan financings(662)
Net premiums included in mortgage loan financings (2)3,227 
Total$2,997,232 
(1)The allocation of repayments under the Company’s committed loan repurchase facilities is based on the earlier of: (i) the final stated maturity date of each agreement; or (ii) the maximum maturity date of the collateral loans, assuming all extension options are exercised by the borrower. Repayments of the Company's mortgage debt is based on the anticipated repayment dates as defined in the mortgage loan agreements.
(2)Represents sales proceeds received in excess of loan amounts sold into securitizations that are amortized as a reduction to interest expense using the effective interest method over the life of the underlying loan.
v3.25.3
DERIVATIVE INSTRUMENTS (Tables)
9 Months Ended
Sep. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Breakdown of the Derivatives Outstanding The following is a breakdown of the derivatives outstanding as of September 30, 2025 and December 31, 2024 ($ in thousands):
 
September 30, 2025
  Fair ValueRemaining
Maturity
(years)
Contract TypeNotionalAsset(1)Liability(1)
Caps    
1 Month Term SOFR$90,000 $$— 1.04
Futures   
10-year Treasury-Note Futures22,500 276 — 0.26
Total futures22,500 276 — 
Options   
S&P 500 Put OptionsN/A(2)— 0.09
Total derivatives$112,500 $284 $  
(1)Shown as derivative instruments in the accompanying consolidated balance sheet.
(2)The Company held 75 options contracts as of September 30, 2025.


December 31, 2024
  Fair ValueRemaining
Maturity
(years)
Contract TypeNotionalAsset(1)Liability(1)
Caps    
1 Month Term SOFR$90,000 $432 $ 0.62
Options    
OptionsN/A(2)— 0.05
Total credit derivatives 5   
Total derivatives$90,000 $437 $  
(1)Shown as derivative instruments in the accompanying consolidated balance sheet.
(2)The Company held 275 options contracts as of December 31, 2024.
Schedule of Net Realized Gains/(Losses) and Unrealized Appreciation/(Depreciation) on Derivatives
The following table summarizes the net realized gains (losses) and unrealized gains (losses) on derivatives, by primary underlying risk exposure, as included in net result from derivatives transactions in the consolidated statements of income for the three and nine months ended September 30, 2025 and 2024 ($ in thousands):

 Three Months Ended September 30, 2025Nine Months Ended September 30, 2025
Contract TypeUnrealized
Gain/(Loss)
Realized
Gain/(Loss)
Net Result
from
Derivative
Transactions
Unrealized
Gain/(Loss)
Realized
Gain/(Loss)
Net Result
from
Derivative
Transactions
Caps$(142)$126 $(16)$(450)$504 $54 
Futures154 (66)88 276 1,596 1,872 
Options— (51)(51)— (56)(56)
Total$12 $9 $21 $(174)$2,044 $1,870 
 
 Three Months Ended September 30, 2024Nine Months Ended September 30, 2024
Contract TypeUnrealized
Gain/(Loss)
Realized
Gain/(Loss)
Net Result
from
Derivative
Transactions
Unrealized
Gain/(Loss)
Realized
Gain/(Loss)
Net Result
from
Derivative
Transactions
Caps$(589)$421 $(168)$(1,220)$1,258 $38 
Futures(311)(282)(593)(376)4,215 3,839 
Options— (5)(5)— (6)(6)
Total$(900)$134 $(766)$(1,596)$5,467 $3,871 
v3.25.3
OFFSETTING ASSETS AND LIABILITIES (Tables)
9 Months Ended
Sep. 30, 2025
Offsetting [Abstract]  
Schedule of Offsetting of Financial Assets
The following table represents offsetting of financial assets and derivative assets as of September 30, 2025 ($ in thousands): 
DescriptionGross amounts of
recognized assets
Gross amounts
offset in the
balance sheet
Net amounts of
assets presented
in the balance
sheet
Gross amounts not offset in the
balance sheet
Net amount
Financial
instruments
Cash collateral
received/(posted)(1)
Derivatives$284 $— $284 $— $(574)$(290)
Total$284 $ $284 $ $(574)$(290)
(1)Included in restricted cash on consolidated balance sheet.
The following table represents offsetting of financial assets and derivative assets as of December 31, 2024 ($ in thousands):
DescriptionGross amounts of
recognized assets
Gross amounts
offset in the
balance sheet
Net amounts of
assets presented
in the balance
sheet
Gross amounts not offset in the
balance sheet
Net amount
Financial
instruments
Cash collateral
received/(posted)(1)
Derivatives$437 $— $437 $— $— $437 
Total$437 $ $437 $ $ $437 
(1)Included in restricted cash on consolidated balance sheet.
Schedule of Offsetting of Financial Liabilities
The following table represents offsetting of financial liabilities and derivative liabilities as of September 30, 2025 ($ in thousands): 
DescriptionGross amounts of
recognized
liabilities
Gross amounts
offset in the
balance sheet
Net amounts of
liabilities
presented in the
balance sheet
Gross amounts not offset in the
balance sheet
Net amount
Financial
instruments
collateral
Cash collateral
posted/(received)(1)
Repurchase agreements$361,638 $— $361,638 $361,638 $— $361,638 
Total$361,638 $ $361,638 $361,638 $ $361,638 
(1)Included in restricted cash on consolidated balance sheet.
The following table represents offsetting of financial liabilities and derivative liabilities as of December 31, 2024 ($ in thousands):
DescriptionGross amounts of
recognized
liabilities
Gross amounts
offset in the
balance sheet
Net amounts of
liabilities
presented in the
balance sheet
Gross amounts not offset in the
balance sheet
Net amount
Financial
instruments
collateral
Cash collateral
posted/(received)(1)
Repurchase agreements$62,738 $— $62,738 $62,738 $— $62,738 
Total$62,738 $ $62,738 $62,738 $ $62,738 
(1)Included in restricted cash on consolidated balance sheet.
v3.25.3
EQUITY (Tables)
9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Schedule of Common Stock Repurchase Activity
The following tables summarize the Company’s repurchase activity of its Class A common stock during the nine months ended September 30, 2025 and 2024 ($ in thousands):
SharesAmount(1)
Authorizations remaining as of December 31, 2024$67,604 
Additional authorizations (2)33,201 
Repurchases paid:
January 1, 2025 - January 31, 2025— — 
February 1, 2025 - February 28, 2025— — 
March 1, 2025 - March 31, 202570,506 (805)
April 1, 2025 - April 30, 2025— — 
May 1, 2025 - May 31, 2025401,396 (4,151)
June 1, 2025 - June 30, 2025234,094 (2,456)
July 1, 2025 - July 31, 202536,371 (397)
August 1, 2025 - August 31, 202543,020 (471)
September 1, 2025 - September 30, 202591,321 (1,017)
Authorizations remaining as of September 30, 2025$91,508 
(1)Amount excludes commissions paid associated with share repurchases.
(2)On April 23, 2025, the Board authorized repurchases up to $100.0 million in aggregate.

SharesAmount(1)
Authorizations remaining as of December 31, 2023$44,256 
Additional authorizations (2)31,391 
Repurchases paid:
January 1, 2024 - January 31, 2024— — 
February 1, 2024 - February 29, 2024— — 
March 1, 2024 - March 31, 202460,000 (647)
April 1, 2024 - April 30, 2024— — 
May 1, 2024 - May 31, 20242,100 (23)
June 1, 2024 - June 30, 202417,590 (189)
July 1, 2024 - July 31, 2024— — 
August 1, 2024 - August 31, 2024— — 
September 1, 2024 - September 30, 2024100,001 (1,190)
Authorizations remaining as of September 30, 2024$73,598 
(1)Amount excludes commissions paid associated with share repurchases.
(2)On April 24, 2024, the Board authorized repurchases up to $75.0 million in aggregate.
Schedule of Dividends Declared and Paid
The following table presents dividends declared (on a per share basis) of Class A common stock for the nine months ended September 30, 2025 and 2024:
Declaration DateDividend per Share
March 14, 2025$0.23 
June 13, 20250.23 
September 15, 20250.23 
Total$0.69 
March 15, 2024$0.23 
June 14, 20240.23 
September 13, 20240.23 
Total$0.69 
Schedule of Accumulated Other Comprehensive Income
The following table presents changes in accumulated other comprehensive income related to the cumulative difference between the fair market value and the amortized cost basis of securities classified as available for sale for the nine months ended September 30, 2025 and 2024 ($ in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Accumulated Other Comprehensive Income (Loss) beginning of period$(5,639)$(10,752)$(4,866)$(13,853)
Unrealized gain (loss) on securities, available for sale4,131 2,041 3,570 5,165 
Reclassification adjustment for (gain) loss included in net income (loss)(1,831)— (2,043)(23)
Accumulated Other Comprehensive Income (Loss) end of period$(3,339)$(8,711)$(3,339)$(8,711)
v3.25.3
EARNINGS PER SHARE (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of the Company's Net Income (Loss) and Weighted Average Shares Outstanding
The Company’s net income (loss) and weighted average shares outstanding for the three and nine months ended September 30, 2025 and 2024 consist of the following:
Three Months Ended September 30,Nine Months Ended September 30,
($ in thousands except share amounts)2025202420252024
Basic and Diluted Net income (loss) available for Class A common shareholders$19,189 $27,913 $48,293 $76,869 
Weighted average shares outstanding:    
Basic125,339,188 125,705,754 125,587,121 125,586,075 
Diluted126,115,547 125,905,528 126,198,822 125,757,114 
Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Share Amounts
The calculation of basic and diluted net income (loss) per share amounts for the three and nine months ended September 30, 2025 and 2024 consist of the following:
Three Months Ended September 30,Nine Months Ended September 30,
(In thousands except share and per share amounts) (1)2025202420252024
Basic Net Income (Loss) Per Share of Class A Common Stock    
Numerator:
    
Net income (loss) attributable to Class A common shareholders$19,189 $27,913 $48,293 $76,869 
Denominator:
    
Weighted average number of shares of Class A common stock outstanding125,339,188 125,705,754 125,587,121 125,586,075 
Basic net income (loss) per share of Class A common stock$0.15 $0.22 $0.38 $0.61 
Diluted Net Income (Loss) Per Share of Class A Common Stock  
Numerator:  
Net income (loss) attributable to Class A common shareholders$19,189 $27,913 $48,293 $76,869 
Diluted net income (loss) attributable to Class A common shareholders19,189 27,913 48,293 76,869 
Denominator:  
Basic weighted average number of shares of Class A common stock outstanding125,339,188 125,705,754 125,587,121 125,586,075 
Add - dilutive effect of:    
Incremental shares of unvested Class A restricted stock(1)776,359 199,774 611,701 171,039 
Diluted weighted average number of shares of Class A common stock outstanding (2)(3)126,115,547 125,905,528 126,198,822 125,757,114 
Diluted net income (loss) per share of Class A common stock$0.15 $0.22 $0.38 $0.61 
The Company applies the treasury stock method.
(2)There were 15 and 11,251 anti-dilutive shares for the three and nine months ended September 30, 2025, respectively.
(3)There were 166,571 and 335,482 anti-dilutive shares for the three and nine months ended September 30, 2024, respectively.
v3.25.3
STOCK-BASED AND OTHER COMPENSATION PLANS (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Based Compensation Plans
The following table summarizes the impact on the consolidated statements of income of the various stock-based compensation plans and other compensation plans ($ in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Stock-based compensation expense$3,049 $3,177 $17,260 $16,592 
Total Stock-Based Compensation Expense$3,049 $3,177 $17,260 $16,592 
Schedule of the Grants
A summary of the grants is presented below:
 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Number
of Shares/Options
Weighted
Average
Fair Value
Per Share
Number
of Shares
Weighted
Average
Fair Value
Per Share
Number
of Shares
Weighted
Average
Fair Value
Per Share
Number
of Shares
Weighted
Average
Fair Value
Per Share
Grants - Class A Common Stock31,989 $11.16 — $— 1,852,016 $11.67 1,855,541 $10.70 
Schedule of Nonvested Shares Activity
The table below presents the number of unvested shares of Class A common stock and outstanding stock options at September 30, 2025 and changes during 2025 of the Class A common stock and stock options of Ladder Capital Corp:
Restricted StockWeighted Average Grant Date Fair ValueStock Options
Nonvested/Outstanding at December 31, 20242,020,752 $12.28 623,788 
Granted1,852,016 11.67 — 
Vested(1,778,588)11.49 — 
Expired— — (439,760)
Nonvested/Outstanding at September 30, 20252,094,180 $12.42 184,028 
Exercisable at September 30, 2025 (1)184,028 
(1)The weighted average exercise price of outstanding options is $11.86 at September 30, 2025.
v3.25.3
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
9 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value
The carrying values and estimated fair values of the Company’s financial instruments, which are both reported at fair value on a recurring basis or amortized cost/par, at September 30, 2025 and December 31, 2024 are as follows ($ in thousands):
 
September 30, 2025
      Weighted Average
Assets:Principal Amount Amortized Cost Basis/Purchase PriceFair ValueFair Value MethodYield
%
Remaining
Maturity/Duration (years)
CMBS(1)$1,931,727  $1,930,288 $1,926,855 Internal model5.71 %2.79
CMBS interest-only(1)347,761 (2)1,660 1,754 Internal model8.95 %0.62
GNMA interest-only(3)29,509 (2)149 216 Internal model9.57 %2.79
Agency securities(1) Internal model2.39 %0.38
Equity securities(3) N/A 12,132 11,738 Observable market pricesN/A N/A
Mortgage loan receivables held for investment, net, at amortized cost(4)1,931,210  1,920,588 1,910,180 Discounted Cash Flow(5)8.16 %1.53
Mortgage loan receivables held for sale31,350  27,970 27,970 Internal model, third-party inputs(6)4.57 %6.44
Nonhedge derivatives(1)(7)112,500  284 284 Counterparty quotationsN/A0.26
Liabilities:       
Repurchase agreements - short-term361,638  361,638 361,638 Cost plus Accrued Interest(8)4.69 %0.05
Unsecured Revolving Credit Facility20,000 20,000 20,000 (9)5.37 %3.22
Mortgage loan financing399,092  401,656 397,990 Discounted Cash Flow6.18 %3.37
Senior unsecured notes2,233,409  2,213,938 2,254,223 Internal model5.29 %3.79
(1)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded as a component of other comprehensive income (loss) in equity.
(2)Represents notional outstanding balance of underlying collateral.
(3)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded in current period earnings.
(4)Balance does not include impact of allowance for current expected credit losses of $52.1 million at September 30, 2025.
(5)Fair value for floating rate mortgage loan receivables, held for investment is estimated to approximate the outstanding face amount given the short interest rate reset risk (30 days) and no significant change in credit spreads since origination. Fair value for fixed rate mortgage loan receivables, held for investment is measured using a discounted cash flow model.
(6)Fair value for mortgage loan receivables, held for sale is measured using a hypothetical securitization model utilizing market data from recent securitization spreads and pricing.
(7)The outstanding face amount of the nonhedge derivatives represents the notional amount of the underlying contracts.
(8)For repurchase agreements - short term, the value approximates the cost plus accrued interest.
(9)Fair value for the Unsecured Revolving Credit Facility is estimated to approximate the outstanding face.

December 31, 2024
      Weighted Average
Assets:Principal Amount Amortized Cost Basis/Purchase PriceFair ValueFair Value MethodYield
%
Remaining
Maturity/Duration (years)
CMBS(1)$1,065,985  $1,063,835 $1,058,873 Internal model6.13 %2.41
CMBS interest-only(1)769,724 (2)3,149 3,244 Internal model7.81 %0.87
GNMA interest-only(3)32,710 (2)160 155 Internal model9.38 %3.64
Agency securities(1)11  11 11 Internal model2.60 %0.58
Equity securities(3)N/A19,511 18,575 Observable market pricesN/A N/A
Mortgage loan receivables held for investment, net, at amortized cost(4)1,596,277  1,591,322 1,575,911 Discounted Cash Flow(5)9.36 %0.86
Mortgage loan receivables held for sale31,350  26,898 26,898 Internal model, third-party inputs(6)4.57 %7.18
Nonhedge derivatives(1)(9)90,000  437 437 Counterparty quotationsN/A0.62
Liabilities:       
Repurchase agreements - short-term62,738  62,738 62,738 Cost plus Accrued Interest(7)6.55 %0.74
Mortgage loan financing443,733  446,397 435,048 Discounted Cash Flow6.09 %3.36
CLO debt601,464 601,380 601,430 Discounted Cash Flow(8)2.01 %0.98
Senior unsecured notes2,041,557  2,025,053 2,001,207 Internal model5.22 %3.72
(1)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded as a component of other comprehensive income (loss) in equity.
(2)Represents notional outstanding balance of underlying collateral.
(3)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded in current period earnings.
(4)Balance does not include impact of allowance for current expected credit losses of $52.3 million at December 31, 2024.
(5)Fair value for floating rate mortgage loan receivables, held for investment is estimated to approximate the outstanding face amount given the short interest rate reset risk (30 days) and no significant change in credit spreads since origination. Fair value for fixed rate mortgage loan receivables, held for investment is measured using a discounted cash flow model.
(6)Fair value for mortgage loan receivables, held for sale is measured using a hypothetical securitization model utilizing market data from recent securitization spreads and pricing.
(7)For repurchase agreements - short term, the value approximates the cost plus accrued interest.
(8)For CLO debt, the carrying value approximates the fair value discounting the expected cash flows at current market rates. If the collateral is determined to be impaired, the related financing would be revalued accordingly. There are no impairments on any positions.
(9)The outstanding face amount of the nonhedge derivatives represents the notional amount of the underlying contracts.
Schedule of Financial Assets and Liabilities, both reported at Fair Value on a Recurring Basis or Amortized Cost/Par
The following table summarizes the Company’s financial assets and liabilities, which are both reported at fair value on a recurring basis (as indicated) or amortized cost/par, at September 30, 2025 and December 31, 2024 ($ in thousands):
 
September 30, 2025
 
Financial Instruments Reported at Fair Value on Consolidated Statements of Financial ConditionPrincipal
Amount
 Fair Value
 Level 1Level 2Level 3Total
Assets:      
CMBS(1)$1,922,777  $— $1,918,096 $— $1,918,096 
CMBS interest-only(1)339,765 (2)— 1,621 — 1,621 
GNMA interest-only(3)29,509 (2)— 216 — 216 
Agency securities(1) — — 
Equity securities N/A 11,738 — — 11,738 
Nonhedge derivatives(4)112,500 284 — — 284 
$12,022 $1,919,937 $ $1,931,959 
Financial Instruments Not Reported at Fair Value on Consolidated Statements of Financial ConditionPrincipal
Amount
 Fair Value
 Level 1Level 2Level 3Total
Assets:
Mortgage loan receivables held for investment, net, at amortized cost(5)$1,931,210  $— $— $1,910,180 $1,910,180 
Mortgage loan receivable held for sale(6)31,350  — — 27,970 27,970 
CMBS(7)8,951 — 8,759 — 8,759 
CMBS interest-only(7)7,996 — 133 — 133 
$ $8,892 $1,938,150 $1,947,042 
Liabilities:     
Repurchase agreements - short-term$361,638  $— $361,638 $— $361,638 
Unsecured Revolving Credit Facility20,000 — — 20,000 20,000 
Mortgage loan financing399,092  — — 397,990 397,990 
Senior unsecured notes2,233,409  — 2,254,223 — 2,254,223 
$ $2,615,861 $417,990 $3,033,851 
(1)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded as a component of other comprehensive income (loss) in equity.
(2)Represents notional outstanding balance of underlying collateral. 
(3)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded in current period earnings. 
(4)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded in current period earnings. The outstanding face amount of the nonhedge derivatives represents the notional amount of the underlying contracts.
(5)Balance does not include impact of allowance for current expected credit losses of $52.1 million at September 30, 2025.
(6)A lower of cost or market adjustment was recorded as of September 30, 2025.
(7)Restricted securities which are designated as risk retention securities under the Dodd-Frank Act and are therefore subject to transfer restrictions over the term of the securitization trust, are classified as held-to-maturity and reported at amortized cost.
December 31, 2024
 
Financial Instruments Reported at Fair Value on Consolidated Statements of Financial ConditionPrincipal
Amount
 Fair Value
 Level 1Level 2Level 3Total
Assets:      
CMBS(1)$1,056,844  $— $1,049,986 $— $1,049,986 
CMBS interest-only(1)761,537 (2)— 3,037 — 3,037 
GNMA interest-only(3)32,710 (2)— 155 — 155 
Agency securities(1)11  — 11 — 11 
Equity securities N/A 18,575 — — 18,575 
Nonhedge derivatives(4)90,000 — 437 — 437 
$18,575 $1,053,626 $ $1,072,201 
Financial Instruments Not Reported at Fair Value on Consolidated Statements of Financial ConditionPrincipal
Amount
 Fair Value
 Level 1Level 2Level 3Total
Assets:
Mortgage loan receivables held for investment, net, at amortized cost(5)$1,596,277  $— $— $1,575,911 $1,575,911 
Mortgage loan receivable held for sale(6)31,350  — — 26,898 26,898 
CMBS(7)9,142 — 8,887 — 8,887 
CMBS interest-only(7)8,187 — 207 — 207 
$ $9,094 $1,602,809 $1,611,903 
Liabilities:     
Repurchase agreements - short-term$62,738  $— $62,738 $— $62,738 
Mortgage loan financing443,733  — — 435,048 435,048 
CLO debt601,464 — 601,430 — 601,430 
Senior unsecured notes2,041,557  — 2,001,207 — 2,001,207 
$ $2,665,375 $435,048 $3,100,423 
(1)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded as a component of other comprehensive income (loss) in equity.
(2)Represents notional outstanding balance of underlying collateral. 
(3)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded in current period earnings. 
(4)Measured at fair value on a recurring basis with the net unrealized gains or losses recorded in current period earnings. The outstanding face amount of the nonhedge derivatives represents the notional amount of the underlying contracts.
(5)Balance does not include impact of allowance for current expected credit losses of $52.3 million at December 31, 2024.
(6)A lower of cost or market adjustment was recorded as of December 31, 2024.
(7)Restricted securities which are designated as risk retention securities under the Dodd-Frank Act and are therefore subject to transfer restrictions over the term of the securitization trust, are classified as held-to-maturity and reported at amortized cost.
(8)As of December 31, 2024, the Company determined that $2.0 billion of senior unsecured notes were level 2 based on the Company’s increased observability of the inputs used to internally value the senior unsecured notes.
v3.25.3
COMMITMENTS AND CONTINGENCIES (Tables)
9 Months Ended
Sep. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Future Minimum Lease Obligations under Non-cancelable Operating Leases
Future minimum lease payments under non-cancelable operating leases as of September 30, 2025 are as follows ($ in thousands):

Period ending December 31,Minimum Lease Payments
2025 (last three months)$873 
20262,597 
20272,232 
20282,306 
20292,409 
Thereafter8,629 
Total undiscounted cash flows19,046 
Present value discount (1)(4,151)
Lease liabilities (2)$14,895 
(1)Lease liabilities were discounted at the Company's weighted average incremental borrowing rate, estimated at the time of lease commencement, for similar collateral, which was 6.59%. The average remaining lease term is 7.6 years.
(2)The Company has a five-year extension option on its corporate headquarters office at 320 Park Avenue, New York, New York, which is not reflected in the total lease liability.
v3.25.3
SEGMENT REPORTING (Tables)
9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Schedule of Company's Performance Evaluation by Segment
The Company evaluates performance based on the following financial measures for each segment ($ in thousands):

Three months ended September 30, 2025LoansSecuritiesReal Estate (1)Corporate/Other(2)Company 
Total
Net interest income
Interest income$42,549 $28,272 $39 $908 $71,768 
Interest expense(766)(4,267)(6,334)(32,611)(43,978)
Net interest income (expense)41,783 24,005 (6,295)(31,703)27,790 
(Provision for) release of loan loss reserves31 — — — 31 
Net interest income (expense) after provision for (release of) loan reserves41,814 24,005 (6,295)(31,703)27,821 
Other income (loss)
Real estate operating income— — 26,666 — 26,666 
Net result from mortgage loan receivables held for sale(377)— — — (377)
Fee and other income1,667 2,150 47 — 3,864 
Net result from derivative transactions— — (16)37 21 
Earnings (loss) from investment in unconsolidated ventures— — (414)— (414)
Gain (loss) on extinguishment of debt— — — (106)(106)
Total other income (loss)1,290 2,150 26,283 (69)29,654 
Costs and expenses
Compensation and employee benefits— — — (11,552)(11,552)
Operating expenses— — — (5,276)(5,276)
Real estate operating expenses— — (11,424)— (11,424)
Investment related expenses(643)(3)(132)(77)(855)
Depreciation and amortization— — (8,124)(114)(8,238)
Total costs and expenses(643)(3)(19,680)(17,019)(37,345)
Income (loss) before taxes42,461 26,152 308 (48,791)20,130 
Income tax (expense) benefit— — — (960)(960)
Segment net income (loss)$42,461 $26,152 $308 $(49,751)$19,170 
Total assets as of September 30, 2025$1,896,423 $1,940,547 $724,000 $125,574 $4,686,544 
Three months ended September 30, 2024LoansSecuritiesReal Estate (1)Corporate/Other(2)Company 
Total
Net interest income
Interest income$63,799 $11,727 $86 $20,480 $96,092 
Interest expense(21,718)(4)(7,945)(28,009)(57,676)
Net interest income (expense)42,081 11,723 (7,859)(7,529)38,416 
(Provision for) release of loan loss reserves(3,063)— — — (3,063)
Net interest income (expense) after provision for (release of) loan reserves39,018 11,723 (7,859)(7,529)35,353 
Other income (loss)
Real estate operating income— — 25,294 — 25,294 
Net result from mortgage loan receivables held for sale1,143 — — (51)1,092 
Gain (loss) on real estate, net— — 315 — 315 
Fee and other income6,499 17 25 68 6,609 
Net result from derivative transactions(249)— (168)(349)(766)
Earnings (loss) from investment in unconsolidated ventures— — (14)— (14)
Gain (loss) on extinguishment of debt— — — 20 20 
Total other income (loss)7,393 17 25,452 (312)32,550 
Costs and expenses
Compensation and employee benefits— — — (14,407)(14,407)
Operating expenses— — — (4,508)(4,508)
Real estate operating expenses— — (10,751)— (10,751)
Investment related expenses(691)(45)(97)(795)(1,628)
Depreciation and amortization— — (8,036)(110)(8,146)
Total costs and expenses(691)(45)(18,884)(19,820)(39,440)
Income (loss) before taxes45,720 11,695 (1,291)(27,661)28,463 
Income tax (expense) benefit— — — (901)(901)
Segment net income (loss)$45,720 $11,695 $(1,291)$(28,562)$27,562 
Total assets as of December 31, 2024$1,565,897 $1,080,839 $690,726 $1,507,611 $4,845,073 
Nine months ended September 30, 2025LoansSecuritiesReal Estate (1)Corporate/Other(2)Company 
Total
Net interest income
Interest income$112,780 $71,497 $238 $14,315 $198,829 
Interest expense(14,154)(5,299)(19,578)(90,149)(129,180)
Net interest income (expense)98,626 66,198 (19,340)(75,834)69,649 
(Provision for) release of loan loss reserves154 — — — 154 
Net interest income (expense) after provision for (release of) loan reserves98,780 66,198 (19,340)(75,834)69,803 
Other income (loss)
Real estate operating income— — 74,214 — 74,214 
Net result from mortgage loan receivables held for sale4,700 — — — 4,700 
Gain (loss) on real estate, net— — 3,807 — 3,807 
Fee and other income7,147 4,740 65 — 11,952 
Net result from derivative transactions1,301 — 55 514 1,870 
Earnings (loss) from investment in unconsolidated ventures— — (1,434)— (1,434)
Gain (loss) on extinguishment of debt— — — 151 151 
Total other income (loss)13,148 4,740 76,707 665 95,260 
Costs and expenses
Compensation and employee benefits— — — (41,874)(41,874)
Operating expenses— — — (14,559)(14,559)
Real estate operating expenses— — (30,456)— (30,456)
Investment related expenses(1,376)(170)(324)(1,017)(2,887)
Depreciation and amortization— — (23,286)(331)(23,617)
Total costs and expenses(1,376)(170)(54,066)(57,781)(113,393)
Income (loss) before taxes110,552 70,768 3,301 (132,950)51,670 
Income tax (expense) benefit— — — (3,836)(3,836)
Segment net income (loss)$110,552 $70,768 $3,301 $(136,786)$47,834 
Total assets as of September 30, 2025$1,896,423 $1,940,547 $724,000 $125,574 $4,686,544 
Nine months ended September 30, 2024LoansSecuritiesReal Estate (1)Corporate/Other(2)Company 
Total
Net interest income
Interest income$201,233 $27,670 $268 $51,349 $280,520 
Interest expense(77,159)(61)(24,567)(68,860)(170,647)
Net interest income (expense)124,074 27,609 (24,299)(17,511)109,873 
(Provision for) release of loan loss reserves(13,886)— — — (13,886)
Net interest income (expense) after provision for (release of) loan reserves110,188 27,609 (24,299)(17,511)95,987 
Other income (loss)
Real estate operating income— — 75,314 — 75,314 
Net result from mortgage loan receivables held for sale3,308 — — (2,670)638 
Gain (loss) on real estate, net— — 12,858 — 12,858 
Fee and other income12,195 100 1,352 300 13,947 
Net result from derivative transactions185 80 38 3,568 3,871 
Earnings (loss) from investment in unconsolidated ventures— — (11)— (11)
Gain (loss) on extinguishment of debt— — — 197 197 
Total other income (loss)15,688 180 89,551 1,395 106,814 
Costs and expenses
Compensation and employee benefits— — — (48,917)(48,917)
Operating expenses— — — (14,331)(14,331)
Real estate operating expenses— — (30,930)— (30,930)
Investment related expenses(3,910)(138)(449)(1,412)(5,909)
Depreciation and amortization— — (24,532)(329)(24,861)
Total costs and expenses(3,910)(138)(55,911)(64,989)(124,948)
Income (loss) before taxes121,966 27,651 9,341 (81,105)77,853 
Income tax (expense) benefit— — — (1,737)(1,737)
Segment net income (loss)$121,966 $27,651 $9,341 $(82,842)$76,116 
Total assets as of December 31, 2024$1,565,897 $1,080,839 $690,726 $1,507,611 $4,845,073 
Includes the Company’s investment in unconsolidated ventures that held real estate of $18.5 million and $19.9 million as of September 30, 2025 and December 31, 2024, respectively.
(2)Corporate/Other represents all corporate level and unallocated items including any inter-segment eliminations necessary to reconcile to consolidated Company totals. This segment also includes the Company’s senior unsecured notes of $2.2 billion and $2.0 billion at September 30, 2025 and December 31, 2024, respectively.
v3.25.3
ORGANIZATION AND OPERATIONS (Details)
Sep. 30, 2025
LCFH  
ORGANIZATION AND OPERATIONS  
Ownership interest in LCFH 100.00%
v3.25.3
SIGNIFICANT ACCOUNTING POLICIES (Details)
Sep. 30, 2025
unconsolidatedVenture
Accounting Policies [Abstract]  
Unconsolidated ventures determined to be variable interest entities 2
v3.25.3
MORTGAGE LOAN RECEIVABLES - Mortgage Loans (Details)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2025
USD ($)
loan
Dec. 31, 2024
USD ($)
loan
Jun. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]            
Outstanding Face Amount $ 1,962,560 $ 1,627,627        
Allowance for credit losses (52,135) (52,323) $ (52,166) $ (52,276) $ (54,107) $ (43,165)
Carrying Value $ 1,896,423 $ 1,565,897        
Weighted average yield 8.10% 9.27%        
Remaining maturity 1 year 7 months 6 days 1 year        
Number of non-accrual loans | loan 3 2        
Principal balance of loans on non-accrual status $ 122,920 $ 76,875        
Deferred origination fees and other items 10,800 5,000        
First mortgage loans            
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]            
Outstanding Face Amount 1,923,888 1,584,674        
Carrying value gross, consumer and commercial real estate $ 1,913,275 $ 1,579,740        
Weighted average yield 8.14% 9.34%        
Remaining maturity 1 year 6 months 10 months 24 days        
Mezzanine loans            
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]            
Outstanding Face Amount $ 7,322 $ 11,603        
Carrying value gross, consumer and commercial real estate $ 7,313 $ 11,582        
Weighted average yield 11.24% 11.51%        
Remaining maturity 9 months 18 days 1 year 1 month 6 days        
Total mortgage loans receivable            
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]            
Outstanding Face Amount $ 1,931,210 $ 1,596,277        
Carrying value gross, consumer and commercial real estate $ 1,920,588 $ 1,591,322        
Weighted average yield 8.16% 9.36%        
Remaining maturity 1 year 6 months 10 months 24 days        
Total mortgage loan receivables held for investment, net, at amortized cost            
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]            
Outstanding Face Amount $ 1,931,210 $ 1,596,277        
Allowance for credit losses (52,135) (52,323)   $ (52,276)   $ (43,165)
Carrying Value $ 1,868,453 $ 1,538,999        
Remaining maturity 2 years 8 months 12 days 1 year 7 months 6 days        
First mortgage loans            
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]            
Outstanding Face Amount $ 31,350 $ 31,350        
Carrying Value $ 27,970 $ 26,898        
Weighted average yield 4.57% 4.57%        
Remaining maturity 6 years 4 months 24 days 7 years 2 months 12 days        
Cost or market adjustment of interest 5.03% 5.20%        
v3.25.3
MORTGAGE LOAN RECEIVABLES - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Jun. 30, 2025
Dec. 31, 2024
Jun. 30, 2024
Dec. 31, 2023
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]                
Outstanding face amount $ 1,962,560   $ 1,962,560     $ 1,627,627    
Allowance for current expected credit losses 52,700   52,700     52,800    
General CECL reserve 52,135 $ 52,276 52,135 $ 52,276 $ 52,166 52,323 $ 54,107 $ 43,165
Reserve of unfunded commitments 500   500     500    
Provision for loan loss reserves (31) 3,063 (154) 13,886        
Charge-off for uncollectible reserve   5,000   5,000        
Total mortgage loan receivables held for investment, net, at amortized cost                
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]                
Loans receivable with variable rates of interest $ 1,600,000   $ 1,600,000     $ 1,300,000    
Loans receivable with variable rates of interest 84.40%   84.40%     83.30%    
Loans receivable with variable rates of interest, subject to interest rate floors 100.00%   100.00%     100.00%    
Outstanding face amount $ 1,931,210   $ 1,931,210     $ 1,596,277    
General CECL reserve 52,135 $ 52,276 52,135 52,276   52,323   $ 43,165
Provision for loan loss reserves     (188) $ 14,134        
Mortgage loan  receivables held for sale                
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]                
Outstanding face amount $ 31,350   $ 31,350     $ 31,350    
Percentage of loans receivable with fixed rates of interest 100.00%   100.00%     100.00%    
v3.25.3
MORTGAGE LOAN RECEIVABLES - Activity in Loan Portfolio (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Mortgage loan receivables held for investment, net, at amortized cost:        
Net result from mortgage loan receivables held for sale $ (377) $ 1,092 $ 4,700 $ 638
Allowance for credit losses        
Beginning balance, Allowance for credit losses (52,166) (54,107) (52,323) (43,165)
Release (addition) of provision for current expected credit loss, net 31 (3,063) 154 (13,886)
Ending balance, Allowance for credit losses (52,135) (52,276) (52,135) (52,276)
Unrealized lower of cost or market adjustment reversal     1,100  
Realized gain on loans held for sale     3,600  
Repayments in transit of securities (other assets)     522 0
Mortgage loans receivable        
Mortgage loan receivables held for investment, net, at amortized cost:        
Mortgage loans receivable, ending balance 1,920,588 2,039,545 1,920,588 2,039,545
Total mortgage loan receivables held for investment, net, at amortized cost        
Mortgage loan receivables held for investment, net, at amortized cost:        
Mortgage loans receivable, beginning balance     1,591,322 3,155,089
Origination of mortgage loan receivables     888,703 71,810
Repayment of mortgage loan receivables     (502,101) (1,142,343)
Proceeds from sales of mortgage loan receivables     0 0
Non-cash disposition of loan via foreclosure     (65,078) (55,946)
Net result from mortgage loan receivables held for sale     0 0
Accretion/amortization of discount, premium and other fees     7,742 10,935
Allowance for credit losses        
Beginning balance, Allowance for credit losses     (52,323) (43,165)
Non-cash disposition of loans via foreclosure     0 5,023
Release (addition) of provision for current expected credit loss, net     188 (14,134)
Ending balance, Allowance for credit losses (52,135) (52,276) (52,135) (52,276)
Repayments in transit of securities (other assets)       19,700
Mortgage loan  receivables held for sale        
Mortgage loan receivables held for investment, net, at amortized cost:        
Mortgage loans receivable, beginning balance     26,898 26,868
Origination of mortgage loan receivables     63,360 0
Repayment of mortgage loan receivables     (141) 0
Proceeds from sales of mortgage loan receivables     (66,847) 0
Net result from mortgage loan receivables held for sale     4,700 638
Accretion/amortization of discount, premium and other fees     0 0
Mortgage loans receivable, ending balance $ 27,970 $ 27,506 $ 27,970 27,506
Conduit Mortgage Loans        
Mortgage loan receivables held for investment, net, at amortized cost:        
Proceeds from sales of mortgage loan receivables       $ (82,500)
v3.25.3
MORTGAGE LOAN RECEIVABLES - Provision for Loan Losses (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
loan
Sep. 30, 2025
USD ($)
loan
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
loan
Allowance for Loan and Lease Losses [Roll Forward]          
Allowance for credit losses at beginning of period $ 52,166,000 $ 54,107,000 $ 52,323,000 $ 43,165,000 $ 43,165,000
Provision for (release of) current expected credit loss, net (31,000) 3,192,000 (188,000) 14,134,000  
Charge-offs 0 (5,023,000) 0 (5,023,000)  
Allowance for credit losses at end of period 52,135,000 52,276,000 52,135,000 52,276,000 52,323,000
Amortized cost basis of loans on non-accrual status 122,920,000   122,920,000   76,875,000
Principal balance of loans on non-accrual status 122,900,000   122,900,000    
Total mortgage loan receivables held for investment, net, at amortized cost          
Allowance for Loan and Lease Losses [Roll Forward]          
Allowance for credit losses at beginning of period     52,323,000 43,165,000 43,165,000
Allowance for credit losses at end of period 52,135,000 52,276,000 52,135,000 52,276,000 52,323,000
Interest income on loans     4,000,000    
Asset Specific Reserve, Company Loan          
Allowance for Loan and Lease Losses [Roll Forward]          
Additional asset-specific reserve 0 $ 0 0 $ 0  
One loan | Total mortgage loan receivables held for investment, net, at amortized cost | Office Loan          
Allowance for Loan and Lease Losses [Roll Forward]          
Number of nonaccrual loans | loan   1      
One loan | Total mortgage loan receivables held for investment, net, at amortized cost | Multifamily Loan          
Allowance for Loan and Lease Losses [Roll Forward]          
Amortized cost basis of loans on non-accrual status 60,900,000   $ 60,900,000   $ 60,900,000
Number of nonaccrual loans | loan     1   1
One loan | Total mortgage loan receivables held for investment, net, at amortized cost | Mixed Use Loan          
Allowance for Loan and Lease Losses [Roll Forward]          
Amortized cost basis of loans on non-accrual status         $ 16,000,000
Number of nonaccrual loans | loan         1
One loan | Total mortgage loan receivables held for investment, net, at amortized cost | Hotel Loan          
Allowance for Loan and Lease Losses [Roll Forward]          
Amortized cost basis of loans on non-accrual status 11,900,000   $ 11,900,000    
Number of nonaccrual loans | loan     1    
One loan | Total mortgage loan receivables held for investment, net, at amortized cost | Second Multifamily Loan          
Allowance for Loan and Lease Losses [Roll Forward]          
Amortized cost basis of loans on non-accrual status $ 50,100,000   $ 50,100,000    
Number of nonaccrual loans | loan     1    
v3.25.3
MORTGAGE LOAN RECEIVABLES - Individually Impaired Loans (Details)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
USD ($)
property
loan
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
property
loan
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
loan
Financing Receivable, Credit Quality Indicator [Line Items]          
Total loans $ 1,920,588   $ 1,920,588   $ 1,591,322 [1]
Subtotal loans, Year One 890,056   890,056   176,789
Subtotal loans, Year Two 164,776   164,776   14,636
Subtotal loans, Year Three 14,641   14,641   179,369
Subtotal loans, Year Four 91,101   91,101   980,026
Subtotal loans, Year Five and Earlier 760,014   760,014   240,502
Subtotal mortgage loans receivable 1,920,588   1,920,588   1,591,322
Individually impaired loans, Year One 0   0   0
Individually impaired loans, Year Two 0   0   0
Individually impaired loans, Year Three 0   0   0
Individually impaired loans, Year Four 0   0   0
Individually impaired loans, Year Five and Earlier 0   0   0
Individually impaired loans 0   0   0
Total loans, Year One 890,056   890,056   176,789
Total loans, Year Two 164,776   164,776   14,636
Total loans, Year Three 14,641   14,641   179,369
Total loans, Year Four 91,101   91,101   980,026
Total loans, Year Five and Earlier 760,014   760,014   240,502
Accrued interest receivable 9,800   $ 9,800   $ 9,400
Mortgage loan receivable held for investment (percentage)     8.10%   9.27%
Mortgage loan receivable with a borrower collateralized 1,896,423   $ 1,896,423   $ 1,565,897
Write-off 0 $ 5,023 0 $ 5,023  
Financing Receivable, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]         Accrued interest receivable
Multifamily          
Financing Receivable, Credit Quality Indicator [Line Items]          
Year One 662,980   662,980   $ 126,588
Year Two 127,107   127,107   14,636
Year Three 14,641   14,641   105,324
Year Four 23,206   23,206   272,291
Year Five and Earlier 110,977   110,977   0
Total loans $ 938,911   $ 938,911   $ 518,839
Loans collateralized by property, valuations used to calculate allowance 2   2   1
Office          
Financing Receivable, Credit Quality Indicator [Line Items]          
Year One $ 21,945   $ 21,945   $ 0
Year Two 0   0   0
Year Three 0   0   59,944
Year Four 55,950   55,950   518,663
Year Five and Earlier 572,551   572,551   185,242
Total loans 650,446   $ 650,446   $ 763,849
Loans collateralized by property, valuations used to calculate allowance | loan         1
Office | Debt issuance costs included in mortgage loan financings          
Financing Receivable, Credit Quality Indicator [Line Items]          
Mortgage loan receivable held for investment (percentage)     12.00%    
Mortgage loan receivable with a borrower collateralized 228,000   $ 228,000    
Industrial          
Financing Receivable, Credit Quality Indicator [Line Items]          
Year One 123,379   123,379   $ 26,368
Year Two 27,212   27,212   0
Year Three 0   0   0
Year Four 0   0   0
Year Five and Earlier 0   0   0
Total loans 150,591   150,591   26,368
Mixed Use          
Financing Receivable, Credit Quality Indicator [Line Items]          
Year One 18,198   18,198   0
Year Two 0   0   0
Year Three 0   0   0
Year Four 0   0   127,380
Year Five and Earlier 33,121   33,121   0
Total loans 51,319   51,319   $ 127,380
Loans collateralized by property, valuations used to calculate allowance | loan         2
Other          
Financing Receivable, Credit Quality Indicator [Line Items]          
Year One 48,730   48,730   $ 0
Year Two 0   0   0
Year Three 0   0   14,101
Year Four 11,945   11,945   0
Year Five and Earlier 0   0   0
Total loans 60,675   60,675   14,101
Retail          
Financing Receivable, Credit Quality Indicator [Line Items]          
Year One 14,824   14,824   23,833
Year Two 10,457   10,457   0
Year Three 0   0   0
Year Four 0   0   48,628
Year Five and Earlier 24,111   24,111   0
Total loans 49,392   49,392   72,461
Hospitality          
Financing Receivable, Credit Quality Indicator [Line Items]          
Year One 0   0   0
Year Two 0   0   0
Year Three 0   0   0
Year Four 0   0   13,064
Year Five and Earlier 19,254   19,254   55,260
Total loans $ 19,254   $ 19,254   68,324
Loans collateralized by property, valuations used to calculate allowance | property 1   1    
Hospitality | Debt issuance costs included in mortgage loan financings          
Financing Receivable, Credit Quality Indicator [Line Items]          
Loans collateralized by property, valuations used to calculate allowance | loan 1   1    
Oakland, CA          
Financing Receivable, Credit Quality Indicator [Line Items]          
Write-off         $ 5,000
Number of real estate properties | loan         1
[1] Includes amounts relating to consolidated variable interest entities. Refer to Note 2 and Note 6.
v3.25.3
SECURITIES - Company Securities (Details)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2025
USD ($)
security
Dec. 31, 2024
USD ($)
security
Debt Securities, Available-for-sale [Line Items]    
Outstanding Face Amount $ 2,309,001 $ 1,868,430
Amortized Cost Basis 1,932,101 1,067,155
Gross Unrealized Gains 4,474 3,492
Gross Unrealized Losses (7,746) (8,363)
Carrying Value $ 1,928,829 $ 1,062,284
# of Securities | security 131 113
Weighted Average Coupon 4.78% 3.56%
Weighted Average Yield 5.68% 6.03%
Remaining Duration (years) 2 years 9 months 7 days 2 years 4 months 13 days
Allowance for current expected credit losses $ (20) $ (20)
Total Amortized Cost Basis 1,944,233 1,086,666
Total securities Gross Unrealized Gains 4,480 3,495
Total securities, Gross Unrealized Losses (8,166) (9,322)
Carrying Value $ 1,940,547 $ 1,080,839
Total Number of Securities | security 139 121
CMBS    
Debt Securities, Available-for-sale [Line Items]    
Outstanding Face Amount $ 1,931,727 $ 1,065,985
Amortized Cost Basis 1,930,288 1,063,835
Gross Unrealized Gains 4,258 3,335
Gross Unrealized Losses (7,691) (8,296)
Carrying Value $ 1,926,855 $ 1,058,874
# of Securities | security 112 92
Weighted Average Coupon 5.63% 5.97%
Weighted Average Yield 5.71% 6.13%
Remaining Duration (years) 2 years 9 months 14 days 2 years 4 months 28 days
Risk retention requirement, amount $ 8,800 $ 8,900
CMBS interest-only    
Debt Securities, Available-for-sale [Line Items]    
Outstanding Face Amount 347,761 769,724
Amortized Cost Basis 1,660 3,149
Gross Unrealized Gains 94 104
Gross Unrealized Losses 0 (9)
Carrying Value $ 1,754 $ 3,244
# of Securities | security 5 7
Weighted Average Coupon 0.44% 0.38%
Weighted Average Yield 8.95% 7.81%
Remaining Duration (years) 7 months 13 days 10 months 13 days
Risk retention requirement, amount $ 100 $ 200
GNMA interest-only    
Debt Securities, Available-for-sale [Line Items]    
Outstanding Face Amount 29,509 32,710
Amortized Cost Basis 149 160
Gross Unrealized Gains 122 53
Gross Unrealized Losses (55) (58)
Carrying Value $ 216 $ 155
# of Securities | security 13 13
Weighted Average Coupon 0.31% 0.33%
Weighted Average Yield 9.57% 9.38%
Remaining Duration (years) 2 years 9 months 14 days 3 years 7 months 20 days
Agency securities    
Debt Securities, Available-for-sale [Line Items]    
Outstanding Face Amount $ 4 $ 11
Amortized Cost Basis 4 11
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Carrying Value $ 4 $ 11
# of Securities | security 1 1
Weighted Average Coupon 4.00% 4.00%
Weighted Average Yield 2.39% 2.60%
Remaining Duration (years) 4 months 17 days 6 months 29 days
Equity securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost Basis $ 12,132 $ 19,511
Gross Unrealized Gains 6 3
Gross Unrealized Losses (400) (939)
Carrying Value $ 11,738 $ 18,575
# of Securities | security 8 8
v3.25.3
SECURITIES - Securities by Remaining Maturity (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Debt Securities, Available-for-sale [Line Items]    
Within 1 year $ 357,137 $ 173,875
1-5 years 1,571,692 888,320
5-10 years 0 89
After 10 years 0  
Total 1,928,829 1,062,284
Equity securities 11,700 18,600
Allowance for current expected credit losses (20) (20)
CMBS    
Debt Securities, Available-for-sale [Line Items]    
Within 1 year 355,351 170,874
1-5 years 1,571,504 888,000
5-10 years 0 0
After 10 years 0  
Total 1,926,855 1,058,874
CMBS interest-only    
Debt Securities, Available-for-sale [Line Items]    
Within 1 year 1,754 2,937
1-5 years 0 307
5-10 years 0 0
After 10 years 0  
Total 1,754 3,244
GNMA interest-only    
Debt Securities, Available-for-sale [Line Items]    
Within 1 year 28 53
1-5 years 188 13
5-10 years 0 89
After 10 years 0  
Total 216 155
Agency securities    
Debt Securities, Available-for-sale [Line Items]    
Within 1 year 4 11
1-5 years 0 0
5-10 years 0 0
After 10 years 0  
Total $ 4 $ 11
v3.25.3
SECURITIES - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Investments, Debt and Equity Securities [Abstract]        
Sale of equity securities $ 9.5 $ 0.0 $ 42.1 $ 1.8
v3.25.3
SECURITIES - Realized and Unrealized Gain (Loss) on Securities (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Investments, Debt and Equity Securities [Abstract]        
Realized gain (loss) on securities $ 2,032 $ 0 $ 3,061 $ 75
Unrealized gain (loss) on securities (176) 5 613 (22)
Total realized and unrealized gain (loss) on securities $ 1,856 $ 5 $ 3,674 $ 53
v3.25.3
REAL ESTATE AND RELATED LEASE INTANGIBLES, NET - Real Estate Portfolio (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Real estate and related lease intangibles, net    
Less: Accumulated depreciation and amortization $ (254,121) $ (233,595)
Real estate and related lease intangibles, net 705,511 670,803 [1]
Below market lease intangibles, net (other liabilities) (23,180) (25,340)
Unencumbered real estates 308,500 213,400
Accumulated amortization of below market lease 17,700 16,500
In-place leases and other intangibles    
Real estate and related lease intangibles, net    
Real estate 116,304 107,899
Undepreciated real estate and related lease intangibles    
Real estate and related lease intangibles, net    
Real estate 959,632 904,398
Land    
Real estate and related lease intangibles, net    
Real estate 190,277 173,798
Building    
Real estate and related lease intangibles, net    
Real estate $ 653,051 $ 622,701
[1] Includes amounts relating to consolidated variable interest entities. Refer to Note 2 and Note 6.
v3.25.3
REAL ESTATE AND RELATED LEASE INTANGIBLES, NET - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Real Estate [Line Items]          
Unbilled rent receivables $ 2.8   $ 2.8   $ 2.6
Tenant recoveries (1.5) $ (1.8) (4.0) $ (5.1)  
Disposal Group, Held-for-sale, Not Discontinued Operations          
Real Estate [Line Items]          
Real estate $ 0.0   $ 0.0   $ 0.0
v3.25.3
REAL ESTATE AND RELATED LEASE INTANGIBLES, NET - Depreciation and Amortization Expense on Real Estate (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Real Estate [Abstract]        
Depreciation expense $ 6,250 $ 6,323 $ 18,766 $ 19,058
Amortization expense 1,988 1,823 4,851 5,803
Total real estate depreciation and amortization expense 8,238 8,146 23,617 24,861
Depreciation on corporate fixed assets $ 100 $ 100 $ 300 $ 300
v3.25.3
REAL ESTATE AND RELATED LEASE INTANGIBLES, NET - Unamortized Favorable Lease Intangibles (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Business Combination [Line Items]          
Gross intangible assets $ 116,304   $ 116,304   $ 107,899
Accumulated amortization 62,051   62,051   57,281
Net intangible assets 54,253   54,253   50,618
Unamortized favorable lease intangibles 4,500   4,500   $ 2,300
Increase in operating lease income for amortization of below market lease intangibles acquired 509 $ 518 1,506 $ 1,572  
Total 320 425 1,067 1,287  
Above Market Leases          
Business Combination [Line Items]          
Reduction in operating lease income for amortization of above market lease intangibles acquired $ (189) $ (93) $ (439) $ (285)  
v3.25.3
REAL ESTATE AND RELATED LEASE INTANGIBLES, NET - Expected Future Amortization Expense (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Finite-Lived Intangible Assets [Line Items]    
Net intangible assets $ 54,253 $ 50,618
Increase/(Decrease) to Operating Lease Income    
Finite-Lived Intangible Assets [Line Items]    
2025 (last three months) 248  
2026 997  
2027 961  
2028 1,023  
2029 1,194  
Thereafter 14,295  
Net intangible assets 18,718  
Amortization Expense    
Finite-Lived Intangible Assets [Line Items]    
2025 (last three months) 1,768  
2026 6,606  
2027 6,430  
2028 5,359  
2029 3,589  
Thereafter 27,538  
Net intangible assets $ 51,290  
v3.25.3
REAL ESTATE AND RELATED LEASE INTANGIBLES, NET - Future Minimum Rental Payments Receivable (Details)
$ in Thousands
Sep. 30, 2025
USD ($)
Real Estate [Abstract]  
2025 (last three months) $ 18,240
2026 67,378
2027 57,108
2028 51,313
2029 48,242
Thereafter 133,934
Total $ 376,215
v3.25.3
REAL ESTATE AND RELATED LEASE INTANGIBLES, NET - Real Estate Properties Acquired (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2025
USD ($)
Apr. 30, 2025
USD ($)
property
Sep. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Apr. 30, 2024
USD ($)
security
Feb. 29, 2024
USD ($)
property
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Dec. 31, 2024
loan
Business Combination [Line Items]                    
Total real estate acquisitions               $ 65,078,000 $ 48,796,000  
Sales Proceeds               13,079,000 57,645,000  
Charge-off for uncollectible reserve             $ 5,000,000   5,000,000  
Carmel, IN | Office                    
Business Combination [Line Items]                    
Purchase Price/Fair Value on the Date of Foreclosure   $ 42,400,000                
Ownership Interest   100.00%                
Number of properties acquired | property   2                
Terminal capitalization rate   11.60%                
Carmel, IN | Office | Real Estate Acquired in Satisfaction of Debt                    
Business Combination [Line Items]                    
Realized gain (loss) on disposition of loan $ 0 $ 0                
Rockville, MD | Office                    
Business Combination [Line Items]                    
Purchase Price/Fair Value on the Date of Foreclosure $ 22,678,000             $ 22,678,000    
Ownership Interest 100.00%             100.00%    
Terminal capitalization rate 10.80%                  
Los Angeles, CA | Multifamily                    
Business Combination [Line Items]                    
Purchase Price/Fair Value on the Date of Foreclosure       $ 11,455,000   $ 14,110,000        
Ownership Interest       100.00%   100.00%        
Number of properties acquired | property           3        
Terminal capitalization rate           5.50%        
Los Angeles, CA | Multifamily | Real Estate Acquired in Satisfaction of Debt                    
Business Combination [Line Items]                    
Realized gain (loss) on disposition of loan       $ 0   $ 0        
Longview, TX | Multifamily                    
Business Combination [Line Items]                    
Purchase Price/Fair Value on the Date of Foreclosure         $ 6,080,000          
Ownership Interest         100.00%          
Number of properties acquired | security         2          
Realized gain (loss) on disposition of loan         $ 400,000          
Sales Proceeds       $ 6,100,000            
Amarillo, TX | Multifamily                    
Business Combination [Line Items]                    
Purchase Price/Fair Value on the Date of Foreclosure         $ 9,651,000          
Ownership Interest         100.00%          
Terminal capitalization rate         8.30%          
Amarillo, TX | Multifamily | Real Estate Acquired in Satisfaction of Debt                    
Business Combination [Line Items]                    
Realized gain (loss) on disposition of loan         $ 0          
Oakland, CA                    
Business Combination [Line Items]                    
Number of properties acquired | loan                   1
Oakland, CA | Office                    
Business Combination [Line Items]                    
Purchase Price/Fair Value on the Date of Foreclosure     $ 7,500,000       $ 7,500,000   $ 7,500,000  
Ownership Interest     100.00%       100.00%   100.00%  
Terminal capitalization rate     7.50%              
Oakland, CA | Office | Real Estate Acquired in Satisfaction of Debt                    
Business Combination [Line Items]                    
Charge-off for uncollectible reserve     $ 5,000,000              
v3.25.3
REAL ESTATE AND RELATED LEASE INTANGIBLES, NET - Real Estate Properties Sold (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 31, 2025
USD ($)
property
Jul. 31, 2024
USD ($)
property
Jun. 30, 2024
USD ($)
property
May 31, 2024
USD ($)
property
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
[1]
Disposal Groups, Including Discontinued Operations [Line Items]                  
Sales Proceeds             $ 13,079 $ 57,645  
Net Book Value         $ 705,511   705,511   $ 670,803
Realized Gain/(Loss)         0 $ 315 3,807 12,858  
Multifamily | Longview, TX                  
Disposal Groups, Including Discontinued Operations [Line Items]                  
Sales Proceeds     $ 6,100            
2024 Disposal Properties                  
Disposal Groups, Including Discontinued Operations [Line Items]                  
Sales Proceeds             13,079 57,645  
Net Book Value         $ 9,272 $ 45,190 9,272 45,190  
Realized Gain/(Loss)             $ 3,807 $ 12,858  
2024 Disposal Properties | Retail | Jenks, OK                  
Disposal Groups, Including Discontinued Operations [Line Items]                  
Sales Proceeds $ 13,079                
Net Book Value 9,272                
Realized Gain/(Loss) $ 3,807                
Properties | property 1                
2024 Disposal Properties | Retail | Waldorf, MD                  
Disposal Groups, Including Discontinued Operations [Line Items]                  
Sales Proceeds     23,734            
Net Book Value     11,424            
Realized Gain/(Loss)     $ 12,310            
Properties | property     1            
2024 Disposal Properties | Office | Peoria, IL                  
Disposal Groups, Including Discontinued Operations [Line Items]                  
Sales Proceeds       $ 1,227          
Net Book Value       2,320          
Realized Gain/(Loss)       $ (1,093)          
Properties | property       1          
2024 Disposal Properties | Multifamily | Los Angeles, CA                  
Disposal Groups, Including Discontinued Operations [Line Items]                  
Sales Proceeds   $ 11,770 $ 14,834            
Net Book Value   11,455 13,911            
Realized Gain/(Loss)   $ 315 $ 923            
Properties | property   1 3            
2024 Disposal Properties | Multifamily | Longview, TX                  
Disposal Groups, Including Discontinued Operations [Line Items]                  
Sales Proceeds     $ 6,080            
Net Book Value     6,080            
Realized Gain/(Loss)     $ 403            
Properties | property     2            
[1] Includes amounts relating to consolidated variable interest entities. Refer to Note 2 and Note 6.
v3.25.3
DEBT OBLIGATIONS, NET - Company's Debt Obligations (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Assets Sold under Agreements to Repurchase [Line Items]    
Carrying Value $ 361,638 $ 62,738
Carrying Value of Collateral 0 0
Committed Master Repurchase Agreements    
Assets Sold under Agreements to Repurchase [Line Items]    
Committed Amount 856,000 1,156,000
Outstanding Principal Amount 0 62,738
Carrying Value 0 62,738
Carrying Value of Collateral 14,641 111,890
Unamortized debt issuance expense 2,800 2,100
Master Repurchase Agreements    
Assets Sold under Agreements to Repurchase [Line Items]    
Committed Amount 856,000  
Outstanding Principal Amount 361,638  
Carrying Value 361,638  
Carrying Value of Collateral 416,970  
Debt Obligations    
Assets Sold under Agreements to Repurchase [Line Items]    
Committed Amount 1,706,000 1,881,000
Outstanding Principal Amount 3,014,139 3,149,492
Carrying Value 2,997,232 3,135,617
Carrying Value of Collateral 814,023 1,395,040
Maturing on 27 September 2028 | Committed Master Repurchase Agreements    
Assets Sold under Agreements to Repurchase [Line Items]    
Committed Amount 300,000  
Outstanding Principal Amount 0  
Carrying Value $ 0  
Average Cost of Funds (as a percent) 0.00%  
Carrying Value of Collateral $ 0  
Maturing on 27 September 2025 | Committed Master Repurchase Agreements    
Assets Sold under Agreements to Repurchase [Line Items]    
Committed Amount   500,000
Outstanding Principal Amount   62,738
Carrying Value   $ 62,738
Average Cost of Funds (as a percent)   6.55%
Carrying Value of Collateral   $ 97,254
Maturing on 21 October 2027 | Committed Master Repurchase Agreements    
Assets Sold under Agreements to Repurchase [Line Items]    
Committed Amount 300,000 300,000
Outstanding Principal Amount 0 0
Carrying Value $ 0 $ 0
Average Cost of Funds (as a percent) 0.00% 0.00%
Carrying Value of Collateral $ 0 $ 0
Maturing on 3 October 2025 | Committed Master Repurchase Agreements    
Assets Sold under Agreements to Repurchase [Line Items]    
Committed Amount 200,000 200,000
Outstanding Principal Amount 0 0
Carrying Value $ 0 $ 0
Average Cost of Funds (as a percent) 0.00% 0.00%
Carrying Value of Collateral $ 14,641 $ 14,636
Maturing on 22 January 2025 | Committed Master Repurchase Agreements    
Assets Sold under Agreements to Repurchase [Line Items]    
Committed Amount   100,000
Outstanding Principal Amount   0
Carrying Value   $ 0
Average Cost of Funds (as a percent)   0.00%
Carrying Value of Collateral   $ 0
Maturing on 30 April 2026 | Committed Master Repurchase Agreements    
Assets Sold under Agreements to Repurchase [Line Items]    
Committed Amount 56,000 56,000
Outstanding Principal Amount 0 0
Carrying Value $ 0 $ 0
Average Cost of Funds (as a percent) 0.00% 0.00%
Carrying Value of Collateral $ 0 $ 0
Maturing on October 2025 | Securities Repurchases    
Assets Sold under Agreements to Repurchase [Line Items]    
Committed Amount 0  
Outstanding Principal Amount 361,638  
Carrying Value $ 361,638  
Average Cost of Funds (as a percent) 4.69%  
Carrying Value of Collateral $ 402,329  
Maturing on Various Date | Mortgage Debt    
Assets Sold under Agreements to Repurchase [Line Items]    
Outstanding Principal Amount 399,092 443,733
Carrying Value $ 401,656 $ 446,397
Average Cost of Funds (as a percent) 6.18% 6.09%
Carrying Value of Collateral $ 397,053 $ 451,880
Maturing on Various Date | CLO Debt    
Assets Sold under Agreements to Repurchase [Line Items]    
Outstanding Principal Amount   601,464
Carrying Value   $ 601,429
Average Cost of Funds (as a percent)   6.36%
Carrying Value of Collateral   $ 831,270
Maturing on Various Date | Senior Unsecured Notes    
Assets Sold under Agreements to Repurchase [Line Items]    
Outstanding Principal Amount 2,233,409 2,041,557
Carrying Value $ 2,213,938 $ 2,025,053
Average Cost of Funds (as a percent) 5.29% 5.22%
Maturing on 20 December 2028 | Unsecured Revolving Credit Facility    
Assets Sold under Agreements to Repurchase [Line Items]    
Committed Amount $ 850,000 $ 725,000
Outstanding Principal Amount 20,000 0
Carrying Value $ 20,000 $ 0
Average Cost of Funds (as a percent) 5.37% 0.00%
Unamortized debt issuance expense $ 7,500 $ 7,100
v3.25.3
DEBT OBLIGATIONS, NET - Senior Unsecured Notes (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Debt Instrument [Line Items]        
Gain on extinguishment of debt $ (106,000) $ 20,000 $ 151,000 $ 197,000
Senior Unsecured Notes        
Debt Instrument [Line Items]        
Senior notes 2,200,000,000   2,200,000,000  
Senior Unsecured Notes | Senior Notes Due 2027        
Debt Instrument [Line Items]        
Notes issued $ 599,500,000   $ 599,500,000  
Stated interest rate on debt instrument 4.25%   4.25%  
Notes repurchased     $ 12,400,000  
Gain on extinguishment of debt     250,000  
Senior Unsecured Notes | Senior Notes Due 2029        
Debt Instrument [Line Items]        
Notes issued $ 633,900,000   $ 633,900,000  
Stated interest rate on debt instrument 4.75%   4.75%  
Senior Unsecured Notes | Senior Note Due 2030        
Debt Instrument [Line Items]        
Notes issued $ 500,000,000.0   $ 500,000,000.0  
Stated interest rate on debt instrument 5.50%   5.50%  
Senior Unsecured Notes | Senior Notes Due 2031        
Debt Instrument [Line Items]        
Notes issued $ 500,000,000.0   $ 500,000,000.0  
Stated interest rate on debt instrument 7.00%   7.00%  
Senior Unsecured Notes | Senior Notes Due 2025        
Debt Instrument [Line Items]        
Stated interest rate on debt instrument 5.25%   5.25%  
Gain on extinguishment of debt     $ (99,000)  
v3.25.3
DEBT OBLIGATIONS, NET - Revolving Credit Facility (Details) - USD ($)
$ in Thousands
1 Months Ended 9 Months Ended
Dec. 20, 2024
Sep. 30, 2025
Sep. 30, 2025
Jan. 02, 2025
Dec. 31, 2024
Debt Instrument [Line Items]          
Outstanding borrowings on the revolving credit facility   $ 361,638 $ 361,638   $ 62,738
Line of Credit | Short-Term Debt          
Debt Instrument [Line Items]          
Committed amount on credit agreement   $ 100,000 100,000    
Debt instrument term (in years)   5 years      
Permitted borrowing capacity   $ 0 0    
Utilized borrowing capacity   0 $ 0    
Unsecured Revolving Credit Facility          
Debt Instrument [Line Items]          
Committed amount on credit agreement $ 725,000     $ 850,000  
Line of credit facility, accordion feature, increase limit $ 1,300,000        
Company’s credit rating     1.25%    
Outstanding borrowings on the revolving credit facility   $ 20,000 $ 20,000    
Unsecured Revolving Credit Facility | Minimum          
Debt Instrument [Line Items]          
Company’s credit rating 0.775%        
Unsecured Revolving Credit Facility | Maximum          
Debt Instrument [Line Items]          
Company’s credit rating 1.70%        
v3.25.3
DEBT OBLIGATIONS, NET - Collateralized Loan Obligation Debt (Details) - USD ($)
$ in Thousands
Dec. 02, 2021
Jul. 13, 2021
Sep. 30, 2025
Dec. 31, 2024
Debt Instrument [Line Items]        
Debt obligations, net     $ 2,997,232 $ 3,135,617 [1]
Variable Interest Entity, Primary Beneficiary        
Debt Instrument [Line Items]        
Debt obligations, net       601,429
Variable Interest Entity, Primary Beneficiary | Collateralized Loan Obligation        
Debt Instrument [Line Items]        
Subordinate and controlling interest 15.60% 18.00%    
Subordinate and controlling interest as investment 6.80%      
Non-Recourse Notes | CLO Debt        
Debt Instrument [Line Items]        
Loans financed $ 729,400 $ 607,500    
Advance rate 77.60% 82.00%    
Debt obligations, net $ 566,200 $ 498,200    
Maturing on Various Date | CLO Debt        
Debt Instrument [Line Items]        
Debt obligations, net       $ 601,400
[1] Includes amounts relating to consolidated variable interest entities. Refer to Note 2 and Note 6.
v3.25.3
DEBT OBLIGATIONS, NET - Variable Interest Entities (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Jun. 30, 2025
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Debt Instrument [Line Items]            
Accrued interest receivable $ 14,485   $ 12,936 [1]      
Other assets 47,895   158,149 [1]      
Total assets 4,686,544   4,845,073 [1] $ 4,845,073    
Debt obligations, net 2,997,232   3,135,617 [1]      
Accrued expenses 55,446   74,824 [1]      
Total liabilities 3,193,130   3,312,134 [1]      
Total equity 1,493,414 $ 1,500,070 1,532,939 [1] $ 1,530,692 $ 1,528,495 $ 1,532,198
Total liabilities and equity $ 4,686,544   4,845,073 [1]      
Variable Interest Entity, Primary Beneficiary            
Debt Instrument [Line Items]            
Mortgage loan receivables held for investment, net, at amortized cost     831,270      
Accrued interest receivable     5,530      
Other assets     42,621      
Total assets     879,421      
Debt obligations, net     601,429      
Accrued expenses     1,806      
Total liabilities     603,235      
Net equity in VIEs (eliminated in consolidation)     276,186      
Total equity     276,186      
Total liabilities and equity     $ 879,421      
[1] Includes amounts relating to consolidated variable interest entities. Refer to Note 2 and Note 6.
v3.25.3
DEBT OBLIGATIONS, NET - Loan and Securities Repurchase Financing (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2025
USD ($)
security
agreement
loan
Dec. 31, 2024
USD ($)
Debt Instrument [Line Items]    
Number of counterparties with collateral exceeding borrowed amounts | security 0  
Amount of collateral exceeding borrowings $ 149,300  
Amount of collateral exceeding borrowings (in percent) 10.00%  
Committed Master Repurchase Agreements    
Debt Instrument [Line Items]    
Number of repurchase agreements | agreement 4  
Committed Amount $ 856,000 $ 1,156,000
Outstanding Principal Amount 0 $ 62,738
Uncommitted Master Repurchase Agreements | Maturing on July 2025    
Debt Instrument [Line Items]    
Securities repurchase debt outstanding $ 361,600  
Loan Repurchase Facilities    
Debt Instrument [Line Items]    
Number of facilities due within than 90 days | loan 1  
Specified period facilities are due, greater than 90 days 30 days  
v3.25.3
DEBT OBLIGATIONS, NET - Mortgage Loan Financing (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
USD ($)
agreement
Sep. 30, 2024
USD ($)
agreement
Sep. 30, 2025
USD ($)
agreement
Sep. 30, 2024
USD ($)
agreement
Dec. 31, 2024
USD ($)
Debt Instrument [Line Items]          
Amortization of (premium)/discount on mortgage loan financing included in interest expense     $ (493) $ (558)  
Mortgage loan financing          
Debt Instrument [Line Items]          
Carrying amount $ 401,700   401,700   $ 446,400
Net unamortized premiums 3,200   3,200   $ 3,700
Amortization of (premium)/discount on mortgage loan financing included in interest expense $ 200 $ (200) $ 500 $ (600)  
Number of agreements | agreement 0 6 0 16  
Mortgage loan financing | Mortgages Executed Y          
Debt Instrument [Line Items]          
Outstanding debt balance $ 13,000 $ 81,900 $ 13,000 $ 81,900  
v3.25.3
DEBT OBLIGATIONS, NET - Contractual Payments Under Borrowings by Maturity (Details)
$ in Thousands
Sep. 30, 2025
USD ($)
Long-term Debt, Fiscal Year Maturity [Abstract]  
2025 (last three months) $ 376,033
2026 26,424
2027 805,391
2028 24,317
2029 689,484
Thereafter 1,092,490
Subtotal 3,014,139
Net premiums included in mortgage loan financings 3,227
Total 2,997,232
Debt issuance costs included in senior unsecured notes  
Long-term Debt, Fiscal Year Maturity [Abstract]  
Unamortized debt issuance costs (19,472)
Debt issuance costs included in mortgage loan financings  
Long-term Debt, Fiscal Year Maturity [Abstract]  
Unamortized debt issuance costs $ (662)
v3.25.3
DERIVATIVE INSTRUMENTS - Derivatives Outstanding (Details)
$ in Thousands
Sep. 30, 2025
USD ($)
option
Dec. 31, 2024
USD ($)
option
Derivative [Line Items]    
Notional $ 112,500 $ 90,000
Fair value, asset 284 437
Fair value, liability 0 0
1 Month Term SOFR    
Derivative [Line Items]    
Notional 90,000 90,000
Fair value, asset 4 432
Fair value, liability $ 0 $ 0
Remaining Maturity (years) 1 year 14 days 7 months 13 days
10-year Treasury-Note Futures    
Derivative [Line Items]    
Notional $ 22,500  
Fair value, asset 276  
Fair value, liability $ 0  
Remaining Maturity (years) 3 months 3 days  
Total futures    
Derivative [Line Items]    
Notional $ 22,500  
Fair value, asset 276  
Fair value, liability 0  
Options    
Derivative [Line Items]    
Fair value, asset 4 $ 5
Fair value, liability $ 0 $ 0
Remaining Maturity (years) 1 month 2 days 18 days
Option contracts held | option 75 275
Total credit derivatives    
Derivative [Line Items]    
Notional   $ 0
Fair value, asset   5
Fair value, liability   $ 0
v3.25.3
DERIVATIVE INSTRUMENTS - Realized Gains (Losses) on Derivatives (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Derivative [Line Items]        
Unrealized Gain/(Loss) $ 12 $ (900) $ (174) $ (1,596)
Realized Gain/(Loss) 9 134 2,044 5,467
Net Result from Derivative Transactions 21 (766) 1,870 3,871
Caps        
Derivative [Line Items]        
Unrealized Gain/(Loss) (142) (589) (450) (1,220)
Realized Gain/(Loss) 126 421 504 1,258
Net Result from Derivative Transactions (16) (168) 54 38
Futures        
Derivative [Line Items]        
Unrealized Gain/(Loss) 154 (311) 276 (376)
Realized Gain/(Loss) (66) (282) 1,596 4,215
Net Result from Derivative Transactions 88 (593) 1,872 3,839
Options        
Derivative [Line Items]        
Unrealized Gain/(Loss) 0 0 0 0
Realized Gain/(Loss) (51) (5) (56) (6)
Net Result from Derivative Transactions $ (51) $ (5) $ (56) $ (6)
v3.25.3
DERIVATIVE INSTRUMENTS - Additional Information (Details) - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Cash margins held as collateral for derivatives by counterparties $ 0.6 $ 0.0
v3.25.3
OFFSETTING ASSETS AND LIABILITIES - Offsetting Assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Offsetting Derivative Assets [Abstract]    
Gross amounts of recognized assets $ 284 $ 437
Gross amounts offset in the balance sheet 0 0
Net amounts of assets presented in the balance sheet 284 437
Total Derivative Assets, Gross Amounts Not Offset in the Statements of Condition, Financial Instruments 0 0
Total Derivative Assets, Gross Amounts Not Offset in the Statements of Condition, Cash Collateral Received (574) 0
Total Derivative Assets, Gross Amounts Not Offset in the Statements of Condition, Net Amount (290) 437
Offsetting Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed [Abstract]    
Total Assets, Gross Amounts Recognized 284 437
Total Assets, Gross Amounts Offset in the Statements of Condition 0 0
Derivative instruments 284 437
Total Assets, Gross Amounts Not Offset in the Statements of Condition, Financial Instruments 0 0
Total Assets, Gross Amounts Not Offset in the Statements of Condition, Cash Collateral Received (574) 0
Total Assets, Net amount $ (290) $ 437
v3.25.3
OFFSETTING ASSETS AND LIABILITIES - Offsetting Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Repurchase agreements    
Outstanding borrowings on the revolving credit facility $ 361,638 $ 62,738
Gross amounts offset in the balance sheet 0 0
Net amounts of liabilities presented in the balance sheet 361,638 62,738
Financial instruments collateral 361,638 62,738
Cash collateral posted/(received)(1) 0 0
Net amount 361,638 62,738
Total    
Total Liabilities, Gross Amounts Recognized 361,638 62,738
Total Liabilities, Gross Amounts Offset in the Statements of Condition 0 0
Total Liabilities, Net Amounts Presented in the Statement of Condition 361,638 62,738
Total Liabilities, Gross Amounts Not Offset in the Statements of Condition, Financial Instruments 361,638 62,738
Total Liabilities, Gross Amounts Not Offset in the Statements of Condition, Cash Collateral Pledged 0 0
Total Liabilities, Net Amount $ 361,638 $ 62,738
v3.25.3
EQUITY - Additional Information (Details) - 2014 Share Repurchase Authorization Program - USD ($)
$ / shares in Units, $ in Thousands
Sep. 30, 2025
Apr. 23, 2025
Apr. 22, 2025
Dec. 31, 2024
Sep. 30, 2024
Apr. 24, 2024
Dec. 31, 2023
Class of Stock [Line Items]              
Remaining amount available for repurchase $ 91,500            
Percentage of aggregate common stock outstanding under Repurchase Program 6.60%            
Closing price (in dollars per share) $ 10.91            
Class A Common Stock              
Class of Stock [Line Items]              
Additional authorizations   $ 100,000 $ 66,800     $ 75,000  
Remaining amount available for repurchase $ 91,508     $ 67,604 $ 73,598   $ 44,256
v3.25.3
EQUITY - Repurchase of Treasury Stock Activity (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 23, 2025
Apr. 24, 2024
Sep. 30, 2025
Aug. 31, 2025
Jul. 31, 2025
Jun. 30, 2025
May 31, 2025
Apr. 30, 2025
Mar. 31, 2025
Feb. 28, 2025
Jan. 31, 2025
Sep. 30, 2024
Aug. 31, 2024
Jul. 31, 2024
Jun. 30, 2024
May 31, 2024
Apr. 30, 2024
Mar. 31, 2024
Feb. 29, 2024
Jan. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Apr. 22, 2025
Treasury Stock [Roll Forward]                                                  
Repurchases paid                                         $ (1,885) $ (1,191) $ (9,311) $ (2,049)  
2014 Share Repurchase Authorization Program                                                  
Treasury Stock [Roll Forward]                                                  
Authorizations remaining amount, end of period     $ 91,500                                   91,500   91,500    
2014 Share Repurchase Authorization Program | Class A Common Stock                                                  
Class of Stock [Line Items]                                                  
Purchase of treasury stock (in shares)     91,321 43,020 36,371 234,094 401,396 0 70,506 0 0 100,001 0 0 17,590 2,100 0 60,000 0 0          
Treasury Stock [Roll Forward]                                                  
Authorizations remaining amount, beginning of period                     $ 67,604                 $ 44,256     67,604 44,256  
Additional authorizations $ 33,201 $ 31,391                                              
Repurchases paid     $ (1,017) $ (471) $ (397) $ (2,456) $ (4,151) $ 0 $ (805) $ 0 $ 0 $ (1,190) $ 0 $ 0 $ (189) $ (23) $ 0 $ (647) $ 0 $ 0          
Authorizations remaining amount, end of period     $ 91,508                 $ 73,598                 $ 91,508 $ 73,598 $ 91,508 $ 73,598  
Additional authorizations $ 100,000 $ 75,000                                             $ 66,800
v3.25.3
EQUITY - Dividends Declared (Details) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Class A Common Stock                
Class of Stock [Line Items]                
Dividends per share of Class A common stock (in dollars per share) $ 0.23 $ 0.23 $ 0.23 $ 0.23 $ 0.23 $ 0.23 $ 0.69 $ 0.69
v3.25.3
EQUITY - Changes in Accumulated Other Comprehensive Income (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
AOCI Attributable to Parent [Roll Forward]        
Beginning Balance $ 1,500,070 $ 1,528,495 $ 1,532,939 [1] $ 1,532,198
Unrealized gain (loss) on securities, available for sale 4,131 2,041 3,570 5,165
Ending Balance 1,493,414 1,530,692 1,493,414 1,530,692
Accumulated Other Comprehensive Income (Loss)        
AOCI Attributable to Parent [Roll Forward]        
Beginning Balance (5,639) (10,752) (4,866) (13,853)
Unrealized gain (loss) on securities, available for sale       5,165
Ending Balance $ (3,339) $ (8,711) $ (3,339) $ (8,711)
[1] Includes amounts relating to consolidated variable interest entities. Refer to Note 2 and Note 6.
v3.25.3
NONCONTROLLING INTERESTS (Details) - Consolidated Venture
$ in Millions
Sep. 30, 2025
USD ($)
property
jointVenture
Noncontrolling Interest [Line Items]  
Number of consolidated ventures | jointVenture 2
Isla Vista, CA | Student Housing  
Noncontrolling Interest [Line Items]  
Number of real estate properties | property 40
Property book value $ 77.0
Oakland County, MI | Office Building  
Noncontrolling Interest [Line Items]  
Property book value $ 8.3
Consolidated Ventures | Minimum  
Noncontrolling Interest [Line Items]  
Noncontrolling interest ownership 10.00%
Consolidated Ventures | Maximum  
Noncontrolling Interest [Line Items]  
Noncontrolling interest ownership 25.00%
v3.25.3
EARNINGS PER SHARE - Net Income and Weighted Average Shares Outstanding (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Weighted average shares outstanding:        
Basic (in shares) 125,339,188 125,705,754   125,586,075
Diluted (in shares) 126,115,547 125,905,528   125,757,114
Class A Common Stock        
Earnings Per Share        
Basic Net income (loss) available for Class A common shareholders $ 19,189 $ 27,913 $ 48,293 $ 76,869
Diluted Net income (loss) available for Class A common shareholders $ 19,189 $ 27,913 $ 48,293 $ 76,869
Weighted average shares outstanding:        
Basic (in shares) 125,339,188 125,705,754 125,587,121 125,586,075
Diluted (in shares) 126,115,547 125,905,528 126,198,822 125,757,114
v3.25.3
EARNINGS PER SHARE - Calculation of Basic and Diluted EPS (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Denominator:        
Weighted average number of shares of Class A common stock outstanding (in shares) 125,339,188 125,705,754   125,586,075
Basic net income (loss) per share of Class A common stock (in dollars per share) $ 0.15 $ 0.22 $ 0.38 $ 0.61
Denominator:        
Basic, weighted average number of shares of Class A common stock outstanding (in shares) 125,339,188 125,705,754   125,586,075
Diluted weighted average number of shares of Class A common stock outstanding (in shares) 126,115,547 125,905,528   125,757,114
Diluted net income (loss) per share of Class A common stock (in dollars per share) $ 0.15 $ 0.22 $ 0.38 $ 0.61
Anti-dilutive shares (in shares) 15 166,571 11,251 335,482
Class A Common Stock        
Numerator:        
Net income (loss) attributable to Class A common shareholders $ 19,189 $ 27,913 $ 48,293 $ 76,869
Denominator:        
Weighted average number of shares of Class A common stock outstanding (in shares) 125,339,188 125,705,754 125,587,121 125,586,075
Basic net income (loss) per share of Class A common stock (in dollars per share) $ 0.15 $ 0.22 $ 0.38 $ 0.61
Numerator:        
Net income (loss) attributable to Class A common shareholders $ 19,189 $ 27,913 $ 48,293 $ 76,869
Diluted net income (loss) attributable to Class A common shareholders $ 19,189 $ 27,913 $ 48,293 $ 76,869
Denominator:        
Basic, weighted average number of shares of Class A common stock outstanding (in shares) 125,339,188 125,705,754 125,587,121 125,586,075
Diluted weighted average number of shares of Class A common stock outstanding (in shares) 126,115,547 125,905,528 126,198,822 125,757,114
Diluted net income (loss) per share of Class A common stock (in dollars per share) $ 0.15 $ 0.22 $ 0.38 $ 0.61
Class A Common Stock | Restricted Stock        
Denominator:        
Incremental shares of unvested Class A restricted stock (in shares) 776,359 199,774 611,701 171,039
v3.25.3
STOCK-BASED AND OTHER COMPENSATION PLANS - Stock Based Compensation Plans (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]        
Stock-based compensation expense $ 3,049 $ 3,177 $ 17,260 $ 16,592
Total Stock-Based Compensation Expense $ 3,049 $ 3,177 $ 17,260 $ 16,592
v3.25.3
STOCK-BASED AND OTHER COMPENSATION PLANS - Grants (Details) - Restricted Stock - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares (in shares)     1,852,016  
Class A Common Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares (in shares) 31,989 0 1,852,016 1,855,541
Weighted average fair value per share (in dollars per share) $ 11.16 $ 0 $ 11.67 $ 10.70
v3.25.3
STOCK-BASED AND OTHER COMPENSATION PLANS - Nonvested Shares Outstanding (Details) - USD ($)
$ / shares in Units, $ in Millions
9 Months Ended
Sep. 30, 2025
Weighted Average Grant Date Fair Value  
Nonvested/Outstanding weighted average grant date fair value, beginning balance (in dollars per share) $ 12.28
Granted, weighted average grant date fair value (in dollars per share) 11.67
Vested, weighted average grant date fair value (in dollars per share) 11.49
Expired, weighted average grant date fair value (in dollars per share) 0
Nonvested/Outstanding weighted average grant date fair value, ending balance (in dollars per share) 12.42
Stock Options  
Weighted average exercise price of outstanding options (in dollars per share) $ 12.42
Unrecognized compensation cost $ 13.3
Period of recognition for unrecognized compensation costs 35 months 3 days
Remaining vesting period 23 months 24 days
Restricted Stock  
Restricted Stock  
Nonvested/Outstanding at beginning balance (in shares) 2,020,752
Granted (in shares) 1,852,016
Vested (in shares) (1,778,588)
Expired (in shares) 0
Nonvested/Outstanding at ending balance (in shares) 2,094,180
Stock Options  
Stock Options  
Nonvested/Outstanding (in shares) 623,788
Granted (in shares) 0
Vested (in shares) 0
Expired (in shares) (439,760)
Nonvested/Outstanding (in shares) 184,028
Exercisable (in shares) 184,028
Options, warrants and rights  
Weighted Average Grant Date Fair Value  
Nonvested/Outstanding weighted average grant date fair value, ending balance (in dollars per share) $ 11.86
Stock Options  
Weighted average exercise price of outstanding options (in dollars per share) $ 11.86
v3.25.3
STOCK-BASED AND OTHER COMPENSATION PLANS - Omnibus Incentive Plan and Other Awards (Details)
$ in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 18, 2025
USD ($)
shares
Feb. 18, 2024
USD ($)
shares
Feb. 18, 2023
USD ($)
shares
Feb. 28, 2025
installment
Feb. 29, 2024
installment
Feb. 28, 2023
installment
Sep. 30, 2025
shares
Sep. 30, 2024
shares
Sep. 30, 2025
shares
Sep. 30, 2024
shares
Jun. 06, 2023
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Aggregate value of awards granted | $ $ 11.0 $ 10.0 $ 8.5                
Restricted Stock                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Granted (in shares)                 1,852,016    
Restricted Stock | Class A Common Stock                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Granted (in shares)             31,989 0 1,852,016 1,855,541  
Non-Management Grantee | Mr. Miceli and Ms. Porcella                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Unrestricted shares granted (in shares) 21,658 22,939 19,558                
Non-Management Grantee | Performance Based Vesting | Other Non-Management Grantees                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Shares granted with certain vesting rights (in shares) 412,499 441,212 325,709                
Non-Management Grantee | Time-Based Vesting | Other Non-Management Grantees                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Shares granted with certain vesting rights (in shares) 390,859 418,285 306,162                
Non-Management Grantee | Restricted Stock | Class A Common Stock                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Aggregate value of awards granted | $ $ 9.6 $ 9.4 $ 7.5                
Granted (in shares) 825,016 882,436 651,429                
Management Grantees | Restricted Stock | Time and Performance Based Vesting | Class A Common Stock                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Aggregate value of awards granted | $ $ 1.5 $ 1.4 $ 1.2                
Board of Directors | Restricted Stock | Class A Common Stock                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Granted (in shares) 32,190 35,545 32,525                
Grant date fair value | $ $ 0.4 $ 0.4 $ 0.4                
Vesting period 1 year 1 year 1 year                
Omnibus Incentive Plan 2023                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Number of shares available for issuance (in shares)                     3,000,000
Omnibus Incentive Plan 2023 | Non-Management Grantee | Restricted Stock                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Number of installments | installment       3              
Omnibus Incentive Plan 2023 | Management Grantees | Restricted Stock | Class A Common Stock                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Granted (in shares) 962,821                    
Omnibus Incentive Plan 2023 | Management Grantees | Restricted Stock | Performance Based Vesting                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Minimum performance target percentage       8.00%              
Performance period       3 years              
Omnibus Incentive Plan 2023 | Management Grantees | Restricted Stock | Time and Performance Based Vesting | Class A Common Stock                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Granted (in shares) 125,871                    
2014 Omnibus Incentive Plan                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Number of shares available for issuance (in shares)                     10,253,867
2014 Omnibus Incentive Plan | Non-Management Grantee | Restricted Stock                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Number of installments | installment         3 3          
2014 Omnibus Incentive Plan | Management Grantees | Class A Common Stock | Ms. McCormack and Mr. Perelman                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Number of shares of unrestricted stock   50.00% 50.00% 50.00%              
2014 Omnibus Incentive Plan | Management Grantees | Performance Based Vesting | Class A Common Stock | Mr. Miceli and Ms. Porcella                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Vesting percentage   50.00% 50.00% 50.00%              
2014 Omnibus Incentive Plan | Management Grantees | Catch-up Provision | Class A Common Stock | Ms. McCormack and Mr. Perelman                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Vesting percentage   50.00% 50.00% 50.00%              
2014 Omnibus Incentive Plan | Management Grantees | Time-Based Vesting | Class A Common Stock | Mr. Miceli and Ms. Porcella                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Vesting percentage   50.00% 50.00% 50.00%              
2014 Omnibus Incentive Plan | Management Grantees | Restricted Stock | Class A Common Stock                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Granted (in shares)   937,560 733,607                
2014 Omnibus Incentive Plan | Management Grantees | Restricted Stock | Catch-up Provision                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Vesting percentage       66.67% 66.67% 66.67%          
2014 Omnibus Incentive Plan | Management Grantees | Restricted Stock | Time and Performance Based Vesting | Class A Common Stock                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Granted (in shares)   127,275 101,344                
v3.25.3
STOCK-BASED AND OTHER COMPENSATION PLANS - Change in Control and Performance Target (Details)
9 Months Ended
Sep. 30, 2025
non-managementGrantee
Sep. 18, 2025
Share-Based Payment Arrangement [Abstract]    
Number of non-management grantee 1  
Number of specified grantee 1  
Share-based compensation arrangement by share-based payment award, terms of award, performance target percentage   0.06
v3.25.3
FAIR VALUE OF FINANCIAL INSTRUMENTS - Estimated Fair Values of Financial Instruments (Details)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2025
USD ($)
Dec. 31, 2024
USD ($)
Jun. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Assets:            
Amortized Cost Basis $ 1,932,101 $ 1,067,155        
Fair Value 1,928,829 1,062,284        
Liabilities:            
Allowance for credit losses (52,135) (52,323) $ (52,166) $ (52,276) $ (54,107) $ (43,165)
CMBS            
Assets:            
Amortized Cost Basis 1,930,288 1,063,835        
Fair Value 1,926,855 1,058,874        
CMBS interest-only            
Assets:            
Amortized Cost Basis 1,660 3,149        
Fair Value 1,754 3,244        
GNMA interest-only            
Assets:            
Amortized Cost Basis 149 160        
Fair Value 216 155        
Agency securities            
Assets:            
Amortized Cost Basis 4 11        
Fair Value $ 4 $ 11        
Total mortgage loan receivables held for investment, net, at amortized cost            
Liabilities:            
Period of short interest rate reset risk 30 days 30 days        
Recurring | CMBS            
Assets:            
Principal Amount $ 1,931,727 $ 1,065,985        
Amortized Cost Basis 1,930,288 1,063,835        
Fair Value $ 1,926,855 $ 1,058,873        
Recurring | CMBS | Internal model | Yield %            
Liabilities:            
Financial instruments, measurement input 0.0571 0.0613        
Recurring | CMBS | Internal model | Remaining Maturity/Duration (years)            
Liabilities:            
Financial instruments, measurement input 2.79 2.41        
Recurring | CMBS interest-only            
Assets:            
Principal Amount $ 347,761 $ 769,724        
Amortized Cost Basis 1,660 3,149        
Fair Value $ 1,754 $ 3,244        
Recurring | CMBS interest-only | Internal model | Yield %            
Liabilities:            
Financial instruments, measurement input 0.0895 0.0781        
Recurring | CMBS interest-only | Internal model | Remaining Maturity/Duration (years)            
Liabilities:            
Financial instruments, measurement input 0.62 0.87        
Recurring | GNMA interest-only            
Assets:            
Principal Amount $ 29,509 $ 32,710        
Amortized Cost Basis 149 160        
Fair Value $ 216 $ 155        
Recurring | GNMA interest-only | Internal model | Yield %            
Liabilities:            
Financial instruments, measurement input 0.0957 0.0938        
Recurring | GNMA interest-only | Internal model | Remaining Maturity/Duration (years)            
Liabilities:            
Financial instruments, measurement input 2.79 3.64        
Recurring | Agency securities            
Assets:            
Principal Amount $ 4 $ 11        
Amortized Cost Basis 4 11        
Fair Value $ 4 $ 11        
Recurring | Agency securities | Internal model | Yield %            
Liabilities:            
Financial instruments, measurement input 0.0239 0.0260        
Recurring | Agency securities | Internal model | Remaining Maturity/Duration (years)            
Liabilities:            
Financial instruments, measurement input 0.38 0.58        
Recurring | Equity securities            
Assets:            
Amortized Cost Basis $ 12,132 $ 19,511        
Fair Value 11,738 18,575        
Recurring | Total mortgage loan receivables held for investment, net, at amortized cost            
Assets:            
Principal Amount   1,596,277        
Amortized Cost Basis 1,920,588 1,591,322        
Fair Value 1,910,180 1,575,911        
Recurring | Total mortgage loan receivables held for investment, net, at amortized cost | Discounted Cash Flow            
Liabilities:            
Allowance for credit losses $ (52,100) $ (52,300)        
Recurring | Total mortgage loan receivables held for investment, net, at amortized cost | Discounted Cash Flow | Yield %            
Liabilities:            
Financial instruments, measurement input 0.0816 0.0936        
Recurring | Total mortgage loan receivables held for investment, net, at amortized cost | Discounted Cash Flow | Remaining Maturity/Duration (years)            
Liabilities:            
Financial instruments, measurement input 1.53 0.86        
Recurring | Mortgage loan  receivables held for sale            
Assets:            
Principal Amount $ 31,350 $ 31,350        
Amortized Cost Basis 27,970 26,898        
Fair Value $ 27,970 $ 26,898        
Recurring | Mortgage loan  receivables held for sale | Internal model, third-party inputs | Yield %            
Liabilities:            
Financial instruments, measurement input 0.0457 0.0457        
Recurring | Mortgage loan  receivables held for sale | Internal model, third-party inputs | Remaining Maturity/Duration (years)            
Liabilities:            
Financial instruments, measurement input 6.44 7.18        
Recurring | Nonhedge derivatives            
Assets:            
Non Hedge derivatives $ 112,500 $ 90,000        
Amortized Cost Basis 284 437        
Fair Value $ 284 $ 437        
Recurring | Nonhedge derivatives | Counterparty quotations | Remaining Maturity/Duration (years)            
Liabilities:            
Financial instruments, measurement input 0.26 0.62        
Recurring | Repurchase agreements - short-term            
Liabilities:            
Principal Amount $ 361,638 $ 62,738        
Amortized Cost Basis/Purchase Price 361,638 62,738        
Fair Value $ 361,638 $ 62,738        
Recurring | Repurchase agreements - short-term | Cost plus Accrued Interest | Yield %            
Liabilities:            
Financial instruments, measurement input 0.0469 0.0655        
Recurring | Repurchase agreements - short-term | Cost plus Accrued Interest | Remaining Maturity/Duration (years)            
Liabilities:            
Financial instruments, measurement input 0.05 0.74        
Recurring | Unsecured Revolving Credit Facility            
Liabilities:            
Principal Amount $ 20,000          
Amortized Cost Basis/Purchase Price 20,000          
Fair Value $ 20,000          
Recurring | Unsecured Revolving Credit Facility | Yield %            
Liabilities:            
Financial instruments, measurement input 0.0537          
Recurring | Unsecured Revolving Credit Facility | Remaining Maturity/Duration (years)            
Liabilities:            
Financial instruments, measurement input 3.22          
Recurring | Mortgage loan financing            
Liabilities:            
Principal Amount $ 399,092 $ 443,733        
Amortized Cost Basis/Purchase Price 401,656 446,397        
Fair Value $ 397,990 $ 435,048        
Recurring | Mortgage loan financing | Discounted Cash Flow | Yield %            
Liabilities:            
Financial instruments, measurement input 0.0618 0.0609        
Recurring | Mortgage loan financing | Discounted Cash Flow | Remaining Maturity/Duration (years)            
Liabilities:            
Financial instruments, measurement input 3.37 3.36        
Recurring | CLO debt            
Liabilities:            
Principal Amount   $ 601,464        
Amortized Cost Basis/Purchase Price   601,380        
Fair Value   $ 601,430        
Recurring | CLO debt | Discounted Cash Flow | Yield %            
Liabilities:            
Financial instruments, measurement input   0.0201        
Recurring | CLO debt | Discounted Cash Flow | Remaining Maturity/Duration (years)            
Liabilities:            
Financial instruments, measurement input   0.98        
Recurring | Senior unsecured notes            
Liabilities:            
Principal Amount $ 2,233,409 $ 2,041,557        
Amortized Cost Basis/Purchase Price 2,213,938 2,025,053        
Fair Value $ 2,254,223 $ 2,001,207        
Recurring | Senior unsecured notes | Internal model | Yield %            
Liabilities:            
Financial instruments, measurement input 0.0529 0.0522        
Recurring | Senior unsecured notes | Internal model | Remaining Maturity/Duration (years)            
Liabilities:            
Financial instruments, measurement input 3.79 3.72        
v3.25.3
FAIR VALUE OF FINANCIAL INSTRUMENTS - Financial Assets and Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Jun. 30, 2025
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Assets:            
Fair value of assets $ 1,947,042   $ 1,611,903      
Liabilities:            
Fair value of liabilities 3,033,851   3,100,423      
Allowance for credit losses (52,135) $ (52,166) (52,323) $ (52,276) $ (54,107) $ (43,165)
Repurchase agreements - short-term            
Liabilities:            
Principal Amount 361,638   62,738      
Fair value of liabilities 361,638   62,738      
Unsecured Revolving Credit Facility            
Liabilities:            
Principal Amount 20,000          
Fair value of liabilities 20,000          
Mortgage loan financing            
Liabilities:            
Principal Amount 399,092   443,733      
Fair value of liabilities 397,990   435,048      
CLO debt            
Liabilities:            
Principal Amount     601,464      
Fair value of liabilities     601,430      
Senior unsecured notes            
Liabilities:            
Principal Amount 2,233,409   2,041,557      
Fair value of liabilities 2,254,223   2,001,207      
CMBS            
Assets:            
Principal Amount 8,951   9,142      
Fair value of assets 8,759   8,887      
CMBS interest-only            
Assets:            
Principal Amount 7,996   8,187      
Fair value of assets 133   207      
Total mortgage loan receivables held for investment, net, at amortized cost            
Assets:            
Principal Amount 1,931,210   1,596,277      
Fair value of assets 1,910,180   1,575,911      
Mortgage loan  receivables held for sale            
Assets:            
Principal Amount 31,350   31,350      
Fair value of assets 27,970   26,898      
Level 1            
Assets:            
Fair value of assets 0   0      
Liabilities:            
Fair value of liabilities 0   0      
Level 1 | Repurchase agreements - short-term            
Liabilities:            
Fair value of liabilities 0   0      
Level 1 | Unsecured Revolving Credit Facility            
Liabilities:            
Fair value of liabilities 0          
Level 1 | Mortgage loan financing            
Liabilities:            
Fair value of liabilities 0   0      
Level 1 | CLO debt            
Liabilities:            
Fair value of liabilities     0      
Level 1 | Senior unsecured notes            
Liabilities:            
Fair value of liabilities 0   0      
Level 1 | CMBS            
Assets:            
Fair value of assets 0   0      
Level 1 | CMBS interest-only            
Assets:            
Fair value of assets 0   0      
Level 1 | Total mortgage loan receivables held for investment, net, at amortized cost            
Assets:            
Fair value of assets 0   0      
Level 1 | Mortgage loan  receivables held for sale            
Assets:            
Fair value of assets 0   0      
Level 2            
Assets:            
Fair value of assets 8,892   9,094      
Liabilities:            
Fair value of liabilities 2,615,861   2,665,375      
Level 2 | Repurchase agreements - short-term            
Liabilities:            
Fair value of liabilities 361,638   62,738      
Level 2 | Unsecured Revolving Credit Facility            
Liabilities:            
Fair value of liabilities 0          
Level 2 | Mortgage loan financing            
Liabilities:            
Fair value of liabilities 0   0      
Level 2 | CLO debt            
Liabilities:            
Fair value of liabilities     601,430      
Level 2 | Senior unsecured notes            
Liabilities:            
Fair value of liabilities 2,254,223   2,001,207      
Level 2 | CMBS            
Assets:            
Fair value of assets 8,759   8,887      
Level 2 | CMBS interest-only            
Assets:            
Fair value of assets 133   207      
Level 2 | Total mortgage loan receivables held for investment, net, at amortized cost            
Assets:            
Fair value of assets 0   0      
Level 2 | Mortgage loan  receivables held for sale            
Assets:            
Fair value of assets 0   0      
Level 3            
Assets:            
Fair value of assets 1,938,150   1,602,809      
Liabilities:            
Fair value of liabilities 417,990   435,048      
Level 3 | Repurchase agreements - short-term            
Liabilities:            
Fair value of liabilities 0   0      
Level 3 | Unsecured Revolving Credit Facility            
Liabilities:            
Fair value of liabilities 20,000          
Level 3 | Mortgage loan financing            
Liabilities:            
Fair value of liabilities 397,990   435,048      
Level 3 | CLO debt            
Liabilities:            
Fair value of liabilities     0      
Level 3 | Senior unsecured notes            
Liabilities:            
Fair value of liabilities 0   0      
Level 3 | CMBS            
Assets:            
Fair value of assets 0   0      
Level 3 | CMBS interest-only            
Assets:            
Fair value of assets 0   0      
Level 3 | Total mortgage loan receivables held for investment, net, at amortized cost            
Assets:            
Fair value of assets 1,910,180   1,575,911      
Level 3 | Mortgage loan  receivables held for sale            
Assets:            
Fair value of assets 27,970   26,898      
Recurring            
Assets:            
Fair value of assets 1,931,959   1,072,201      
Recurring | CMBS interest-only            
Assets:            
Principal Amount 347,761   769,724      
Recurring | Total mortgage loan receivables held for investment, net, at amortized cost            
Assets:            
Principal Amount     1,596,277      
Recurring | Total mortgage loan receivables held for investment, net, at amortized cost | Discounted Cash Flow            
Liabilities:            
Allowance for credit losses (52,100)   (52,300)      
Recurring | CMBS            
Assets:            
Principal Amount 1,922,777   1,056,844      
Fair value of assets 1,918,096   1,049,986      
Recurring | CMBS interest-only            
Assets:            
Principal Amount 339,765   761,537      
Fair value of assets 1,621   3,037      
Recurring | GNMA interest-only            
Assets:            
Principal Amount 29,509   32,710      
Fair value of assets 216   155      
Recurring | Agency securities            
Assets:            
Principal Amount 4   11      
Fair value of assets 4   11      
Recurring | Equity securities            
Assets:            
Fair value of assets 11,738   18,575      
Recurring | Nonhedge derivatives            
Assets:            
Principal Amount 112,500   90,000      
Fair value of assets 284   437      
Recurring | Level 1            
Assets:            
Fair value of assets 12,022   18,575      
Recurring | Level 1 | CMBS            
Assets:            
Fair value of assets 0   0      
Recurring | Level 1 | CMBS interest-only            
Assets:            
Fair value of assets 0   0      
Recurring | Level 1 | GNMA interest-only            
Assets:            
Fair value of assets 0   0      
Recurring | Level 1 | Agency securities            
Assets:            
Fair value of assets 0   0      
Recurring | Level 1 | Equity securities            
Assets:            
Fair value of assets 11,738   18,575      
Recurring | Level 1 | Nonhedge derivatives            
Assets:            
Fair value of assets 284   0      
Recurring | Level 2            
Assets:            
Fair value of assets 1,919,937   1,053,626      
Recurring | Level 2 | CMBS            
Assets:            
Fair value of assets 1,918,096   1,049,986      
Recurring | Level 2 | CMBS interest-only            
Assets:            
Fair value of assets 1,621   3,037      
Recurring | Level 2 | GNMA interest-only            
Assets:            
Fair value of assets 216   155      
Recurring | Level 2 | Agency securities            
Assets:            
Fair value of assets 4   11      
Recurring | Level 2 | Equity securities            
Assets:            
Fair value of assets 0   0      
Recurring | Level 2 | Nonhedge derivatives            
Assets:            
Fair value of assets 0   437      
Recurring | Level 3            
Assets:            
Fair value of assets 0   0      
Recurring | Level 3 | CMBS            
Assets:            
Fair value of assets 0   0      
Recurring | Level 3 | CMBS interest-only            
Assets:            
Fair value of assets 0   0      
Recurring | Level 3 | GNMA interest-only            
Assets:            
Fair value of assets 0   0      
Recurring | Level 3 | Agency securities            
Assets:            
Fair value of assets 0   0      
Recurring | Level 3 | Equity securities            
Assets:            
Fair value of assets 0   0      
Recurring | Level 3 | Nonhedge derivatives            
Assets:            
Fair value of assets $ 0   $ 0      
v3.25.3
FAIR VALUE OF FINANCIAL INSTRUMENTS - Additional Information (Details) - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Fair Value Disclosures [Abstract]    
Fair value Level 3 financial instruments $ 0 $ 0
v3.25.3
INCOME TAXES (Details)
3 Months Ended 9 Months Ended
Jul. 04, 2025
Jul. 03, 2025
Sep. 30, 2025
USD ($)
subsidiary
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
subsidiary
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Income Tax Disclosure [Abstract]              
Income tax expense (benefit)     $ 1,000,000.0 $ 400,000 $ 2,100,000 $ 1,200,000  
Deferred tax liabilities     (6,300,000)   (6,300,000)   $ (4,600,000)
Deferred income tax expense (benefit)     (100,000) $ 500,000 1,700,000 $ 600,000  
Deferred tax asset related to capital losses     100,000   100,000    
Deferred tax assets related to interest expense limitation     $ 2,100,000   $ 2,100,000    
Number of subsidiary entities currently under an IRS audit for tax year 2020 | subsidiary     2   2    
Unrecognized tax benefits     $ 0   $ 0   $ 0
Effective income tax rate reconciliation deduction dividend percent 20.00%            
Effective income tax rate reconciliation deduction percent 25.00% 20.00%          
v3.25.3
RELATED PARTY TRANSACTIONS (Details)
9 Months Ended
Sep. 30, 2025
USD ($)
Related Party Transactions [Abstract]  
Related party relationships $ 0
v3.25.3
COMMITMENTS AND CONTINGENCIES - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Unfunded Loan Commitments          
Lease liabilities $ (14,895)   $ (14,895)    
Operating lease, right-of-use asset $ 14,000   $ 14,000    
Operating Lease, Liability, Statement of Financial Position [Extensible List] Other liabilities   Other liabilities    
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Other assets   Other assets    
Operating expenses $ 900 $ 500 $ 2,800 $ 1,600  
Treasury securities traded and not yet settled 0 $ (79,708) 0 $ (79,708)  
Provision for loan losses          
Unfunded Loan Commitments          
Unfunded commitments of mortgage loan receivables held for investment $ 76,000   $ 76,000   $ 34,600
Length of additional mortgage loan financing     3 years    
Unfunded commitments of mortgage loan receivables held for investment, additional funds     52.00%    
U.S. Treasury Securities Traded, Not Yet Settled          
Unfunded Loan Commitments          
Treasury securities traded and not yet settled         $ (10,000)
v3.25.3
COMMITMENTS AND CONTINGENCIES - Future Minimum Operating Lease Obligation (Details)
$ in Thousands
Sep. 30, 2025
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
2025 (last three months) $ 873
2026 2,597
2027 2,232
2028 2,306
2029 2,409
Thereafter 8,629
Total undiscounted cash flows 19,046
Present value discount (4,151)
Lease liabilities $ 14,895
Weighted average incremental borrowing rate 6.59%
Remaining lease term 7 years 7 months 6 days
Extended lease term 5 years
v3.25.3
SEGMENT REPORTING - Additional Information (Details)
9 Months Ended
Sep. 30, 2025
segment
Segment Reporting [Abstract]  
Number of reportable segments 3
v3.25.3
SEGMENT REPORTING - Company's Performance Evaluation by Segment (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Net interest income          
Interest income $ 71,768 $ 96,092 $ 198,829 $ 280,520  
Interest expense (43,978) (57,676) (129,180) (170,647)  
Net interest income (expense) 27,790 38,416 69,649 109,873  
Release (addition) of provision for current expected credit loss, net 31 (3,063) 154 (13,886)  
Net interest income (expense) after provision for (release of) loan reserves 27,821 35,353 69,803 95,987  
Other income (loss)          
Real estate operating income 26,666 25,294 74,214 75,314  
Net result from mortgage loan receivables held for sale (377) 1,092 4,700 638  
Gain (loss) on real estate, net 0 315 3,807 12,858  
Fee and other income 3,864 6,609 11,952 13,947  
Net result from derivative transactions 21 (766) 1,870 3,871  
Earnings (loss) from investment in unconsolidated ventures (414) (14) (1,434) (11)  
Gain (loss) on extinguishment of debt (106) 20 151 197  
Total other income (loss) 29,654 32,550 95,260 106,814  
Costs and expenses          
Compensation and employee benefits (11,552) (14,407) (41,874) (48,917)  
Operating expenses (5,276) (4,508) (14,559) (14,331)  
Real estate operating expenses (11,424) (10,751) (30,456) (30,930)  
Investment related expenses (855) (1,628) (2,887) (5,909)  
Depreciation and amortization (8,238) (8,146) (23,617) (24,861)  
Total costs and expenses (37,345) (39,440) (113,393) (124,948)  
Income (loss) before taxes 20,130 28,463 51,670 77,853  
Income tax (expense) benefit (960) (901) (3,836) (1,737)  
Net income (loss) 19,170 27,562 47,834 76,116  
Total assets 4,686,544 4,845,073 4,686,544 4,845,073 $ 4,845,073 [1]
Investment in unconsolidated ventures 18,489   18,489   19,923 [1]
Operating Segment | Loans          
Net interest income          
Interest income 42,549 63,799 112,780 201,233  
Interest expense (766) (21,718) (14,154) (77,159)  
Net interest income (expense) 41,783 42,081 98,626 124,074  
Release (addition) of provision for current expected credit loss, net 31 (3,063) 154 (13,886)  
Net interest income (expense) after provision for (release of) loan reserves 41,814 39,018 98,780 110,188  
Other income (loss)          
Real estate operating income 0 0 0 0  
Net result from mortgage loan receivables held for sale (377) 1,143 4,700 3,308  
Gain (loss) on real estate, net   0 0 0  
Fee and other income 1,667 6,499 7,147 12,195  
Net result from derivative transactions 0 (249) 1,301 185  
Earnings (loss) from investment in unconsolidated ventures 0 0 0 0  
Gain (loss) on extinguishment of debt 0 0 0 0  
Total other income (loss) 1,290 7,393 13,148 15,688  
Costs and expenses          
Compensation and employee benefits 0 0 0 0  
Operating expenses 0 0 0 0  
Real estate operating expenses 0 0 0 0  
Investment related expenses (643) (691) (1,376) (3,910)  
Depreciation and amortization 0 0 0 0  
Total costs and expenses (643) (691) (1,376) (3,910)  
Income (loss) before taxes 42,461 45,720 110,552 121,966  
Income tax (expense) benefit 0 0 0 0  
Net income (loss) 42,461 45,720 110,552 121,966  
Total assets 1,896,423 1,565,897 1,896,423 1,565,897  
Operating Segment | Securities          
Net interest income          
Interest income 28,272 11,727 71,497 27,670  
Interest expense (4,267) (4) (5,299) (61)  
Net interest income (expense) 24,005 11,723 66,198 27,609  
Release (addition) of provision for current expected credit loss, net 0 0 0 0  
Net interest income (expense) after provision for (release of) loan reserves 24,005 11,723 66,198 27,609  
Other income (loss)          
Real estate operating income 0 0 0 0  
Net result from mortgage loan receivables held for sale 0 0 0 0  
Gain (loss) on real estate, net   0 0 0  
Fee and other income 2,150 17 4,740 100  
Net result from derivative transactions 0 0 0 80  
Earnings (loss) from investment in unconsolidated ventures 0 0 0 0  
Gain (loss) on extinguishment of debt 0 0 0 0  
Total other income (loss) 2,150 17 4,740 180  
Costs and expenses          
Compensation and employee benefits 0 0 0 0  
Operating expenses 0 0 0 0  
Real estate operating expenses 0 0 0 0  
Investment related expenses (3) (45) (170) (138)  
Depreciation and amortization 0 0 0 0  
Total costs and expenses (3) (45) (170) (138)  
Income (loss) before taxes 26,152 11,695 70,768 27,651  
Income tax (expense) benefit 0 0 0 0  
Net income (loss) 26,152 11,695 70,768 27,651  
Total assets 1,940,547 1,080,839 1,940,547 1,080,839  
Operating Segment | Real Estate          
Net interest income          
Interest income 39 86 238 268  
Interest expense (6,334) (7,945) (19,578) (24,567)  
Net interest income (expense) (6,295) (7,859) (19,340) (24,299)  
Release (addition) of provision for current expected credit loss, net 0 0 0 0  
Net interest income (expense) after provision for (release of) loan reserves (6,295) (7,859) (19,340) (24,299)  
Other income (loss)          
Real estate operating income 26,666 25,294 74,214 75,314  
Net result from mortgage loan receivables held for sale 0 0 0 0  
Gain (loss) on real estate, net   315 3,807 12,858  
Fee and other income 47 25 65 1,352  
Net result from derivative transactions (16) (168) 55 38  
Earnings (loss) from investment in unconsolidated ventures (414) (14) (1,434) (11)  
Gain (loss) on extinguishment of debt 0 0 0 0  
Total other income (loss) 26,283 25,452 76,707 89,551  
Costs and expenses          
Compensation and employee benefits 0 0 0 0  
Operating expenses 0 0 0 0  
Real estate operating expenses (11,424) (10,751) (30,456) (30,930)  
Investment related expenses (132) (97) (324) (449)  
Depreciation and amortization (8,124) (8,036) (23,286) (24,532)  
Total costs and expenses (19,680) (18,884) (54,066) (55,911)  
Income (loss) before taxes 308 (1,291) 3,301 9,341  
Income tax (expense) benefit 0 0 0 0  
Net income (loss) 308 (1,291) 3,301 9,341  
Total assets 724,000 690,726 724,000 690,726  
Investment in unconsolidated ventures 18,500   18,500   19,900
Corporate/Other          
Net interest income          
Interest income 908 20,480 14,315 51,349  
Interest expense (32,611) (28,009) (90,149) (68,860)  
Net interest income (expense) (31,703) (7,529) (75,834) (17,511)  
Release (addition) of provision for current expected credit loss, net 0 0 0 0  
Net interest income (expense) after provision for (release of) loan reserves (31,703) (7,529) (75,834) (17,511)  
Other income (loss)          
Real estate operating income 0 0 0 0  
Net result from mortgage loan receivables held for sale 0 (51) 0 (2,670)  
Gain (loss) on real estate, net   0 0 0  
Fee and other income 0 68 0 300  
Net result from derivative transactions 37 (349) 514 3,568  
Earnings (loss) from investment in unconsolidated ventures 0 0 0 0  
Gain (loss) on extinguishment of debt (106) 20 151 197  
Total other income (loss) (69) (312) 665 1,395  
Costs and expenses          
Compensation and employee benefits (11,552) (14,407) (41,874) (48,917)  
Operating expenses (5,276) (4,508) (14,559) (14,331)  
Real estate operating expenses 0 0 0 0  
Investment related expenses (77) (795) (1,017) (1,412)  
Depreciation and amortization (114) (110) (331) (329)  
Total costs and expenses (17,019) (19,820) (57,781) (64,989)  
Income (loss) before taxes (48,791) (27,661) (132,950) (81,105)  
Income tax (expense) benefit (960) (901) (3,836) (1,737)  
Net income (loss) (49,751) (28,562) (136,786) (82,842)  
Total assets 125,574 $ 1,507,611 125,574 $ 1,507,611  
Corporate/Other | Senior Unsecured Notes          
Costs and expenses          
Senior notes $ 2,200,000   $ 2,200,000   $ 2,000,000
[1] Includes amounts relating to consolidated variable interest entities. Refer to Note 2 and Note 6.